{"questionType": "单选题", "questionId": "dev_1", "questionText": "收集用药清单，整理医嘱，发现不适当用药并建议调整治疗方案的过程称为", "option": ["A.处方审核", "B.药物评价", "C.药物重整", "D.药物等效性评价", "E.药品综合评价"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_2", "questionText": "患者多年前曾用过心得安，现到药店购买此药，药师应提供的药品是", "option": ["A.普萘洛尔", "B.硝苯地平", "C.硝酸异山梨酯", "D.维拉帕米", "E.美西律"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_3", "questionText": "要求“冷处”贮存的药品，贮存的温度应该是", "option": ["A.10°C~30°C", "B.不超过 20°C", "C.2°C~10°C", "D.0°C", "E.-10°C"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_4", "questionText": "规格为 25mg 的片剂，处方上用法为 25 mg tid，药师粘贴用法标签时正确的写法是", "option": ["A.每日 3 次，每次 0.5 片", "B.每日 3 次，每次 1 片", "C.每日 2 次，每次 1 片", "D.每日 2 次，每次 2 片", "E.每日 1 次，每次 1 片"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_5", "questionText": "药品说明书中提及“两种药物在吸收过程中，会发生相互影响，不能同时服药”，但没有 明示服药间隔时间，通常建议的间隔时间是", "option": ["A.0.5 小时", "B.1 小时", "C.2 小时", "D.3 小时", "E.4 小时"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_6", "questionText": "根据时辰规律给药有助于提高疗效、减少不良反应。下列药物中宜在清晨给药的是", "option": ["A.氟西汀", "B.辛伐他汀", "C.氯苯那敏", "D.比沙可啶", "E.艾司唑仑"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_7", "questionText": "服用时需限制饮水的药物是", "option": ["A.止咳糖浆", "B.二羟丙茶碱", "C.熊去氧胆酸", "D.利托那韦", "E.阿仑膦酸钠"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_8", "questionText": "患者，女，52 岁，诊断为缺铁性贫血，医师给予硫酸亚铁片 0.3g tid 治疗，该药物的主 要不良反应是", "option": ["A.心动过速", "B.头晕", "C.胃肠道不适", "D.肌肉酸痛", "E.尿频尿急"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_9", "questionText": "\"患者，男，66 岁，2 型糖尿病，长期口服二甲双胍，格列美脲。近日查空腹血糖 12.3mmol/L， 糖化血红蛋白 9.0%，主诊医师加用“甘精胰岛素每日 1 次+门冬胰岛素每日 3 次\"\"，关于该患 者药物治疗方案的说法，正确的是\"", "option": ["A.门冬胰岛素应在三餐前 30 分钟皮下注射", "B.因采用一日多次胰岛素治疗，格列美脲应停用", "C.患者为 2 型糖尿病，加用胰岛素一日 4 次方案不适宜", "D.甘精胰岛素应避免与二甲双胍联合使用", "E.因采用一日多次胰岛素治疗，二甲双胍应停用"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_10", "questionText": "关于哺乳期妇女用药安全的说法，正确的是（", "option": ["A.口服避孕药可分泌至乳汁中，降低乳汁中吡哆醇含量，哺乳期应禁用", "B.依那普利可分泌至乳汁中，因含巯基可引起乳儿骨髓抑制，哺乳期应避免使用", "C.头孢呋辛易分泌至乳汁中，哺乳期不宜使用", "D.阿奇霉素很少分泌至乳汁中哺乳期可以使用", "E.青霉素 G 极易分泌至乳汁中，哺乳期不宜使用"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_11", "questionText": "患者，男，41 岁，因甲状腺功能亢进症，服用甲巯咪唑治疗 5 个月，目前剂量是 10mg qd， 今日查血常规：白细胞 1.50×109/L（成人正常参考值为 4×109/L~10×109/L），中性粒细胞 0.5×109/L（成人正常参考值为 1.8×109/L~6.3×109/L）。根据血常规检查结果，关于该患 者用药方案调整的说法，正确的是", "option": ["A.将甲巯咪唑减量至每日 5mg", "B.将甲巯咪唑减量至每日 5mg，并加用粒细胞集落刺激因子", "C.停用甲巯咪唑，严密观察，必要时加用粒细胞集落刺激因子", "D.停用甲巯咪唑，改为丙硫氧嘧啶 50mg tid", "E.停用抗甲状腺药，立即手术治疗"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_12", "questionText": "患者因关节疼痛就诊，诊断为骨性关节炎，有磺胺类药物过敏史，该患者禁用的止痛药是", "option": ["A.萘普生", "B.布洛芬", "C.对乙酰氨基酚", "D.塞来昔布", "E.美洛昔康"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_13", "questionText": "治疗肠易激综合征（腹泻型）的药物中，应避免睡前服用的是", "option": ["A.匹维溴铵", "B.曲美布汀", "C.洛哌丁胺", "D.复方地芬诺酯", "E.蒙脱石散"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_14", "questionText": "在巨幼细胞贫血的治疗中，为避免加重神经系统损害，应与叶酸联合应用的药（", "option": ["A.维生素 B1", "B.维生素 B12", "C.维生素 B", "D.维生素 K1", "E.维生素 C"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_15", "questionText": "患者，男，36 岁，肥胖，2 型糖尿病，肝肾功能正常，在饮食和运动管理基础上长期服用 二甲双胍 2g/d，血糖控制不理想。为控制血糖，且不增加患者体重可加用的降糖药物是", "option": ["A.格列喹酮", "B.瑞格列奈", "C.利拉鲁肽", "D.胰岛素", "E.罗格列酮"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_16", "questionText": "关于胃食管反流病治疗方案的说法，错误的是", "option": ["A.存在夜间酸突破时，可以加用法莫替丁 20mg bid", "B.一种 PPI 无效时，可以换用另一种 PPI", "C.标准剂量 PPI 无效时，可改为 2 倍标准剂量", "D.PPI 单用疗效不佳时，可以加用莫沙必利", "E.存在胆汁反流时，可以加用铝碳酸镁咀嚼片"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_17", "questionText": "患者，男，23 岁，因近日脚趾间瘙痒、有明显脱皮就诊，诊断为足癣。关于该患者用药 指导和健康教育的说法，错误的是", "option": ["A.应注意保持鞋袜、足部清洁干燥", "B.不与他人共用生活物品，如指甲刀、拖鞋等，以免交叉传染", "C.可使用咪康唑、酮康唑或特比奈芬等局部抗真菌药治疗", "D.使用局部抗真菌药，症状消失 1~2 天后即可停药", "E.在局部用药期间，用温水清洗患处皮肤，尽量少用或不用肥皂"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_18", "questionText": "关于前列腺增生症药物治疗的说法，错误的是", "option": ["A.a 受体阻断剂可快速起效", "B.M 受体阻断剂可减少残余尿量", "C.5a 还原酶抑制剂可缩小前列腺体积", "D.5a 还原酶抑制剂可使血清前列腺特异性抗原（PSA）水平降低约 50%", "E.5a 还原酶抑制剂可长期使用"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_19", "questionText": "患者，男，53 岁，近日体检发现高血压，血压 170/95mmHg，化验显示：肝肾功能正常，血尿酸 535μmol/L。该患者不宣选用的降压药是官方网站:www.youlu.com - 8 - - 8 - 血尿酸 535μmol/L。该患者不宣选用的降压药是", "option": ["A.氨氯地平", "B.依那普利", "C.特拉唑嗪", "D.氢氯噻嗪", "E.氯沙坦钾"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_20", "questionText": "关于β受体阻断剂用于冠状动脉粥样硬化性心脏病治疗的说法，错误的是", "option": ["A.可减少心绞痛发作，提高运动耐量", "B.应作为稳定型心绞痛的初始治疗药物", "C.使用剂量应个体化", "D.是变异型心绞痛的首选治疗药物", "E.支气管哮喘急性发作期禁用"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_21", "questionText": "在妊娠期不同阶段，药物对胎儿的影响不同。妊娠期用药时极少观察到致畸作用的时间段 是", "option": ["A.妊娠 4～8 周", "B.妊娠 8~12 周", "C.受精后 2 周内", "D.妊娠 13～20 周", "E.妊娠 21-28 周"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_22", "questionText": "下列治疗心力衰竭的药物中，不能延缓心肌重构的是", "option": ["A.依那普利", "B.呋塞米", "C.坎地沙坦", "D.美托洛尔", "E.螺内酯"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_23", "questionText": "患者，女，14 岁，诊断为原发性痛经。该患者宜优先采用的治疗方案是", "option": ["A.服用非甾体抗炎药", "B.性激素周期疗法", "C.扩张宫颈，以利经血流出", "D.雄激素周期疗法", "E.服用弱阿片类药物"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_24", "questionText": "患者，女，37 岁，体检发现 Hb56g/L，拟静脉补铁，可选用的药物是", "option": ["A.硫酸亚铁", "B.多糖铁复合物", "C.蔗糖铁", "D.葡萄糖酸亚铁", "E.琥珀酸亚铁"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_25", "questionText": "关于药物在肝功能不全患者药动学和药效学变化的说法，错误的是", "option": ["A.主要在肝内代谢清除的药物，生物利用度提高", "B.需要肝脏生物转化的前体药物，药效降低", "C.蛋白结合率高的药物，血中游离药物浓度增加", "D.首过消除明显的药物，药理作用维持时间缩短", "E.血胆汁酸和胆红素升高，血浆蛋白与药物结合的能力下降"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_26", "questionText": "患者，男，45 岁。1 月前因突发右侧肢体无力、言语障碍就诊，诊断为缺血性脑卒中，现 服用阿托伐他汀钙片，每晚 1 次，每次 20mg，该患者 LDL-C 的控制目标值是", "option": ["A.<1.8mmol/L", "B.<4.4mmol/l", "C.<34mmol/L", "D.<2.6mmol/l", "E.<1.0mmol/L"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_27", "questionText": "患者，男，41 岁，BMI30.2kg/m2，因上腹胀 1 年就诊，常年饮酒（酒精量 10d）腹部 B 超 显示：脂肪肝。生化检查：ALT100U/L，AST210U/L，y-GGT130U/L TG3.3mmol/L，血糖正常， 肝炎病毒相关检查（-），关于该患者疾病管理的说法，错误的是", "option": ["A.定期复查肝功能和腹部 B 超", "B.高蛋白、低脂饮食", "C.减轻体重", "D.使用依折麦布调节血脂", "E.戒酒"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_28", "questionText": "患者，男，50 岁，主诉咳嗽、咳白痰 3 天，查体：体温 36.9℃，呼吸 20 次/min，不吸氧 的情况下，指氧饱和度为 98%。血常规正常，经胸部 X 线检查，诊断为急性支气管炎。该患 者宜选用的药物是", "option": ["A.莫西沙星", "B.氨溴索", "C.阿莫西林", "D.阿奇霉素", "E.利巴韦林"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_29", "questionText": "患者，女，65 岁，有反复发作的胃溃疡史多年，1 月前行冠脉支架植入术（PCl），口服 阿司匹林和氯吡格雷，近日胃溃疡发作，除停用阿司匹林外，应避免选用的治疗药物是", "option": ["A.奥美拉唑", "B.泮托拉唑", "C.雷贝拉唑", "D.硫糖铝", "E.枸橼酸铋钾"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_30", "questionText": "因半衰期较长，无需强调晚间或睡前服用的药物是", "option": ["A.瑞舒伐他汀", "B.辛伐他汀", "C.洛伐他汀", "D.普伐他汀", "E.氟伐他汀"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_31", "questionText": "患者，男，65 岁，COPD20 余年。近 1 年因肺部感染、COPD 急性加重先后住院 4 次。现再 次出现咳黄痰，喘憋，FEV1 25%。对于该患者使用抗菌药物治疗的建议，错误的是", "option": ["A.头孢他啶+左氧氟沙星", "B.头孢吡肟+环丙沙星", "C.亚胺培南西司他汀", "D.头孢呋辛+阿奇霉素", "E.头孢哌酮舒巴坦+环丙沙星"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_32", "questionText": "下列药物服用方法正确的是", "option": ["A.呋塞米，睡前服用", "B.多潘立酮，餐前服用", "C.奥利司他，空腹服用", "D.阿卡波糖，餐后服用", "E.阿仑磷酸钠，餐后服用"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_33", "questionText": "类风湿关节炎一经确诊，应尽早使用改善病情的抗风湿药（DMARDs）治疗，首选的药物是", "option": ["A.柳氨磺吡啶", "B.来氟米特", "C.甲氨蝶呤", "D.环磷酰胺", "E.环孢素"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_34", "questionText": "患者，男，46 岁，因支气管哮喘使用布地奈德-福莫特罗粉吸入剂治疗，症状控制良好， 4 个月内无急性发作，拟进行降级治疗。关于哮喘降级治疗原则的说法，错误的是", "option": ["A.以最低剂量的福莫特罗维持治疗，直到最终停药", "B.降级治疗应选择适当时机，需避开患者呼吸道感染等情况", "C.首先减少激素剂量，再减少使用频率", "D.通常每 3 个月减少布地奈德剂量 25%-50%", "E.每一次降级治疗都需要密切观察病情变化，按期随访"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_35", "questionText": "患者，女，16 岁，因尿频和尿痛 1 天就诊，查体：体温 37.2℃，耻骨上有轻度压痛。尿 常规示：白细胞 500/ul，临床考虑急性膀胱炎。患者既往有青霉素过敏史。关于该患者的治 疗策略和用药注意事项的说法，错误的是", "option": ["A.可经验性用药，用药前送检尿培养", "B.可使用血药浓度和尿药浓度均较高的左氧氟沙星", "C.用药 3 天，多数患者可治愈", "D.治疗 3 天症状无改善，应根据尿培养药敏结果调整用药", "E.停药 7 天后复查尿培养，以明确是否治愈"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_36", "questionText": "患者，男，66 岁，身高 176cm，体重 79kg，BMI25.5kg/m2，腰围 88cm，高血压病史 3 年， 规律服药，血压控制良好，有冠心病和糖尿病家族史。该患者目前的营养状况和应采取的措 施是", "option": ["A.肥胖，首选控制饮食和增加运动", "B.超重，首选控制饮食和增加运动", "C.腹型肥胖，首选药物辅助减重", "D.超重，首选药物辅助减重", "E.体重正常，应控制体重，不可超过 81kg"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_37", "questionText": "在房颤治疗中，关于控制心室率常用药物用法用量的说法，错误的是", "option": ["A.比索洛尔片，每次 5mg，每日 2 次，口服", "B.酒石酸美托洛尔片，每次 25mg，每日 2 次，口服", "C.琥珀酸美托洛尔缓释片，每次 47.5mg，每日 1 次，口服", "D.卡维地洛片，每次 25mg，每日 2 次，口服", "E.胺碘酮胶囊，每次 100mg，每日 1 次，口服"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_38", "questionText": "患者，女，26 岁，因上腹痛就诊，胃镜显示胃溃疡，13C 呼气试验结果为阳性，青霉素皮 试阴性，医师开具阿莫西林、克拉霉素、奥美拉唑和枸橼酸铋钾 4 种药物，关于两种抗菌药 物服用时间的说法，正确的是", "option": ["A.二者均饭后服用，提高胃内药物浓度", "B.二者均饭前服用，避免食物影响吸收", "C.二者均饭前服用，减少胃酸对药物破坏", "D.阿莫西林饭前服用吸收好，克拉霉素饭后服用对胃刺激小。", "E.二者均饭后服用减轻对胃部刺激"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_39", "questionText": "患者，男，47 岁，肾移植术后，抗排异治疗，不应选用的药物是", "option": ["A.环孢素", "B.他克莫司", "C.吗替麦考酚酯", "D.伏立康唑", "E.糖皮质激素"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_40", "questionText": "关于单纯疱疹病毒（HSV）感染的说法，错误的是", "option": ["A.对生殖器 HSV 感染的产妇，宜行剖宫产，以避免分娩时感染胎儿", "B.使用安全套是降低生殖器 HSV-2 传播风险的有效手段", "C.HSV 感染与癌症发病相关", "D.HSV 可潜伏在人体多种器官内", "E.可接种 HSV 疫苗进行预防"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_41", "questionText": "患者，男，36 岁，近期因看电脑时间过长出现眼睛干涩、酸困等症状，该患者适宜选用官方网站:www.youlu.com - 17 - - 17 - 药物是", "option": ["A.左氧氟沙星滴眼液", "B.毛果芸香碱滴眼液", "C.玻璃酸钠滴眼液", "D.色甘酸钠滴眼液", "E.阿昔洛韦滴眼液"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_42", "questionText": "患者，男，43 岁，有季节性过敏性结膜炎，该患者适宜选用药物是", "option": ["A.左氧氟沙星滴眼液", "B.毛果芸香碱滴眼液", "C.玻璃酸钠滴眼液", "D.色甘酸钠滴眼液", "E.阿昔洛韦滴眼液"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_43", "questionText": "患者，男，28 岁，游泳后回到家中，发现眼睛出现瘙痒、异物感，并有黄色黏液性分泌 物，该患者适宜选用药物是", "option": ["A.左氧氟沙星滴眼液", "B.毛果芸香碱滴眼液", "C.玻璃酸钠滴眼液", "D.色甘酸钠滴眼液", "E.阿昔洛韦滴眼液"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_44", "questionText": "患者咳嗽，但无感染证据，给予阿奇霉素口服，属于", "option": ["A.有用药禁忌", "B.无适应证用药", "C.重复用药", "D.无明确指征联合用药", "E.无正当理由超说明书用药"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_45", "questionText": "患者因高血压同时服用厄贝沙坦和缬沙坦，属于", "option": ["A.有用药禁忌", "B.无适应证用药", "C.重复用药", "D.无明确指征联合用药", "E.无正当理由超说明书用药"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_46", "questionText": "可使大便颜色变黑的药物是", "option": ["A.硫酸亚铁", "B.维生素 C", "C.碳酸氢钠", "D.维生素 B", "E.叶酸"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_47", "questionText": "同时服用可减少铁剂吸收的药物是", "option": ["A.硫酸亚铁", "B.维生素 C", "C.碳酸氢钠", "D.维生素 B", "E.叶酸"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_48", "questionText": "可与口服铁剂合用以促进铁吸收的药物是", "option": ["A.硫酸亚铁", "B.维生素 C", "C.碳酸氢钠", "D.维生素 B", "E.叶酸"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_49", "questionText": "适用绝经过渡期早期，调整卵巢功能衰退过程中出现的治疗方案是", "option": ["A.阴道局应用雌激素", "B.雌、孕激素序贯方案", "C.单孕激素补充方案", "D.单雌激素补充方案", "E.雌、孕激素连续联合方案"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_50", "questionText": "适用于已切除子宫的绝经期妇女的治疗方案是", "option": ["A.阴道局应用雌激素", "B.雌、孕激素序贯方案", "C.单孕激素补充方案", "D.单雌激素补充方案", "E.雌、孕激素连续联合方案"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_51", "questionText": "适用于有完整子宫、不希望有月经样出血的绝经期妇女的治疗方案是", "option": ["A.阴道局应用雌激素", "B.雌、孕激素序贯方案", "C.单孕激素补充方案", "D.单雌激素补充方案", "E.雌、孕激素连续联合方案"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_52", "questionText": "易引起直立性低血压的药物是", "option": ["A.多沙唑嗪", "B.赖诺普利", "C.羟考酮", "D.辛伐他汀", "E.氨氯地平"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_53", "questionText": "可能引起足踝部水肿的药物是", "option": ["A.多沙唑嗪", "B.赖诺普利", "C.羟考酮", "D.辛伐他汀", "E.氨氯地平"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_54", "questionText": "易引起便秘的药物是", "option": ["A.多沙唑嗪", "B.赖诺普利", "C.羟考酮", "D.辛伐他汀", "E.氨氯地平"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_55", "questionText": "高血压合并糖尿病患者，若无禁忌证，首选的降压药物是", "option": ["A.β受体阻断剂", "B.噻嗪类利尿剂", "C.a 受体阻断剂", "D.二氢吡啶类钙通道阻滞剂", "E.血管紧张素转换酶抑制剂"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_56", "questionText": "高血压合并前列腺增生患者，若血压控制欠佳，建议加用的药物是", "option": ["A.β受体阻断剂", "B.噻嗪类利尿剂", "C.a 受体阻断剂", "D.二氢吡啶类钙通道阻滞剂", "E.血管紧张素转换酶抑制剂"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_57", "questionText": "高血压合并糖尿病患者，为避免掩盖低血糖症状，应慎用的药物是", "option": ["A.β受体阻断剂", "B.噻嗪类利尿剂", "C.a 受体阻断剂", "D.二氢吡啶类钙通道阻滞剂", "E.血管紧张素转换酶抑制剂"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_58", "questionText": "服用辛伐他汀期间不宜食用的是", "option": ["A.绿叶蔬菜", "B.咖啡", "C.葡萄柚汁", "D.奶制品", "E.深海鱼油"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_59", "questionText": "长期服用糖皮质激素的患者宜多食用的是", "option": ["A.绿叶蔬菜", "B.咖啡", "C.葡萄柚汁", "D.奶制品", "E.深海鱼油"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_60", "questionText": "适用于急性期焦虑患者短期服用的药物是", "option": ["A.劳拉西泮", "B.美金刚", "C.多塞平", "D.多奈哌齐", "E.左乙拉西坦"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_61", "questionText": "育龄期女性癫痫病患者可酌情使用的药物是", "option": ["A.劳拉西泮", "B.美金刚", "C.多塞平", "D.多奈哌齐", "E.左乙拉西坦"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_62", "questionText": "可改善认知功能但有加重消化性溃疡风险的药物是", "option": ["A.劳拉西泮", "B.美金刚", "C.多塞平", "D.多奈哌齐", "E.左乙拉西坦"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_63", "questionText": "用于铜、汞、铅中毒解救，治疗肝豆状核变性病的药物是", "option": ["A.纳洛酮", "B.氟马西尼", "C.青霉胺", "D.乙酰半胱氨酸", "E.亚甲蓝"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_64", "questionText": "用于氰化物中毒解救的药物是", "option": ["A.纳洛酮", "B.氟马西尼", "C.青霉胺", "D.乙酰半胱氨酸", "E.亚甲蓝"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_65", "questionText": "用于苯二氮草类药物中毒解救的药物是", "option": ["A.纳洛酮", "B.氟马西尼", "C.青霉胺", "D.乙酰半胱氨酸", "E.亚甲蓝"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_66", "questionText": "属于时间依赖性且半衰期很短的抗菌药物是", "option": ["A.利奈唑胺", "B.莫西沙星", "C.阿奇霉素", "D.氟康唑", "E.氨苄西林"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_67", "questionText": "属于浓度依赖性的抗菌药物是", "option": ["A.利奈唑胺", "B.莫西沙星", "C.阿奇霉素", "D.氟康唑", "E.氨苄西林"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_68", "questionText": "可引起嗜睡，司机、高空作业或操作机器者慎用的药物是", "option": ["A.氨溴索", "B.对乙酰氨基酚", "C.右美沙芬", "D.喷托维林", "E.伪麻黄碱"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_69", "questionText": "患者，男，49 岁，平素体健，因感冒服药后出现血压升高，可能引起此的药物是", "option": ["A.氨溴索", "B.对乙酰氨基酚", "C.右美沙芬", "D.喷托维林", "E.伪麻黄碱"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_70", "questionText": "可迅速控制痛风急性期症状的药物是", "option": ["A.碳酸氢钠", "B.非布司他", "C.别嘌醇", "D.秋水仙碱", "E.氟溴马隆"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_71", "questionText": "患者用药前建议筛查 HLA-B*5801 基因，阳性者禁用的药物是", "option": ["A.碳酸氢钠", "B.非布司他", "C.别嘌醇", "D.秋水仙碱", "E.氟溴马隆"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_72", "questionText": "其神经毒性常累及感觉神经末梢的药物是", "option": ["A.奥沙利铂", "B.异环磷酰胺", "C.伊立替康", "D.丝裂霉素", "E.氟尿嘧啶"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_73", "questionText": "容易导致出血性膀胱炎的药物是(", "option": ["A.奥沙利铂", "B.异环磷酰胺", "C.伊立替康", "D.丝裂霉素", "E.氟尿嘧啶"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_74", "questionText": "治疗滴虫性阴道炎，应选用的药物是", "option": ["A.甲硝唑", "B.克林霉素", "C.克霉唑", "D.孕激素", "E.雌激素"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_75", "questionText": "改善泌尿生殖系统绝经综合征，首选的药物是", "option": ["A.甲硝唑", "B.克林霉素", "C.克霉唑", "D.孕激素", "E.雌激素"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_76", "questionText": "治疗外阴阴道假丝酵母菌病，应选用的药物是", "option": ["A.甲硝唑", "B.克林霉素", "C.克霉唑", "D.孕激素", "E.雌激素"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_77", "questionText": "可引起 Q-T 间期轻度延长的药物是", "option": ["A.兰索拉唑", "B.多潘立酮", "C.枸橼酸铋钾", "D.法莫替丁", "E.硫糖铝"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_78", "questionText": "长期服用可引起低磷血症的药物是", "option": ["A.兰索拉唑", "B.多潘立酮", "C.枸橼酸铋钾", "D.法莫替丁", "E.硫糖铝"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_79", "questionText": "能引起大便颜色变黑的药物是", "option": ["A.兰索拉唑", "B.多潘立酮", "C.枸橼酸铋钾", "D.法莫替丁", "E.硫糖铝"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_80", "questionText": "患儿，男，4 岁，因感冒出现鼻塞，可选用的治疗方案是", "option": ["A.口服氯苯那敏片", "B.口服头孢呋辛酯片", "C.生理盐水冲洗鼻腔", "D.口服伪麻黄碱缓释片", "E.口服对乙酰氨基酚片"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_81", "questionText": "患者，女，26 岁，孕 36 周，因感冒出现高热，体温 39.3℃，物理降温无效，可选用的治 疗方案是", "option": ["A.口服氯苯那敏片", "B.口服头孢呋辛酯片", "C.生理盐水冲洗鼻腔", "D.口服伪麻黄碱缓释片", "E.口服对乙酰氨基酚片"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_82", "questionText": "可快速而持久地缓解哮喘症状，但不宜长期单独使用的药物是", "option": ["A.福莫特罗", "B.布地奈德", "C.茶碱", "D.噻托溴铵", "E.沙丁胺醇"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_83", "questionText": "患者，男，58 岁，COPD 稳定期，接受吸入剂治疗后出现口干，可能引起这一反应的药物是", "option": ["A.福莫特罗", "B.布地奈德", "C.茶碱", "D.噻托溴铵", "E.沙丁胺醇"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_84", "questionText": "患者，女，55 岁，患有垂体瘤，泌乳素水平高，餐后上腹饱胀，恶心 2 周，禁用的药物 是", "option": ["A.艾司奥美拉唑", "B.铝碳酸镁", "C.法莫替丁", "D.复方消化酶", "E.多潘立酮"], "year": "2020", "answer": ["E"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_85", "questionText": "患者，男，67 岁，慢性胰腺炎，餐后上腹胀，进食油腻食物后明显，近 1 年体重明显下 降，大便中有油滴，宜选用的药物是", "option": ["A.艾司奥美拉唑", "B.铝碳酸镁", "C.法莫替丁", "D.复方消化酶", "E.多潘立酮"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_86", "questionText": "磺胺类药物过敏者应禁用的药物是", "option": ["A.环孢素", "B.羟氯喹", "C.柳氮磺吡啶", "D.甲氨蝶呤", "E.来氟米特"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_87", "questionText": "可引起齿龈增生和多毛的药物是", "option": ["A.环孢素", "B.羟氯喹", "C.柳氮磺吡啶", "D.甲氨蝶呤", "E.来氟米特"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_88", "questionText": "可引起视网膜变性的药物是", "option": ["A.环孢素", "B.羟氯喹", "C.柳氮磺吡啶", "D.甲氨蝶呤", "E.来氟米特"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_89", "questionText": "需要避光保存的药品是", "option": ["A.二甲双胍片", "B.过氧化氢溶液", "C.多酶片", "D.双氯芬酸钠", "E.硫酸镁注射液"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_90", "questionText": "易受环境温度影响而变质的药品是", "option": ["A.二甲双胍片", "B.过氧化氢溶液", "C.多酶片", "D.双氯芬酸钠", "E.硫酸镁注射液"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_91", "questionText": "患者，男，62 岁，因骨性关节炎，药物治疗效果不佳，关节坏死，拟行人工节置换术。适宜该患者预防性使用的抗菌药物是", "option": ["A.头孢曲松", "B.头孢唑林", "C.头炮哌酮", "D.头孢他啶", "E.氨曲南"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_92", "questionText": "患者，男，62 岁，因骨性关节炎，药物治疗效果不佳，关节坏死，拟行人工节置换术。关于该患者手术时预防性抗菌药物给药时机的说法，正确的是", "option": ["A.应在皮肤、黏膜切开前 0.5~1 小时内静脉滴注", "B.应在皮肤、黏膜切开前 15~30 分钟内静脉滴注", "C.应在皮肤、黏膜切开前 1.5~2 小时内静脉滴注", "D.应在皮肤、黏膜切开前 2.5~3 小时内静脉滴注", "E.应在皮肤、黏膜切开前 3~4 小时内静脉滴注"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_93", "questionText": "患者，女，32 岁，已婚未孕。3 个月前出现腹泻，多为稀糊状，间断为黏液及脓血便每日 8~12 次，有里急后重感，结肠镜检查诊断溃疡性结肠炎（全结肠型），医师处方美沙拉秦缓释片 和美沙拉秦灌肠剂。关于美沙拉秦治疗作用的说法，正确的是", "option": ["A.美沙拉秦缓释片仅作用于近端结肠", "B.美沙拉秦主要通过在肠道内发挥局部作用而产生治疗作用", "C.美沙拉秦为柳氮磺吡啶的前体药物，水解后起效", "D.美沙拉秦灌肠剂仅能作用于直肠局部病变", "E.美沙拉秦通过结构中的磺胺吡啶所具有的抗菌活性产生治疗作用"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_94", "questionText": "患者，女，32 岁，已婚未孕。3 个月前出现腹泻，多为稀糊状，间断为黏液及脓血便每日 8~12 次，有里急后重感，结肠镜检查诊断溃疡性结肠炎（全结肠型），医师处方美沙拉秦缓释片 和美沙拉秦灌肠剂。关于该患者用药注意事项的说法，正确的是", "option": ["A.美沙拉秦缓释片不可随餐服用，必须空腹服用", "B.用药期间需常规补充叶酸", "C.美沙拉秦缓释片可掰开后服用，但不能咀嚼", "D.美沙拉秦灌肠剂应清晨给药", "E.无需监测肾功能，但需监测血常规"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_95", "questionText": "患者，女，65 岁，间断腹胀、纳差 6 年，因病情加重伴精神恍惚 3 天为主诉入院，实验室检 查：ALT 200U/L，AST 320U/L，诊断为肝硬化失代偿期、肝性脑病。患者乙肝病史 20 年，间 断服用中药（具体不详）治疗。糖尿病史 10 年，便秘多年，3~4 天排便一次。为治疗该患者的便秘并改善肝性脑病症状，应首选的药物是", "option": ["A.比沙可啶", "B.乳果糖", "C.硫酸镁", "D.开塞露", "E.聚乙二醇"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_96", "questionText": "患者，女，65 岁，间断腹胀、纳差 6 年，因病情加重伴精神恍惚 3 天为主诉入院，实验室检 查：ALT 200U/L，AST 320U/L，诊断为肝硬化失代偿期、肝性脑病。患者乙肝病史 20 年，间 断服用中药（具体不详）治疗。糖尿病史 10 年，便秘多年，3~4 天排便一次。现计划对该患者进行抗乙肝治疗，宜首选的抗病毒药物是", "option": ["A.干扰素 a", "B.聚乙二醇干扰素 a", "C.恩替卡韦", "D.利巴韦林", "E.更昔洛韦"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_97", "questionText": "患者，女，65 岁，间断腹胀、纳差 6 年，因病情加重伴精神恍惚 3 天为主诉入院，实验室检 查：ALT 200U/L，AST 320U/L，诊断为肝硬化失代偿期、肝性脑病。患者乙肝病史 20 年，间 断服用中药（具体不详）治疗。糖尿病史 10 年，便秘多年，3~4 天排便一次。可为该患者选择的保肝降酶药物是", "option": ["A.水溶性维生素", "B.多烯磷脂酰胆碱", "C.辅酶 A", "D.维生素 B1", "E.谷维素"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_98", "questionText": "患者，女，27 岁，孕 8 周，身高 168cm，体重 58kg，因体检尿常规结果异常就诊，白细胞 300/ μl。今日尿培养汇报：尿细菌计数 2.13×10^5cfu/ml，患者自述无尿频、尿急、尿痛，无 肉眼可见血尿，无腰痛、寒战或发热。根据以上病情描述，该患者最有可能患有的疾病是", "option": ["A.急性膀胱炎", "B.急性肾盂肾炎", "C.无症状菌尿", "D.急性复杂性尿路感染", "E.慢性肾盂肾炎"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_99", "questionText": "患者，女，27 岁，孕 8 周，身高 168cm，体重 58kg，因体检尿常规结果异常就诊，白细胞 300/ μl。今日尿培养汇报：尿细菌计数 2.13×10^5cfu/ml，患者自述无尿频、尿急、尿痛，无 肉眼可见血尿，无腰痛、寒战或发热。关于该患者治疗方案的说法，正确的是", "option": ["A.不需要抗感染治疗，患者没有尿路刺激症状", "B.需要抗感染治疗，否则可增加早产或低出生体重儿发生概率", "C.不需要抗感染治疗，药物可增加胎儿畸形风险", "D.不需要抗感染治疗，是自限性疾病", "E.需要抗感染治疗，否则可导致孕妇发生败血症"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_100", "questionText": "患者，女，27 岁，孕 8 周，身高 168cm，体重 58kg，因体检尿常规结果异常就诊，白细胞 300/ μl。今日尿培养汇报：尿细菌计数 2.13×10^5cfu/ml，患者自述无尿频、尿急、尿痛，无 肉眼可见血尿，无腰痛、寒战或发热。该患者一旦发生尿路感染，宜选用的抗菌药物是", "option": ["A.阿莫西林", "B.左氧氟沙星", "C.阿米卡星", "D.甲硝唑", "E.亚胺培南"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_101", "questionText": "患者，女，27 岁，孕 8 周，身高 168cm，体重 58kg，因体检尿常规结果异常就诊，白细胞 300/ μl。今日尿培养汇报：尿细菌计数 2.13×10^5cfu/ml，患者自述无尿频、尿急、尿痛，无 肉眼可见血尿，无腰痛、寒战或发热。如需使用抗菌药物，该患者适宜的治疗疗程应为", "option": ["A.3-7 天", "B.14 天", "C.4 周", "D.6 周", "E.>3 个月"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_102", "questionText": "患者，男，69 岁，患高血压 20 年，高脂血症 10 年，冠心病 5 年。1 个月前因急性心肌梗死，于前降支植入一枚药物洗脱支架。该患者术后应进行双联抗血小板治疗。其持续治疗时间至少为", "option": ["A.6 个月", "B.9 个月", "C.12 个月", "D.18 个月", "E.24 个月"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_103", "questionText": "患者，男，69 岁，患高血压 20 年，高脂血症 10 年，冠心病 5 年。1 个月前因急性心肌梗死， 于前降支植入一枚药物洗脱支架。关于该患者抗血小板治疗方案的说法，错误的是", "option": ["A.双联抗血小板药物可选用阿司匹林+氯吡格雷", "B.双联抗血小板药物可选用阿司匹林+替格瑞洛", "C.双联抗血小板疗程结束后，可长期单用阿司匹林", "D.双联抗血小板疗程结束后，若阿司匹林不耐受，可长期单用替格瑞洛", "E.双联抗血小板疗程结束后，若阿司匹林不耐受，可长期单用氯吡格雷"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_104", "questionText": "患者，男，69 岁，患高血压 20 年，高脂血症 10 年，冠心病 5 年。1 个月前因急性心肌梗死， 于前降支植入一枚药物洗脱支架。该患者于支架植入术后 2 个月出现柏油便，Hb60g/L，考虑消化道大出血。在立即给予抑酸、止血和支持治疗的同时，对抗血小板方案进行调整，正确的方案是", "option": ["A.立即停用所有抗血小板药物", "B.降低现用抗血小板药物的剂量", "C.换用其他抗血小板药物", "D.换用口服抗凝药", "E.换用低分子肝素皮下给药"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_105", "questionText": "患者，男，71 岁，因“慢性咳嗽、咯痰 20 余年，活动后气短 1 年”就诊。曾确诊为 COPD。近 1 年平地走 200~300 米即感到气短，近期无发热，痰液量和外观无明显变化，但常有心悸、手抖，并且口中有苦涩的金属味道。目前应用茶碱缓释片口服，沙丁胺醇气雾剂吸入，异丙托溴胺气雾剂吸入。患者有长期吸烟史，无其他慢性病。关于该患者用药教育的说法，错误的是", "option": ["A.茶碱是 COPD 的首选治疗药物，安全性良好", "B.短效支气管舒张剂用于缓解急性发作症状", "C.沙丁胺醇过量时可能引起骨骼肌震颤", "D.沙丁胺醇可能引起心动过速", "E.异丙托溴胺可能与口中的金属味道相关"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_106", "questionText": "患者，男，71 岁，因“慢性咳嗽、咯痰 20 余年，活动后气短 1 年”就诊。曾确诊为 COPD。 近 1 年平地走 200~300 米即感到气短，近期无发热，痰液量和外观无明显变化，但常有心悸、 手抖，并且口中有苦涩的金属味道。目前应用茶碱缓释片口服，沙丁胺醇气雾剂吸入，异丙 托溴胺气雾剂吸入。患者有长期吸烟史，无其他慢性病。关于该患者 COPD 治疗及疾病管理的说法，错误的是", "option": ["A.吸烟是 COPD 最重要的发病因素，建议戒烟", "B.建议长期单独吸入沙丁胺醇，以降低病死率", "C.稳定期规律吸入长效支气管扩张剂，以减少急性加重的频率", "D.建议在专业人员指导下进行适度运动", "E.建议每年接种流感疫苗"], "year": "2020", "answer": ["B"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_107", "questionText": "患者，女，28 岁，体重 80kg。12 年前于颅脑外伤后出现癫痫全面强直-阵挛性发作，间断有失神发作，最初服用丙戊酸钠缓释片，后因效果不佳，陆续加用奥卡西平片、拉莫三嗪片，三药合用至今已 3 年；另外间断服用碳酸钙片、骨化三醇胶丸。现患者出现低钠血症，血钠 121mmol/L，导致该患者血钠降低的药物可能是", "option": ["A.奥卡西平片", "B.丙戊酸钠缓释片", "C.拉莫三嗪片", "D.碳酸钙片大", "E.骨化三醇胶丸"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_108", "questionText": "患者，女，28 岁，体重 80kg。12 年前于颅脑外伤后出现癫痫全面强直-阵挛性发作，间断有 失神发作，最初服用丙戊酸钠缓释片，后因效果不佳，陆续加用奥卡西平片、拉莫三嗪片， 三药合用至今已 3 年；另外间断服用碳酸钙片、骨化三醇胶丸。丙戊酸钠的有效血药浓度为", "option": ["A.40~100ug/mL", "B.4~12ug/mL", "C.2.5~15ug/mL", "D.10~20ug/mL", "E.15~40ug/mL"], "year": "2020", "answer": ["A"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_109", "questionText": "患者，女，28 岁，体重 80kg。12 年前于颅脑外伤后出现癫痫全面强直-阵挛性发作，间断有 失神发作，最初服用丙戊酸钠缓释片，后因效果不佳，陆续加用奥卡西平片、拉莫三嗪片， 三药合用至今已 3 年；另外间断服用碳酸钙片、骨化三醇胶丸。因患者计划怀孕，需调整给药方案，应首先考虑更换的药物是", "option": ["A.奥卡西平片", "B.拉莫三嗪片", "C.丙戊酸钠缓释片", "D.碳酸钙片", "E.骨化三醇胶丸"], "year": "2020", "answer": ["C"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_110", "questionText": "患者，女，28 岁，体重 80kg。12 年前于颅脑外伤后出现癫痫全面强直-阵挛性发作，间断有 失神发作，最初服用丙戊酸钠缓释片，后因效果不佳，陆续加用奥卡西平片、拉莫三嗪片， 三药合用至今已 3 年；另外间断服用碳酸钙片、骨化三醇胶丸。关于抗癫病药使用注意事项和患者教育的说法，错误的是", "option": ["A.应长期规律用药", "B.停药时应逐渐减量", "C 停药后复发率 20%-40%", "D.若持续 1 年以上无癫痫发作，可停药", "E.复发多在停药后 2 年内发生"], "year": "2020", "answer": ["D"], "subject": "2020药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_111", "questionText": "既可以通过口腔给药，又可以通过鼻腔、皮肤或肺部给药的剂型是", "option": ["A.口服液", "B.吸入制剂", "C.贴剂", "D.喷雾剂", "E.粉雾剂"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_112", "questionText": "关于药物制成剂型意义的说法，错误的是", "option": ["A.可改变药物的作用性质", "B.可调节药物的作用速度", "C.可调节药物的作用靶标", "D.可降低药物的不良反应", "E.可提高药物的稳定性"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_113", "questionText": "药物的光敏性是指药物被光降解的敏感程度。下列药物中光敏性最强的是", "option": ["A.氯丙嗪", "B.硝普钠", "C.维生素B2", "D.叶酸", "E.氢化可的松"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_114", "questionText": "关于药品质量标准中检查项的说法，错误的是", "option": ["A.检查项包括反映药品安全性与有效性的试验方法和限度、均一性与纯度等制备工艺要求", "B.除另有规定外，凡规定检查溶出度或释放度的片剂，不再检查崩解时限", "C.单剂标示量小于 50mg 或主药含量小于单剂重量 50%的片剂，应检查含量均匀度", "D.凡规定检查含量均匀度的制剂，不再检查重/装量差异", "E.崩解时限、溶出度与释放度、含量均匀度检查法属于特性检查法"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_115", "questionText": "高效液相色谱法用于药物鉴别的依据是", "option": ["A.色谱柱理论板数", "B.色谱峰峰高", "C.色谱峰保留时间", "D.色谱峰分离度", "E.色谱峰面积重复性"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_116", "questionText": "关于药物制剂稳定性试验的说法，错误的是", "option": ["A.为药品生产、包装、贮存、运输条件提供科学依据", "B.通过试验建立药品的有效期", "C.影响因素试验包括高温试验、高湿试验和强光照射试验", "D.加速试验是在温度 60°C±2°C 和相对湿度 75%±5%的条件下进行的", "E.长期试验是在接近药品的实际贮存条件下进行的"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_117", "questionText": "仿制药一致性评价中，在相同试验条件下，仿制药品与参比药品生物等效是指", "option": ["A.两种药品在吸收速度上无显著性差异", "B.两种药品在消除时间上无显著性差异", "C.两种药品在动物体内表现相同治疗效果", "D.两种药品吸收速度与程度无显著性差异", "E.两种药品在体内分布、消除的速度与程度一致"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_118", "questionText": "需长期使用糖皮质激素的慢性疾病最适宜的给药方案是", "option": ["A.早晨 1 次", "B. 晚饭前1次", "C. 每日3次", "D. 午饭后1次", "E.睡前 1 次"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_119", "questionText": " 胰岛素受体属于", "option": ["A.G 蛋白偶联受体", "B.酪氨酸激酶受体", "C.配体门控离子通道受体", "D.细胞内受体", "E.电压门控离子通道受体"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_120", "questionText": "关于药物引起 II 型变态反应的说法，错误的是", "option": ["A.II 型变态反应需要活化补体、诱导粒细胞浸润及吞噬作用", "B.II 型变态反应主要导致血液系统疾病和自身免疫性疾病", "C.II 型变态反应只由 IgM 介导", "D.II 型变态反应可由“氧化性”药物引起，导致免疫性溶血性贫血", "E.II 型变态反应可致靶细胞溶解，又称为溶细胞型反应"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_121", "questionText": "根据片剂中各亚剂型设计特点，起效速度最快的剂型是", "option": ["A.普通片", "B.控释片", "C.多层片", "D.分散片", "E.肠溶片"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_122", "questionText": "药物产生副作用的药理学基础是", "option": ["A.药物作用靶点特异性高", "B.药物作用部位选择性低", "C.药物剂量过大", "D.血药浓度过高", "E.药物分布范围窄"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_123", "questionText": " 抗过敏药物特非那定因可引发致死性尖端扭转型室性心动过速，导致药源性心律失常而撤市，其主要原因是", "option": ["A. 药物结构中含有致心脏毒性的基团", "B.药物抑制心肌快速延迟整流钾离子通道 hERG", "C.药物与非治疗部位靶标结合", "D.药物抑制心肌钠离子通道", "E.药物在体内代谢产生具有心脏毒性的醌类代谢物"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_124", "questionText": "属于CYP450酶系最主要的代谢亚型酶，大约有50%的药物是其底物，该亚型酶是", "option": ["A.CYPA12", "B.CYP3A4", "C.CYP2A6", "D.CYP2D6", "E.CYP2E1"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_125", "questionText": "芬太尼透皮贴用于中重度慢性疼痛，效果良好，其原因是", "option": ["A.经皮吸收，主要蓄积于皮下组织", "B.经皮吸收迅速，5~10 分钟即可产生治疗效果", "C.主要经皮肤附属器如汗腺等迅速吸收", "D.经皮吸收后可发挥全身治疗作用", "E.贴于疼痛部位直接发挥作用"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_126", "questionText": "关于分子结构中引入羟基的说法，错误的是", "option": ["A.可以增加药物分子的水溶性", "B.可以增加药物分子的解离度", "C.可以与受体发生氢键结合，增强与受体的结合能力", "D.可以增加药物分子的亲脂性", "E.在脂肪链上引入羟基，可以减弱药物分子的毒性"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_127", "questionText": "通过拮抗多巴胺 D2 受体，增加乙酰胆碱释放，同时又能抑制乙酰胆碱酯酶活性，减少乙酰胆碱分解，从而增强胃收缩力加速胃排空的药物是", "option": ["A.多潘立酮", "B.伊托必利", "C.莫沙必利", "D.甲氧氯普胺", "E.雷尼替丁"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_128", "questionText": "在注射剂中，用于调节渗透压的辅料是", "option": ["A.乳酸", "B.果胶", "C.甘油", "D.聚山梨酯 80", "E.酒石酸"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_129", "questionText": "关于药物制剂规格的说法，错误的是", "option": ["A.阿司匹林规格为 0.1g，是指平均片重为 0.1g", "B.药物制剂的规格是指每一单位制剂中含有主药的重量或效价或含量或%装量", " C.葡萄糖酸钙口服溶液规格为 10%，是指每 100ml 口服溶液中含葡萄糖酸钙 10g ", "D.注射用胰蛋白酶规格为 5 万单位，是指每支注射剂中含胰蛋白酶 5 万单位", "E.硫酸庆大霉素注射液规格为 1m1:20mg（2 万单位），是指每支注射液的装量为 1ml、含庆大霉素20mg（2 万单位）"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_130", "questionText": "分子中存在羧酸酯结构，具有起效快、维持时间短的特点，适合诱导和维持全身麻醉期间止痛， 以及插管和手术切口止痛。该药物是", "option": ["A.芬太尼 img.png", "B.美沙酮 img.png", "C.舒芬太尼 img.png", "D.阿芬太尼 img.png", "E.瑞芬太尼 img.png"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_131", "questionText": "氯司替勃的化学骨架图，其名称是 img.png", "option": ["A.吩噻嗪", "B.孕甾烷", "C.苯并二氮䓬", "D.雄甾烷", "E.雌甾烷"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_132", "questionText": "关于口腔黏膜给药特点的说法，错误的是", "option": ["A.无全身治疗作用", "B.起效快", "C.给药方便", "D.适用于急症治疗", "E.可避开肝脏首关效应"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_133", "questionText": "盐酸昂丹司琼的化学结构如下图，关于其结构特点和应用的说法，错误的是img.png", "option": ["A.分子中含有咔唑酮结构", "B.止吐和改善恶心症状效果较好，但有锥体外系副作用", "C.分子中含有 2-甲基咪唑结构", "D.属于高选择性的 5-HT3 受体阻断药", "E.可用于预防和治疗手术后的恶心和呕吐"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_134", "questionText": "药物制剂常用的表面活性剂中，毒性最大的是", "option": ["A.高级脂肪酸盐", "B.卵磷脂", "C.聚山梨酯", "D.季铵化合物", " E.蔗糖脂肪酸酯"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_135", "questionText": "在三个给药剂量下，甲、乙两种药物的半衰期数据如表所示，下列说法正确的是img.png", "option": ["A.药物甲以一级过程消除", "B.药物甲以非线性动力学过程消除", "C..药物乙以零级过程消除", "D.两种药物均以零级过程消除", "E.两种药物均以一级过程消除"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_136", "questionText": "药物产生等效反应的相对剂量或浓度称为", "option": ["A.阈剂量", "B.极量", "C.效价强度", "D.常用量", "E.最小有效量"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_137", "questionText": "苯巴比妥与避孕药合用可引起", "option": ["A.苯巴比妥代谢减慢", "B.避孕药代谢加快", "C.避孕效果增强", "D.镇静作用增强", "E.肝微粒体酶活性降低"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_138", "questionText": "三唑仑化学结构如下图，口服吸收迅速而完全，给药后 15~30 分钟起效，Tmax 约为 2 小时，血浆蛋白结合率约为 90%，t1/2 为 1.5~5.5 小时，上述特性归因于分子中存在可提高脂溶性和易代谢的基团，该基团是img.png", "option": ["A.三氮唑环", "B.苯环 A", "C.甲基", "D.苯环", "E.1,4-二氮䓬环 B"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_139", "questionText": "伊曲康唑的化学结构如下，关于其结构特点和应用说法，错误的是img.png", "option": ["A.代谢产物羟基伊曲康唑的活性比伊曲康唑低", "B.具有较强的脂溶性和较高的血浆蛋白结合率", "C.分子中含有 1,2,4-三氮唑和 1,3,4-三氮唑结构", "D.具有较长的半衰期，t1/2 约为 21 小时", "E.可用于治疗深部和浅表真菌感染"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_140", "questionText": "下列分子中，通常不属于药物毒性作用靶标的是", "option": ["A.DNA", "B.RNA", "C.受体", "D.ATP", "E.酶"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_141", "questionText": "某药稳态分布容积 Vss 为 198L，提示该药", "option": ["A.与血浆蛋白结合率较高", "B.主要分布在血浆中", "C.广泛分布于器官组织中", "D.主要分布在红细胞中", "E.主要分布在血浆和红细胞中"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_142", "questionText": "对湿热敏感的药物需制备成临床快速起效的制剂，首选剂型是", "option": ["A.注射用无菌粉末", "B.口崩片", "C.注射液", "D.输液", " E.气雾剂"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_143", "questionText": "黄体酮混悬型长效注射剂给药途径是", "option": ["A.皮内注射", "B.皮下注射", "C.静脉注射", "D.动脉注射", "E.椎管内注射"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_144", "questionText": "主要通过药酶抑制作用引起药物相互作用的联合用药是", "option": ["A.氯霉素+甲苯磺丁脲", "B.阿司匹林+格列本脲", "C.保泰松+洋地黄毒苷", "D.苯巴比妥+布洛芬", "E.丙磺舒+青霉素"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_145", "questionText": "以下片剂辅料中，主要起崩解作用的是", "option": ["A.羟丙甲纤维素（HPMC）", "B.淀粉", "C.羧甲淀粉钠（CMS-Na）", "D.糊精", "E.羧甲纤维素钠（CMC-Na）"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_146", "questionText": "关于外用制剂临床适应证的说法，错误的是", "option": ["A.冻疮软膏适用于中度破溃的冻疮、手足皲裂的治疗", "B.水杨酸乳膏忌用于糜烂或继发性感染部位的治疗", "C.氧化锌糊剂适用于有少量渗出液的亚急性皮炎、湿疹的治疗", " D.吲|哚美辛软膏适用于风湿性关节炎、类风湿性关节炎的治疗", "E.地塞米松涂剂适用于神经性皮炎、慢性湿疹、扁平苔藓的治疗"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_147", "questionText": "质量要求中需要进行微细粒子剂量检查的制剂是", "option": ["A.吸入制剂", "B.眼用制剂", "C.栓剂", "D.口腔黏膜给药制剂", "E.耳用制剂"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_148", "questionText": "降血糖药物曲格列化学结构如下，上市后不久因发生严重的肝脏毒性被停止使用。其原因是img.png", "option": ["A.曲格列酮被代谢生成乙二醛", "B.曲格列酮被代谢生成 2-苯基丙烯醛", "C.曲格列酮代谢生成次 o-次甲基醌和 p-醌", "D.曲格列酮被代谢生成酰基葡糖醛酸酯", "E.曲格列酮被代谢生成亚胺-醌"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_149", "questionText": "具有较大脂溶性，口服生物利用度为 80%~90%，半衰期为 14~22 小时，每天仅需给药一次的选择性β1 受体阻断药是", "option": ["A.普萘洛尔", "B.噻吗洛尔", "C.艾司洛尔", "D.倍他洛尔", "E.吲哚洛尔"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_150", "questionText": "无明显肾毒性的药物是", "option": ["A.青霉素", "B.环孢素", "C.头孢噻吩", "D.庆大霉素", "E.两性霉素 B"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_151", "questionText": "盐酸苯海索中检查的特殊杂质是", "option": ["A.吗啡", "B.林可霉素 B", "C.哌啶苯丙酮", "D.对氨基酚", "E.对氯酚"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_152", "questionText": "氯贝丁酯中检查的特殊杂质是", "option": ["A.吗啡", "B.林可霉素 B", "C.哌啶苯丙酮", "D.对氨基酚", "E.对氯酚"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_153", "questionText": "磷酸可待因中检查的特殊杂质是", "option": ["A.吗啡", "B.林可霉素 B", "C.哌啶苯丙酮", "D.对氨基酚", "E.对氯酚"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_154", "questionText": "在体内可发生 O-脱甲基代谢，使失去活性的药物是", "option": ["A.沙丁胺醇img.png", "B.肾上腺素img.png", "C.非尔氨酯img.png", "D.吲哚美辛img.png", "E.醋磺己脲img.png"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_155", "questionText": "在体内可被代谢产生 2-苯基丙烯醛，易与蛋白的亲核基团发生迈克尔加成，产生特质性毒性的药物是", "option": ["A.沙丁胺醇img.png", "B.肾上腺素img.png", "C.非尔氨酯img.png", "D.吲哚美辛img.png", "E.醋磺己脲img.png"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_156", "questionText": "在体内可被儿茶酚 O-甲基转移酶快速甲基化，使活性降低的药物是", "option": ["A.沙丁胺醇img.png", "B.肾上腺素img.png", "C.非尔氨酯img.png", "D.吲哚美辛img.png", "E.醋磺己脲img.png"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_157", "questionText": "收载于《中国药典》二部的品种是", "option": ["A.乙基纤维素", "B.交联聚维酮", "C.连花清瘟胶囊", "D.阿司匹林片", "E.冻干人用狂犬病疫苗"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_158", "questionText": "收载于《中国药典》三部的品种是", "option": ["A.乙基纤维素", "B.交联聚维酮", "C.连花清瘟胶囊", "D.阿司匹林片", "E.冻干人用狂犬病疫苗"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_159", "questionText": "具有低溶解度、高渗透性，可通过增加溶解度和溶出速度的方法来改善吸收的药物是", "option": ["A.其他类药", "B.生物药剂学分类系统(BCS)I 类药物", "C.生物药剂学分类系统(BCS)IV 类药物", "D.生物药剂学分类系统(BCS)II 类药物", "E.生物药剂学分类系统（BCS）Ⅲ类药物"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_160", "questionText": "具有高溶解度、高渗透性，只要处方中没有显著影响药物吸收的辅料，通常口服时无生物利用度问题的药物是", "option": ["A.其他类药", "B.生物药剂学分类系统(BCS)I 类药物", "C.生物药剂学分类系统(BCS)IV 类药物", "D.生物药剂学分类系统(BCS)II 类药物", "E.生物药剂学分类系统（BCS）Ⅲ类药物"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_161", "questionText": "国内企业研发，作用于  VEGFR-2，分子中含有氰基，可用于治疗晚期胃癌的药物是", "option": ["A.吉非替尼", "B.伊马替尼", "C.阿帕替尼", "D.索拉替尼", "E.埃克替尼"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_162", "questionText": "第一个上市的蛋白酪氨酸激酶抑制剂，分子中含有哌嗪环，可用于治疗费城染色体阳性的慢性粒细胞白血病和恶性胃肠道间质肿瘤的药物是", "option": ["A.吉非替尼", "B.伊马替尼", "C.阿帕替尼", "D.索拉替尼", "E.埃克替尼"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_163", "questionText": "第一个选择性表皮生长因子受体酪氨酸激酶抑制剂，分子中含有 3-氯-4-氟苯胺基团，用于治疗非小细胞肺癌和转移性非小细胞肺癌的药物是", "option": ["A.吉非替尼", "B.伊马替尼", "C.阿帕替尼", "D.索拉替尼", "E.埃克替尼"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_164", "questionText": "属于第一信使的是", "option": ["A.cGMP", "B.Ca2+", "C.cAMP", "D.肾上腺素", "E.转化因子"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_165", "questionText": "属于第三信使的是", "option": ["A.cGMP", "B.Ca3+", "C.cAMP", "D.肾上腺素", "E.转化因子"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_166", "questionText": "市场流通国产药品监督管理的首要依据是", "option": ["A.企业药品标准", "B.进口药品注册标准", "C.国际药典", "D.国家药品标准", "E.药品注册标准"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_167", "questionText": "药品出厂放行的标准依据是", "option": ["A.企业药品标准", "B.进口药品注册标准", "C.国际药典", "D.国家药品标准", "E.药品注册标准"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_168", "questionText": "用于计算生物利用度的是", "option": ["A.零阶矩", "B.平均稳态血药浓度", "C.一阶矩", "D.平均吸收时间", "E.平均滞留时间"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_169", "questionText": "静脉注射时，能反映药物在体内消除快慢的是", "option": ["A.零阶矩", "B.平均稳态血药浓度", "C.一阶矩", "D.平均吸收时间", "E.平均滞留时间"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_170", "questionText": "在耳用制剂中，可作为抗氧剂的是", "option": ["A.硫柳汞", "B.亚硫酸氢钠", "C.甘油", "D.聚乙烯醇", "E.溶菌酶"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_171", "questionText": "在耳用制剂中，可作为溶剂的是", "option": ["A.硫柳汞", "B.亚硫酸氢钠", "C.甘油", "D.聚乙烯醇", "E.溶菌酶"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_172", "questionText": "在耳用制剂中，可液化分泌物，促进药物分散的是", "option": ["A.硫柳汞", "B.亚硫酸氢钠", "C.甘油", "D.聚乙烯醇", "E.溶菌酶"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_173", "questionText": "不易发生芳环氧化代谢的药物是", "option": ["A.普萘洛尔img.png", "B.丙磺舒img.png", "C.苯妥英钠img.png", "D.华法林img.png", "E.水杨酸img.png"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_174", "questionText": "因代谢过程中苯环被氧化，生成新的手性中心的药物是", "option": ["A.普萘洛尔img.png", "B.丙磺舒img.png", "C.苯妥英钠img.png", "D.华法林img.png", "E.水杨酸img.png"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_175", "questionText": "在体内可发生芳环氧化、N-脱烷基和氧化脱胺代谢的药物是", "option": ["A.普萘洛尔img.png", "B.丙磺舒img.png", "C.苯妥英钠img.png", "D.华法林img.png", "E.水杨酸img.png"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_176", "questionText": "药物与作用靶标之间的一种不可逆的结合形式，作用强而持久，很难断裂，这种键合类型是", "option": ["A.共价键键合", "B.范德华力键合", "C.偶极-偶极相互作用键合", "D.疏水性相互作用键合", "E.氢键键合"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_177", "questionText": "由于羰基的氧原子和碳原子之间因电负性差异，导致电子在氧和碳原子之间的不对称分布，在与另一个极性羰基之间产生静电相互作用，这种键合类型是", "option": ["A.共价键键合", "B.范德华力键合", "C.偶极-偶极相互作用键合", "D.疏水性相互作用键合", "E.氢键键合"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_178", "questionText": "用于诊断与过敏试验的注射途径是", "option": ["A.皮内注射", "B.皮下注射", "C.动脉注射", "D.静脉注射", "E.关节腔注射"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_179", "questionText": "需延长作用时间的药物可采用的注射途径是", "option": ["A.皮内注射", "B.皮下注射", "C.动脉注射", "D.静脉注射", "E.关节腔注射"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_180", "questionText": "栓塞性微球的注射给药途径是", "option": ["A.皮内注射", "B.皮下注射", "C.动脉注射", "D.静脉注射", "E.关节腔注射"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_181", "questionText": "\"苯巴比妥服药后次晨出现“宿醉\"\"现象，属于\"", "option": ["A.停药反应", "B.毒性反应", "C.副作用", "D.继发反应", "E.后遗效应"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_182", "questionText": "二重感染属于", "option": ["A.停药反应", "B.毒性反应", "C.副作用", "D.继发反应", "E.后遗效应"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_183", "questionText": "长期服用中枢性降压药可乐定，停药后出现血压反弹的现象，属于", "option": ["A.停药反应", "B.毒性反应", "C.副作用", "D.继发反应", "E.后遗效应"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_184", "questionText": "因影响细胞内 Ca2+的稳态而导致各种心律失常不良反应的药物是", "option": ["A.多柔比星", "B.索他洛尔", "C.普鲁卡因胺", "D.肾上腺素", "E.强心苷"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_185", "questionText": "因干扰 Na+通道而对心脏产生不良反应的药物是", "option": ["A.多柔比星", "B.索他洛尔", "C.普鲁卡因胺", "D.肾上腺素", "E.强心苷"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_186", "questionText": "口服给药后，通过自身的弱碱性中和胃酸而治疗胃溃疡的药物是", "option": ["A.右旋糖酐", "B.氢氧化铝", "C.甘露醇", "D.硫酸镁", "E.二巯基丁二酸钠"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_187", "questionText": "静脉注射给药后，通过提高渗透压而产生利尿作用的药物是", "option": ["A.右旋糖酐", "B.氢氧化铝", "C.甘露醇", "D.硫酸镁", "E.二巯基丁二酸钠"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_188", "questionText": "在体内发生氧化、还原、水解等反应使得药物极性增大，该代谢类型属于", "option": ["A.弱代谢作用", "B.I 相代谢反应", "C.酶抑制作用", "D.酶诱导作用", "E.II 相代谢反应"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_189", "questionText": "使用某些头孢菌素类药物后饮酒，出现“双硫仑”反应的原因是", "option": ["A.弱代谢作用", "B.I 相代谢反应", "C.酶抑制作用", "D.酶诱导作用", "E.II 相代谢反应"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_190", "questionText": "阿司匹林的代谢产物中含有葡萄糖醛酸结合物，该代谢类型属于", "option": ["A.弱代谢作用", "B.I 相代谢反应", "C.酶抑制作用", "D.酶诱导作用", "E.II 相代谢反应"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_191", "questionText": "表示血管外给药的药物浓度-时间曲线是", "option": ["A.img.png", "B.img.png", "C.img.png", "D.img.png", "E.img.png"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_192", "questionText": "表示非线性消除的药物浓度时间曲线是", "option": ["A.img.png", "B.img.png", "C.img.png", "D.img.png", "E.img.png"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_193", "questionText": "表示二室模型静脉注射给药的药物浓度时间曲线是", "option": ["A.img.png", "B.img.png", "C.img.png", "D.img.png", "E.img.png"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_194", "questionText": ".6 位侧链为苯氧丙酰基，耐酸性较强，可口服，主要用于治疗肺炎、咽炎、扁桃体炎等感染性疾病的药物是", "option": ["A.羧苄西林", "B.非奈西林", "C.苯唑西林", "D.阿度西林", "E.哌拉西林"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_195", "questionText": "6 位侧链具有吸电子的叠氮基团，对酸稳定，口服吸收良好，其抗菌作用与用途类似青霉素 V，主要用于呼吸道、软组织等感染，对流感嗜血杆菌的活性更强的药物是", "option": ["A.羧苄西林", "B.非奈西林", "C.苯唑西林", "D.阿度西林", "E.哌拉西林"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_196", "questionText": "分子中含有膦酰基的血管紧张素转换酶抑制药是", "option": ["A.福辛普利", "B.依那普利", "C.赖诺普利", "D.喹那普利", "E.卡托普利"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_197", "questionText": "分子中含有游离双羧酸的血管紧张素转换酶抑制药是", "option": ["A.福辛普利", "B.依那普利", "C.赖诺普利", "D.喹那普利", "E.卡托普利"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_198", "questionText": "分子中含有巯基的血管紧张素转换酶抑制药是", "option": ["A.福辛普利", "B.依那普利", "C.赖诺普利", "D.喹那普利", "E.卡托普利"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_199", "questionText": "常用于包衣的水不溶性材料是", "option": ["A.聚乙烯醇（PVA）", "B.聚乙二醇（PEG）", "C.交联聚维酮（PVPP）", "D.聚乳酸-羟乙酸（PLGA）", "E.乙基纤维素（EC）"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_200", "questionText": "常用于栓剂基质的水溶性材料是", "option": ["A.聚乙烯醇（PVA）", "B.聚乙二醇（PEG）", "C.交联聚维酮（PVPP）", "D.聚乳酸-羟乙酸（PLGA）", "E.乙基纤维素（EC）"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_201", "questionText": "单剂量包装的鼻用固体或半固体制剂应检查的是", "option": ["A.黏附力", "B.装量差异", "C.递送均一性", "D.微细粒子剂量", "E.沉降体积比"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_202", "questionText": "定量鼻用气雾剂应检查的是", "option": ["A.黏附力", "B.装量差异", "C.递送均一性", "D.微细粒子剂量", "E.沉降体积比"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_203", "questionText": "混悬型滴鼻剂应检查的是", "option": ["A.黏附力", "B.装量差异", "C.递送均一性", "D.微细粒子剂量", "E.沉降体积比"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_204", "questionText": "处方中含有丙二醇的注射剂是", "option": ["A.苯妥英钠注射液", "B.维生素 C 注射液", "C.硫酸阿托品注射液", "D.罗拉匹坦静脉注射乳剂", "E.氟比洛芬酯注射乳剂"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_205", "questionText": "处方中含有抗氧剂的注射剂是", "option": ["A.苯妥英钠注射液", "B.维生素 C 注射液", "C.硫酸阿托品注射液", "D.罗拉匹坦静脉注射乳剂", "E.氟比洛芬酯注射乳剂"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_206", "questionText": "制剂处方中含有果胶辅料的药品是", "option": ["A.维生素 C 泡腾颗粒", "B.蛇胆川贝散", "C.板蓝根颗粒", "D.元胡止痛滴丸", "E.利福昔明干混悬颗粒"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_207", "questionText": "制剂处方中不含辅料的药品是", "option": ["A.维生素 C 泡腾颗粒", "B.蛇胆川贝散", "C.板蓝根颗粒", "D.元胡止痛滴丸", "E.利福昔明干混悬颗粒"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_208", "questionText": "制剂处方中不含辅料的药品是", "option": ["A.维生素 C 泡腾颗粒", "B.蛇胆川贝散", "C.板蓝根颗粒", "D.元胡止痛滴丸", "E.利福昔明干混悬颗粒"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_209", "questionText": "分子中含有咪唑环和氰胍基，第一个应用于临床的 H2受体阻断药是", "option": ["A.罗沙替丁", "B.尼扎替丁", "C.法莫替丁", "D.西咪替丁", "E.雷尼替丁"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_210", "questionText": "分子中的碱性基团为二甲胺甲基呋喃，药效团为二氨基硝基乙烯的 H2受体阻断药是", "option": ["A.罗沙替丁", "B.尼扎替丁", "C.法莫替丁", "D.西咪替丁", "E.雷尼替丁"], "year": "2020", "answer": ["E"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_211", "questionText": "2 型糖尿病患者，女，60 岁，因服用降糖药达格列净出现尿路感染就诊，医师建议改用胰岛素类药物治疗。达格列净属于", "option": ["A.钠-萄萄糖协同转运蛋白-2（SGLT-2）抑制药", "B.促胰岛素分泌药", "C.胰岛素增敏药", "D.α-葡萄糖苷酶抑制药", "E.二肽基肽酶-4（DPP-4）抑制药"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_212", "questionText": "2 型糖尿病患者，女，60 岁，因服用降糖药达格列净出现尿路感染就诊，医师建议改用胰岛素类药物治疗。达格列净系由天然产物结构修饰而来，该天然产物是", "option": ["A.根皮苷", "B.胰岛素", "C.阿卡波糖", "D.芦丁", "E.阿魏酸"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_213", "questionText": "2 型糖尿病患者，女，60 岁，因服用降糖药达格列净出现尿路感染就诊，医师建议改用胰岛素类药物治疗。某胰岛素类药物系由胰岛素化学结构 B 链 3 位的谷氨酰胺被赖氨酸取代，B 链 26 位的赖氨酸被谷氨酸取代而成，该药物是", "option": ["A.门冬胰岛素", "B.赖脯胰岛素", "C.格鲁辛胰岛素", "D.甘精胰岛素", "E.猪胰岛素"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_214", "questionText": "口服 A、B、C 三种不同粒径（0.22um，2.4um 和 13um）的某药，其血药浓度-时间曲线图如下所示。img.png 当原料药粒径较大时，进食时比空腹的 Cmax，AUC 都大，说明", "option": ["A.进食比空腹的胃排空更快", "B.进食能够有效增加药物在胃内的滞留时间", "C.食物能够保证药物连续不断地进入肠道，增加了吸收量", "D.食物刺激胆汁分泌，增加了药物的溶解度", "E.食物增加了药物透过肠道上皮细胞的能力"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_215", "questionText": "口服 A、B、C 三种不同粒径（0.22um，2.4um 和 13um）的某药，其血药浓度-时间曲线图如下所示。img.png 经计算，该药的体内血药浓度-时间曲线符合二室模型，其 t1/2（α）为 2.2 小时，t1/2（β）为 18.0 小时，说明", "option": ["A.该药在体内清除一半需要 18.0 小时", "B.该药在体内清除一半需要 20.2 小时", "C.该药在体内快速分布和缓慢清除", "D.该药在体内基本不代谢", "E.该药一天服用 1 次即可"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_216", "questionText": "口服 A、B、C 三种不同粒径（0.22um，2.4um 和 13um）的某药，其血药浓度-时间曲线图如下所示。img.png 下列可以有效增加难溶性药物溶解度、提高生物利用度的方式中，不属于增加难溶性药.物溶解度的方法是", "option": ["A.制成固体分散体", "B.合并使用膜渗透增强剂", "C.制成盐", "D.制成环糊精包合物", "E.微粉化"], "year": "2020", "answer": ["B"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_217", "questionText": "患者，男，70 岁，因泌尿道慢性感染就诊，经检测属于革兰阴性菌感染。其治疗药品处方组分中包括：主药、微晶纤维素（空白丸核）、乳糖、枸橡酸、Eudragit NE30D EudragitL30D-55、滑石粉、PEG600、十二烷基硫酸钠。该药品处方组分中的“主药”应是", "option": ["A.红霉素", "B.青霉素", "C.阿奇霉素", "D.氧氟沙星", "E.氟康唑"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_218", "questionText": "患者，男，70 岁，因泌尿道慢性感染就诊，经检测属于革兰阴性菌感染。其治疗药品处方组分中包括：主药、微晶纤维素（空白丸核）、乳糖、枸橡酸、Eudragit NE30D EudragitL30D-55、滑石粉、PEG600、十二烷基硫酸钠。该制剂处方中 Eudragit NE30D Eudragit L30D-55 的作用是", "option": ["A.缓释包衣材料", "B.胃溶包衣材料", "C.肠溶包衣材料", "D.肠溶载体", "E.黏合剂"], "year": "2020", "answer": ["A"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_219", "questionText": "患者，男，70 岁，因泌尿道慢性感染就诊，经检测属于革兰阴性菌感染。其治疗药品处方组分中包括：主药、微晶纤维素（空白丸核）、乳糖、枸橡酸、Eudragit NE30D EudragitL30D-55、滑石粉、PEG600、十二烷基硫酸钠。根据处方组分分析，推测该药品的剂型是", "option": ["A.释片剂", "B.缓释小丸", "C.缓释颗粒", "D.缓释胶囊", "E.肠溶小丸"], "year": "2020", "answer": ["D"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_220", "questionText": "患者，男，70 岁，因泌尿道慢性感染就诊，经检测属于革兰阴性菌感染。其治疗药品处方组分中包括：主药、微晶纤维素（空白丸核）、乳糖、枸橡酸、Eudragit NE30D EudragitL30D-55、滑石粉、PEG600、十二烷基硫酸钠。该制剂的主药规格为 0.2g，需要进行的特性检查项目是", "option": ["A.不溶性微粒", "B.崩解时限", "C.释放度", "D.含量均匀度", "E.溶出度"], "year": "2020", "answer": ["C"], "subject": "2020 年执业药师考试《药学专业知识一》药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_221", "questionText": "关于药物制剂稳定性的说法，错误的是", "option": ["A. 药物化学结构直接影响药物制剂的稳定性", "B. 药用辅料要求化学性质稳定，所以辅料不影响", "C. 微生物污染会影响制剂生物稳定性", "D. 制剂物理性能的变化，可能引起化学变化和生物学变化", "E. 稳定性试验可以为制剂生产、包装、储存、运输条件的确定和有效期的建立提供科学依据"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_222", "questionText": "某药物在体内按一级动力学消除，如果k=0.0346h-1，该药物的消除半衰期约为", "option": ["A. 3.46h", "B. 6.92h", "C. 12h", "D. 20h", "E. 24h"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_223", "questionText": "因对心脏快速延迟整流钾离子通道( hERG K+通道)具有抑制作用，可引起Q-T间期延长甚至诱发尖端扭转型室性心动过速，现已撤出市场的药物是", "option": ["A. 卡托普利", "B. 莫沙必利", "C. 赖诺普利", "D. 伊托必利", "E. 西沙必利"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_224", "questionText": "根据生物药剂学分类系统，属于第Ⅳ类低水溶性、低渗透性的药物是", "option": ["A. 双氯芬酸", "B. 吡罗昔康", "C. 阿替洛尔", "D. 雷尼替丁", "E. 酮洛芬"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_225", "questionText": "为了减少对眼部的刺激性，需要调整滴眼剂的渗透压与泪液的渗透压相近、用作滴眼剂渗透压调节剂的辅料是", "option": ["A. 羟苯乙酯", "B. 聚山梨酯-80", "C. 依地酸二钠", "D. 硼砂", "E. 羧甲基纤维素钠"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_226", "questionText": "在配制液体制剂时，为了增加难溶性药物的溶解度，通常需要在溶剂中加入第三种物质，与难溶性药物形成可溶性的分子间络合物、缔合物和复盐等加入的第三种物质的属于", "option": ["A. 助溶剂", "B. 潜溶剂", "C. 增溶剂", "D. 助悬剂", "E. 乳化剂"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_227", "questionText": "患者，男，65岁，患高血压病多年，近三年来一直服用氨氯地平和阿替洛尔，血压控制良好近期因治疗肺结核，服用利福平、乙胺丁醇2周后血压升高引起血压升高的原因可能是", "option": ["A. 利福平促进了阿替洛尔的肾脏排泄", "B. 利福平诱导了肝药酶，促进了氨氯地平的代谢", "C. 乙胺丁醇促进了阿替洛尔的肾脏排泄", "D. 乙胺丁醇诱导了肝药酶，促进了氨氯地平的代谢", "E. 利福平与氨氯地平结合成难溶的复合物"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_228", "questionText": "关于药物吸收的说法正确的是", "option": ["A. 食物可减少药物的吸收，药物均不能与食物同服", "B. 药物的亲脂性会影响药物的吸收，脂水分配系数小的药物吸收较好", "C. 在十二指肠由载体转运吸收的药物，胃排空缓慢有利于其口服吸收", "D. 固体药物粒子越大，溶出越快，吸收越好", "E. 临床上大多数脂溶性小分子药物的吸收过程是主动转运"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_229", "questionText": "多剂量静脉注射给药的平均稳态血药浓度是", "option": ["A.  Css max 与Css min的算术平均值", "B.  重复给药达到稳态后，在一个给药间隔时间内血药浓度-时间曲线下面积除以给药间隔时间的商值", "C. Css max与Css min的几何平均值", "D. 药物的血药浓度-时间曲线下面积除以给药间隔时间的商值", "E. 重复给药的第一个给药间隔时间内血药浓度时间曲线下面积除以给药间隔时间的商值"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_230", "questionText": "将维A酸制成环糊精包合物的目的主要是", "option": ["A. 降低维A酸的溶出度", "B. 提高维A酸的稳定性", "C. 减少维A酸的挥发性损失", "D. 产生靶向作用", "E. 产生缓解效果"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_231", "questionText": "关于药物警戒与药物不良反应监测的说法正确的是", "option": ["A. 药物警戒和不良反应监测的对象都仅限于质量合格的药品", "B. 药物警戒和不良反应监测都包括对已上市药品进行安全性评价", "C. 不良反应监测的重点是药物滥用与误用", "D. 药物警戒不包括研发阶段的药物安全性评价和动物毒理学评价", "E. 药物不良反应监测包括药物上市前的安全性监测"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_232", "questionText": "关于气雾剂质量要求和贮藏条件的说法，错误的是", "option": ["A. 附加剂应无刺激性、无毒性", "B. 容器应能耐受气雾剂", "C. 抛射剂应为适宜的低沸点的液体", "D. 贮藏条件要求是室温", "E. 严重创伤用气雾剂应无菌"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_233", "questionText": "与抗菌药配伍使用后，能增强抗细菌药疗效的药物称为抗菌增效剂属于抗菌增效剂的药物是", "option": ["A. 甲氧苄啶", "B. 氨苄西林", "C. 舒他西林", "D. 磺胺嘧綻", "E. 氨曲南"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_234", "questionText": "通过阻滞钙离子通道发挥药理作用的药物是", "option": ["A. 普鲁卡因胺", "B. 奎尼丁", "C. 胺碘酮", "D. 维拉帕米", "E. 普罗帕酮"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_235", "questionText": "适用于各类高血压，也可用于防治心绞痛的药物是", "option": ["A. 卡托普利", "B. 硝苯地平", "C. 可乐定", "D. 氯沙坦", "E. 哌唑嗪"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_236", "questionText": "头孢克洛生物半衰期约为1h，口服头孢克洛胶囊后，其在体内基本清除干净的时间约是", "option": ["A. 2h", "B. 7h", "C. 3h", "D. 14h", "E. 28h"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_237", "questionText": "《中国药典》收载的阿司匹林标准中，记载在【性状】项下的内容是", "option": ["A. 溶解度", "B. 含量的限度", "C. 溶液的澄清度", "D. 游离水杨酸的限度", "E. 干燥失重的限度"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_238", "questionText": "作用于神经氨酸酶的抗流感病毒药物的是", "option": ["A. 奥司他韦", "B. 阿昔洛韦", "C. 利巴韦林", "D. 膦甲酸钠", "E. 金刚烷胺"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_239", "questionText": "评价药物安全性的药物治疗指数", "option": ["A. ED95/LD5", "B. ED95/LD50", "C. LD1/ED99", "D. LD50/ ED50", "E. ED99/LD1"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_240", "questionText": "世界卫生组织关于药物“严重不良事件”的定义是", "option": ["A. 药物常用剂量引起的与药理学特征有关但非用药目的的作用", "B. 在使用药物期间发生的任何不可预见不良事件不一定与治疗有因果关系", "C. 在任何剂量下发生的不可预见的临床事件，如死亡、危及生命、需住院治疗或延长目前的住院事件导致持续的或显著的功能丧失及导致先天性畸形或出生缺陷", "D. 发生在作为预防、治疗、诊断疾病期间或改变生理功能使用于人体的正常剂量时发生的有害的和非目的的药物反应", "E. 药物的一种不良反应，其性质和严重程度与标记的或批准上市的药物不良反应不符，或是未能预料的不良反应"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_241", "questionText": "关于制剂质量要求和使用特点的说法，正确的是", "option": ["A. 注射剂应进行微生物限度检查", "B. 眼用液体制剂不允许添加抑菌剂", "C. 生物制品一般不宜制成注射用浓溶液", "D. 若需同时使用眼膏剂和滴眼剂，应先使用眼膏剂", "E. 冲洗剂开启使用后，可小心存放，供下次使用"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_242", "questionText": "以PEG为基质的对乙酰氨基酚栓表面的鲸蜡醇层的作用是", "option": ["A. 减轻用药刺激", "B. 促进药物释放", "C. 保持栓剂硬度", "D. 增加栓剂的稳定性", "E. 软化基质"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_243", "questionText": "高血压患者按常规剂量服用哌唑嗪片，开始治疗时产生眩晕、心悸、体位性低血压这种对药物尚未适应而引起的不可耐受的反应称为", "option": ["A. 继发性反应", "B. 后遗效应", "C. 毒性反应", "D. 首剂效应", "E. 副作用"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_244", "questionText": "风湿性心脏病患者行心瓣膜置换术后使用华法林，可发生的典型不良反应是", "option": ["A. 低血糖", "B. 血脂升高", "C. 血压降低", "D. 出血", "E. 肝脏损伤"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_245", "questionText": "利培酮的半衰期大约为3小时但用法为一日2次，其原因被认为是利培酮代谢产物也具有相同的生物活性，利培酮的活性代谢产物是", "option": ["A. 齐拉西酮", "B. 洛沙平", "C. 阿莫沙平", "D. 帕利哌酮", "E. 帕罗西汀"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_246", "questionText": "普鲁卡因和琥珀胆碱联用时，会加重呼吸抑制的不良反应，其可能的原因是", "option": ["A. 普鲁卡因竞争胆碱酯酶，影响琥珀胆碱代谢，导致琥珀胆碱血药浓度增高", "B. 个体遗传性血浆胆碱酯酶活性低下", "C. 琥珀胆碱与普鲁卡因发生药物相互作用激活胆碱酯酶的活性，加快琥珀胆碱代谢", "D. 普鲁卡因抑制肝药酶活性，进而影响了琥珀胆碱的代谢，导致琥珀胆碱血药浓度增高", "E. 琥珀胆碱影响尿液酸碱性，促进普鲁卡因在肾小管的重吸收，导致普鲁卡因血药浓度增高"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_247", "questionText": "为延长脂质体在体内循环时间，通常使用修饰的磷脂制备长循环脂质体，常用的修饰材料是", "option": ["A. 甘露醇", "B. 聚山梨酯", "C. 聚乙二醇", "D. 山梨醇", "E. 聚乙烯醇"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_248", "questionText": "患者，女，60岁，因哮喘服用氨茶碱缓释制剂，近日，因胃溃疡服用西咪替丁，三日后出现心律失常、心悸、恶心等症状将西咪替丁换成法莫替丁后，上述症状消失，引起该患者心律失常及心悸等症状的主要原因是", "option": ["A. 西咪替丁与氨茶碱竞争血浆蛋白", "B. 西咪替丁抑制氨茶碱的肾小管分泌", "C. 西咪替丁促进氨茶碱的吸收", "D. 西咪替丁抑制肝药酶，减慢了氨茶碱的代谢", "E. 西咪替丁增强组织对氨茶碱的敏感性"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_249", "questionText": "苯唑西林的生物半衰期t1/2=0.5h，其30%原形药物经肾排泄，且肾排泄的主要机制是肾小球滤过和肾小球分泌，其余大部分经肝代谢消除，对肝肾功能正常的病人，该药物的肝清除速率常数是", "option": ["A. 4.62h-1", "B. 0.97h-1", "C. 1.98h-1", "D. 1.39h-1", "E. 0.42h-1"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_250", "questionText": "靶向制剂可分为被动靶向制剂、主动靶向制剂和物理化学靶向制剂三大类属于物理化学靶向制剂的是", "option": ["A. 脑部靶向前体药物", "B. 微乳", "C. 磁性纳米囊", "D. 免疫纳米球", "E. 免疫脂质体"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_251", "questionText": "给1型糖尿病患者皮下注射胰岛素控制血糖的机制属于", "option": ["A. 补充体内活性物质", "B. 改变离子通道的通透性", "C. 影响酶的活性", "D. 改变細胞周围环境的理化性质", "E. 影响机体免疫功能"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_252", "questionText": "静脉注射某药80mg，初始血药浓度为20μg/ml，则该药的表观分布容积v为", "option": ["A. 0.25L", "B. 0.4L", "C. 4L", "D. 1.6L", "E. 16L"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_253", "questionText": "通过抑制血管紧张素转化酶发挥药理作用的药物是", "option": ["A. 依那普利", "B. 阿司匹林", "C. 厄贝沙坦", "D. 硝苯地平", "E. 硝酸甘油"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_254", "questionText": "服用阿托品解除胃肠痉挛时，引起口干、心悸的不良反应属于", "option": ["A. 后遗效应", "B. 首剂效应", "C. 副作用", "D. 继发性反应", "E. 变态反应"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_255", "questionText": "易发生水解降解反应的药物是", "option": ["A. 吗啡image.png", "B. 肾上腺素image.png", "C. 布洛芬image.png", "D. 盐酸氯丙嗪image.png", "E. 头炮唑林image.png"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_256", "questionText": "阿昔洛韦的母核结构是image.png", "option": ["A. 嘧啶环", "B. 咪唑环", "C. 鸟嘌呤环", "D. 吡咯环", "E. 吡啶环"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_257", "questionText": "药物分子与机体生物大分子相互作用方式有共价键合和非共价键合两大类，以共价键键合方式与生物大分子作用的药物是", "option": ["A. 美法仑image.png", "B. 美洛昔康image.png", "C. 雌二醇image.png", "D. 乙胺丁醇image.png", "E. 卡托普利image.png"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_258", "questionText": "普鲁卡因在体内与受体之间存在多种结合形式，结合模式如图所示：image.png图中，B区域的结合形式是", "option": ["A. 氢键作用", "B. 离子-偶极作用", "C. 偶极-偶极作用", "D. 电荷转移作用", "E. 疏水作用"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_259", "questionText": "氨茶碱结构如图所示：image.png，《中国药典》规定氨茶碱为白色至微黄色的颗粒或粉末,易结块；在空气中吸收二氧化碳,并分解成茶碱，根据氨茶碱的性状，其贮存的条件应满足", "option": ["A. 遮光，密闭，室温保存", "B. 遮光，密封，室温保存", "C. 遮光，密闭，阴凉处保存", "D. 遮光，严封，阴凉处保存", "E. 遮光，熔封，冷处保存"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_260", "questionText": "对乙酰氨基酚在体內会转化生成乙酰亚胺醌，乙酰亚胺醌会耗竭肝內储存的谷胱甘肽，进而与某些肝脏蛋白的巯基结构形成共价加成物引起肝毒性根据下列药物结构判断，可以作为对乙酰氨基酚中毒解救药物的是image.png", "option": ["A. image.png", "B. image.png", "C. image.png", "D. image.png", "E. image.png"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_261", "questionText": "在规定的介质中，按要求缓慢恒速释放药物的制剂称为", "option": ["A. 物理化学靶向制剂", "B. 主动靶向制剂", "C. 被动靶向制剂", "D. 控释制剂", "E. 缓释制剂"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_262", "questionText": "在规定介质中，按要求缓慢非恒速释放药物的制剂称为", "option": ["A. 物理化学靶向制剂", "B. 主动靶向制剂", "C. 被动靶向制剂", "D. 控释制剂", "E. 缓释制剂"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_263", "questionText": "用修饰的药物载体将药物定向运送至靶部位发挥药效的制剂称为", "option": ["A. 物理化学靶向制剂", "B. 主动靶向制剂", "C. 被动靶向制剂", "D. 控释制剂", "E. 缓释制剂"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_264", "questionText": "葡萄糖-6磷酸脱氢酶G-6-PD)缺陷患者服用对乙酰氨基酚易发生", "option": ["A. 急性肾小管坏死", "B. 溶血性贫血", "C. 系统性红斑狼疮", "D. 血管炎", "E. 周围神经炎"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_265", "questionText": "服用异烟肼，慢乙酰化型患者比快乙酰化型患者更易发生", "option": ["A. 急性肾小管坏死", "B. 溶血性贫血", "C. 系统性红斑狼疮", "D. 血管炎", "E. 周围神经炎"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_266", "questionText": "按药品不良反应新分类方法，抗生素引起的肠道内耐药菌群的过度生长属于", "option": ["A. F类反应(家族性反应)", "B. D类反应(给药反应)", "C. G类反应(基因毒性反应)", "D. A类反应(扩大反应)", "E. B类反应(过度反应)"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_267", "questionText": "按药品不良反应新分类方法，注射液中微粒引起的血管栓塞属于", "option": ["A. F类反应(家族性反应)", "B. D类反应(给药反应)", "C. G类反应(基因毒性反应)", "D. A类反应(扩大反应)", "E. B类反应(过度反应)"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_268", "questionText": "蛋白质和多肽的吸收具有一定的部位特异性，其主要吸收方式是", "option": ["A. 膜动转运", "B. 简单扩散", "C. 主动转运", "D. 滤过", "E. 易化扩散"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_269", "questionText": "细胞外的K+及细胞内的Na+可通过Na+，K+-ATP酶逆浓度差跨膜转运，这种过程称为", "option": ["A. 膜动转运", "B. 简单扩散", "C. 主动转运", "D. 滤过", "E. 易化扩散"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_270", "questionText": "经胃肠道吸收的药物进入体循环前的降解或失活的过程称为()", "option": ["A. 肠-肝循环", "B. 生物转化", "C. 首过效应", "D. 诱导效应", "E. 抑制效应"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_271", "questionText": "药物在体内经药物代谢醉的催化作用,发生结构改变的过程称为()", "option": ["A. 肠-肝循环", "B. 生物转化", "C. 首过效应", "D. 诱导效应", "E. 抑制效应"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_272", "questionText": "《中国药典》规定崩解时限为30分钟的剂型是", "option": ["A. 薄膜衣片", "B. 含片", "C. 泡腾片", "D. 普通片", "E. 肠溶片"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_273", "questionText": "《中国药典》规定崩解时限为5分钟的剂型是", "option": ["A. 薄膜衣片", "B. 含片", "C. 泡腾片", "D. 普通片", "E. 肠溶片"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_274", "questionText": "在不同药物动力学模型中，计算血药浓度与所向关系会涉及不同参数;非房室分析中，平均滞留时间是", "option": ["A. CI", "B. Km，Vm", "C. MRT", "D. Ka", "E. β"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_275", "questionText": "在不同药物动力学模型中，计算血药浓度与所向关系会涉及不同参数;双室模型中，慢配置速度常数是", "option": ["A. CI", "B. Km，Vm", "C. MRT", "D. Ka", "E. β"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_276", "questionText": "服用西地那非，给药剂量在25mg时“蓝视”发生率为3%左右；给药剂量在50~100mg时，“蓝视”发生率上升到10%产生这种差异的原因在影响药物作用因素中属于", "option": ["A. 精神因素", "B. 给药途径因素", "C. 遗传因素", "D. 药物剂量因素", "E. 给药时间因素"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_277", "questionText": "硝酸甘油口服给药效果差，舌下含服起效迅速，导致这种差异的原因在影响药物作用因素中属于", "option": ["A. 精神因素", "B. 给药途径因素", "C. 遗传因素", "D. 药物剂量因素", "E. 给药时间因素"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_278", "questionText": "黄种人服用吗啡后的不良反应发生率高于白种人，引起这种差异的原因在影响药物作用因素中属于", "option": ["A. 精神因素", "B. 给药途径因素", "C. 遗传因素", "D. 药物剂量因素", "E. 给药时间因素"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_279", "questionText": "属于主动转运的肾排泄过程是", "option": ["A. 肾小管分泌", "B. 肾小球滤过", "C. 乳汁排泄", "D. 胆汁排泄", "E. 肾小管重吸收"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_280", "questionText": "可能引起肠肝循环的排泄过程是", "option": ["A. 肾小管分泌", "B. 肾小球滤过", "C. 乳汁排泄", "D. 胆汁排泄", "E. 肾小管重吸收"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_281", "questionText": "连续使用吗啡，人体对吗啡镇痛效应明显减弱,必需增加剂量方可获原用剂量的相同效应，这种对药物的反应性逐渐减弱的状态称为", "option": ["A. 交叉耐药性", "B. 药物耐受性", "C. 反跳反应", "D. 精神依赖性", "E. 身体依赖性"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_282", "questionText": "长期使用β受体拮抗药治疗高血压，如果用药者需要停药应采取逐渐减量的方式若突然停药或减量过快，则会引起原病情加重这种现象称为", "option": ["A. 交叉耐药性", "B. 药物耐受性", "C. 反跳反应", "D. 精神依赖性", "E. 身体依赖性"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_283", "questionText": "长期使用阿片类药物，导致机体对其产生适应状态，停药出现戒断综合征，这种药物的不良反应称为", "option": ["A. 交叉耐药性", "B. 药物耐受性", "C. 反跳反应", "D. 精神依赖性", "E. 身体依赖性"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_284", "questionText": "用于弱酸性药物液体制剂的常用抗氧化剂是", "option": ["A. 酒石酸", "B. 依地酸二钠", "C. 焦亚硫酸钠", "D. 维生素E", "E. 硫代硫酸钠"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_285", "questionText": "用于油溶性液体制剂的常用抗氧化剂是", "option": ["A. 酒石酸", "B. 依地酸二钠", "C. 焦亚硫酸钠", "D. 维生素E", "E. 硫代硫酸钠"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_286", "questionText": "用于碱性药物液体制剂的常用抗氧化剂是", "option": ["A. 酒石酸", "B. 依地酸二钠", "C. 焦亚硫酸钠", "D. 维生素E", "E. 硫代硫酸钠"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_287", "questionText": "生物利用度最高的给药途径是", "option": ["A. 口腔黏膜给药", "B. 静脉给药", "C. 直肠给药", "D. 经皮给药", "E. 易化扩散"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_288", "questionText": "一次给药作用持续时间相对较长的给药途径是", "option": ["A. 口腔黏膜给药", "B. 静脉给药", "C. 直肠给药", "D. 经皮给药", "E. 易化扩散"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_289", "questionText": "属于不溶性骨架缓释材料的是", "option": ["A. 醋酸纤维素酞酸脂", "B. 羟苯乙酯", "C. 乙烯-醋酸乙烯共聚物", "D. 明胶", "E. β-环糊精"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_290", "questionText": "属于肠溶性高分子缓释材料的是", "option": ["A. 醋酸纤维素酞酸脂", "B. 羟苯乙酯", "C. 乙烯-醋酸乙烯共聚物", "D. 明胶", "E. β-环糊精"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_291", "questionText": "属于水溶性高分子增稠材料的是", "option": ["A. 醋酸纤维素酞酸脂", "B. 羟苯乙酯", "C. 乙烯-醋酸乙烯共聚物", "D. 明胶", "E. β-环糊精"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_292", "questionText": "在药品质量标准中，属于药物安全性检查的项目是", "option": ["A. 重量差异", "B. 干燥失重", "C. 溶出度", "D. 热原", "E. 含量均匀度"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_293", "questionText": "在药品质量标准中，属于药物有效性检查的项目是", "option": ["A. 重量差异", "B. 干燥失重", "C. 溶出度", "D. 热原", "E. 含量均匀度"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_294", "questionText": "长期应用广谱抗菌药物导致的“二重感染”属于", "option": ["A. 变态反应", "B. 继发性反应", "C. 特异质反应", "D. 副作用", "E. 毒性反应"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_295", "questionText": "少数病人用药后发生与遗传因素相关(但与药物本身药理作用无关)的有害反应属于", "option": ["A. 变态反应", "B. 继发性反应", "C. 特异质反应", "D. 副作用", "E. 毒性反应"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_296", "questionText": "用药剂量过大或体内蓄积过多时发生的危害机体的反应属于", "option": ["A. 变态反应", "B. 继发性反应", "C. 特异质反应", "D. 副作用", "E. 毒性反应"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_297", "questionText": "对受体亲和力高、结合牢固，缺乏内在活性(α=0)的药物属于", "option": ["A. 反向激动药", "B. 部分激动药", "C. 非竞争性拮抗药", "D. 完全激动药", "E. 竞争性拮抗药"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_298", "questionText": "对受体有很高的亲和力但内在活性不强(α<1)的药物属于", "option": ["A. 反向激动药", "B. 部分激动药", "C. 非竞争性拮抗药", "D. 完全激动药", "E. 竞争性拮抗药"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_299", "questionText": "对受体有很高的亲和力和内在活性(α=1)的药物属于", "option": ["A. 反向激动药", "B. 部分激动药", "C. 非竞争性拮抗药", "D. 完全激动药", "E. 竞争性拮抗药"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_300", "questionText": "他汀类药物可引起肌痛或横纹肌溶解症的不良反应，因该不良反应而撤出市场的药物是", "option": ["A. 辛伐他汀", "B. 氟伐他汀", "C. 普伐他汀", "D. 西立伐他汀", "E. 阿托伐他汀"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_301", "questionText": "含有3，5-二羟基羧酸和吲哚环的第一个全合成他汀类调血脂药物是", "option": ["A. 辛伐他汀", "B. 氟伐他汀", "C. 普伐他汀", "D. 西立伐他汀", "E. 阿托伐他汀"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_302", "questionText": "含有3-羟基-δ-内酯环的结构片段，需要在体内水解为3，5-二羟基羧酸，才能发挥作用的HMG-CoA还原酶抑制剂是", "option": ["A. 辛伐他汀", "B. 氟伐他汀", "C. 普伐他汀", "D. 西立伐他汀", "E. 阿托伐他汀"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_303", "questionText": "合用两种分别作用于生理效应相反的两个特异性受体的激动药，产生的相互作用属于", "option": ["A. 增敏作用", "B. 脱敏作用", "C. 相加作用", "D. 生理性拮抗", "E. 药理性拮抗"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_304", "questionText": "当一种药物与特异性受体结合后，阻止激动药与其结合，产生的相互作用属于", "option": ["A. 增敏作用", "B. 脱敏作用", "C. 相加作用", "D. 生理性拮抗", "E. 药理性拮抗"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_305", "questionText": "HMG-CoA还原酶抑制剂洛伐他汀含有的骨架结构是", "option": ["A. 吡啶环", "B. 十氢化萘环", "C. 嘧啶环", "D. 吡咯环", "E. 吲哚环"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_306", "questionText": "HMG-CoA还原酶抑制剂瑞舒伐他汀含有的骨架结构是", "option": ["A. 吡啶环", "B. 十氢化萘环", "C. 嘧啶环", "D. 吡咯环", "E. 吲哚环"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_307", "questionText": "符合普通片剂溶出规律的溶岀曲线表现为", "option": ["A. image.png", "B. image.png", "C. image.png", "D. image.png", "E. image.png"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_308", "questionText": "具有双室模型特征的某药物静脉注射给药，其血药浓度时间-曲线表现为", "option": ["A. image.png", "B. image.png", "C. image.png", "D. image.png", "E. image.png"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_309", "questionText": "具有肠-肝循环特征的某药物血管外给药，其血药浓度时间-曲线表现为", "option": ["A. image.png", "B. image.png", "C. image.png", "D. image.png", "E. image.png"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_310", "questionText": "含有氧桥结构，中枢作用较强，用于预防和治疗晕动症的药物是", "option": ["A. 阿托品image.png", "B. 氢溴酸东莨菪碱image.png", "C. 氢溴酸后马托品image.png", "D. 异丙托溴铵image.png", "E. 丁溴东莨菪碱image.png"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_311", "questionText": "含有季铵结构，不易进入中枢，用于平喘的药物是", "option": ["A. 阿托品image.png", "B. 氢溴酸东莨菪碱image.png", "C. 氢溴酸后马托品image.png", "D. 异丙托溴铵image.png", "E. 丁溴东莨菪碱image.png"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_312", "questionText": "含有α-羟基苯乙酸酯结构，作用快，持续时间短，用于眼科检查和散瞳的药物是", "option": ["A. 阿托品image.png", "B. 氢溴酸东莨菪碱image.png", "C. 氢溴酸后马托品image.png", "D. 异丙托溴铵image.png", "E. 丁溴东莨菪碱image.png"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_313", "questionText": "属于前药，在体內水解成原药后发挥解热镇痛及抗炎作用的药物是", "option": ["A. 阿司匹林image.png", "B. 对乙酰氨基酚image.png", "C. 贝诺酯image.png", "D. 塞来昔布image.png", "E. 布洛芬image.png"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_314", "questionText": "虽然(S)-异构体的活性比(R)-异构体强，但在体内会发生手性转化，以外消旋体上市的药物是", "option": ["A. 阿司匹林image.png", "B. 对乙酰氨基酚image.png", "C. 贝诺酯image.png", "D. 塞来昔布image.png", "E. 布洛芬image.png"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_315", "questionText": "选择性抑制COX-2的非甾体抗炎药，胃肠道副作用小，但在临床使用中具有潜在心血管事存风险的药物是", "option": ["A. 阿司匹林image.png", "B. 对乙酰氨基酚image.png", "C. 贝诺酯image.png", "D. 塞来昔布image.png", "E. 布洛芬image.png"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_316", "questionText": "药物分子中的16位为甲基，21位为羟基，该羟基可以与磷酸或琥珀酸成酯，进一步与碱金属成盐，增加水溶性，该药物是", "option": ["A. 氢化泼尼松image.png", "B. 曲安西龙image.png", "C. 曲安奈德image.png", "D. 地塞米松image.png", "E. 氢化可地松image.png"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_317", "questionText": "药物分子中9α-位氟原子增加了抗炎活性，16位羟基降低9α-位氟原子带来的钠潴留副作用，将此羟基和17α-位羟基与丙酮生成缩酮，改善了药物动力学性质该具有缩酮结构的药物是", "option": ["A. 氢化泼尼松image.png", "B. 曲安西龙image.png", "C. 曲安奈德image.png", "D. 地塞米松image.png", "E. 氢化可地松image.png"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_318", "questionText": "1，4-二氧吡啶环的4位为3-硝基苯基，能够通过血-脑屏障，选择性地扩张脑血管，增加脑血流量，对局部缺血具有保护作用的药物是", "option": ["A. 硝苯地平image.png", "B. 尼群地平image.png", "C. 尼莫地平image.png", "D. 氨氯地平image.png", "E. 非洛地平image.png"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_319", "questionText": "分子结构具有对称性，可用于治疗冠心病，并能缓解心绞痛的药物是", "option": ["A. 硝苯地平image.png", "B. 尼群地平image.png", "C. 尼莫地平image.png", "D. 氨氯地平image.png", "E. 非洛地平image.png"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_320", "questionText": "1，4-二氢吡啶环的2位为2-氨基乙氧基甲基外消旋体和左旋体均已用于临床的药物是", "option": ["A. 硝苯地平image.png", "B. 尼群地平image.png", "C. 尼莫地平image.png", "D. 氨氯地平image.png", "E. 非洛地平image.png"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_321", "questionText": "关于苯妥英钠药效学、药动学特征的说法，正确的是", "option": ["A. 苯妥英钠在临床上不属于治疗窗窄的药物，无需监测其血药浓度", "B. 苯妥英钠的安全浓度范围较大，使用时较为安全", "C. 制定苯妥英钠给药方案时，只需要根据半衰期制定给药间隔", "D. 随着给药剂量增加，药物消除可能会明显减慢，会引起血药浓度明显增大", "E. 可以根据小剂量时的动力学参数预测高剂量时的血药浓度"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": "苯妥英钠的消除速率与血药浓度有关，在低浓度（低于10μg/ml）时，消除过程属于一级过程；高浓度时，由于肝微粒代谢酶能力有限，则按零级动力学消除，此时只要稍微增加剂量就可使血药浓度显著升高，易出现中毒症状。苯妥英钠在临床上的有效血药浓度范围是10-20μg/ml。"}
{"questionType": "单选题", "questionId": "dev_322", "questionText": "关于静脉注射苯妥英纳的血药浓度-时间曲线的说法，正确的是", "option": ["A. 高浓度下，表现为非线性药物动力学特征：AUC与剂量不成正比", "B. 低浓度下，表现为线性药物动力学特征：剂量增加，消除半衰期延长", "C. 低浓度下，表现为非线性药物动力学特征：不同剂量的血药浓度-时间曲线相互平行", "D. 高浓度下，表现为线性药物动力学特征：剂量增加，半衰期不变", "E. 高浓度下，表现为非线性药物动力学特征：血药浓度与剂量成正比"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": "苯妥英钠的消除速率与血药浓度有关，在低浓度（低于10μg/ml）时，消除过程属于一级过程；高浓度时，由于肝微粒代谢酶能力有限，则按零级动力学消除，此时只要稍微增加剂量就可使血药浓度显著升高，易出现中毒症状。苯妥英钠在临床上的有效血药浓度范围是10-20μg/ml。"}
{"questionType": "单选题", "questionId": "dev_323", "questionText": "关于苯妥英钠在较大浓度范围的消除速率的说法，正确的是", "option": ["A. 用米氏方程表示，消除快慢只与参数Vm有关", "B. 用米氏方程表示，消除快慢只与参数Km有关", "C. 用米氏方程表示，消除快慢与参数Km和Vm有关", "D. 用零级动力学方程表示，消除快慢体现在消除速率常数K0上", "E. 用一级动力学方程表示，消除快慢体现在消除速率常数k上"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": "苯妥英钠的消除速率与血药浓度有关，在低浓度（低于10μg/ml）时，消除过程属于一级过程；高浓度时，由于肝微粒代谢酶能力有限，则按零级动力学消除，此时只要稍微增加剂量就可使血药浓度显著升高，易出现中毒症状。苯妥英钠在临床上的有效血药浓度范围是10-20μg/ml。"}
{"questionType": "单选题", "questionId": "dev_324", "questionText": "己知苯妥英钠在肝肾功能正常病人中的K=12μg/ml，Vm=10mg/(kg.d)，当给药剂量为3mg/(kg.d)，则稳态血药浓度Css=5.1μg/ml；当每天给药剂量为6mg/(kg.d)，则稳态血药浓度Css=18μg/ml己知image.png ，若希望稳态血药浓度达到12μg/ml,则病人的给药剂量是", "option": ["A. 3.5 mg/(kg.d)", "B. 5.0 mg/(kg.d)", "C. 4.0 mg/(kg.d)", "D. 4.35 mg/(kg.d)", "E. 5.6mg/(kg.d)"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": "苯妥英钠的消除速率与血药浓度有关，在低浓度（低于10μg/ml）时，消除过程属于一级过程；高浓度时，由于肝微粒代谢酶能力有限，则按零级动力学消除，此时只要稍微增加剂量就可使血药浓度显著升高，易出现中毒症状。苯妥英钠在临床上的有效血药浓度范围是10-20μg/ml。"}
{"questionType": "单选题", "questionId": "dev_325", "questionText": "按药物来源分类，多西他赛属于", "option": ["A. 天然药物", "B. 半合成天然药物", "C. 合成药物", "D. 生物药物", "E. 半合成抗生素"], "year": "2018", "answer": ["B"], "subject": "2018药一", "backgroundText": "紫杉醇(Taxol)是从美国西海岸的短叶红豆杉的树皮中提取得到的具有紫杉烯环结构的二萜类化合物，属有丝分裂抑制剂或纺锤体毒素。多西他赛( Docetaxel)是由10-去乙酰基浆果赤霉素进行半合成得到的紫杉烷抗肿瘤药物，结构上与紫杉醇有两点不同，一是第10位碳上的取代基，二是3'位上的侧链。多西他赛的水溶性比紫杉醇好，毒性较小，抗肿瘤谱更广。"}
{"questionType": "单选题", "questionId": "dev_326", "questionText": "紫杉醇注射液中通常含有聚环氧化蓖麻油，其作用是", "option": ["A. 助悬剂", "B. 稳定剂", "C. 等渗调节剂", "D. 增溶剂", "E. 金属鳌合剂"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": "紫杉醇(Taxol)是从美国西海岸的短叶红豆杉的树皮中提取得到的具有紫杉烯环结构的二萜类化合物，属有丝分裂抑制剂或纺锤体毒素。多西他赛( Docetaxel)是由10-去乙酰基浆果赤霉素进行半合成得到的紫杉烷抗肿瘤药物，结构上与紫杉醇有两点不同，一是第10位碳上的取代基，二是3'位上的侧链。多西他赛的水溶性比紫杉醇好，毒性较小，抗肿瘤谱更广。"}
{"questionType": "单选题", "questionId": "dev_327", "questionText": "根据构效关系判断，属于多西他赛结构的是", "option": ["A. image.png", "B. image.png", "C. image.png", "D. image.png", "E. image.png"], "year": "2018", "answer": ["E"], "subject": "2018药一", "backgroundText": "紫杉醇(Taxol)是从美国西海岸的短叶红豆杉的树皮中提取得到的具有紫杉烯环结构的二萜类化合物，属有丝分裂抑制剂或纺锤体毒素。多西他赛( Docetaxel)是由10-去乙酰基浆果赤霉素进行半合成得到的紫杉烷抗肿瘤药物，结构上与紫杉醇有两点不同，一是第10位碳上的取代基，二是3'位上的侧链。多西他赛的水溶性比紫杉醇好，毒性较小，抗肿瘤谱更广。"}
{"questionType": "单选题", "questionId": "dev_328", "questionText": "关于导致患者出现血压明显下降及心悸等症状的原因的说法，正确的是", "option": ["A. 由于控释片破碎使较大量的硝苯地平突释", "B. 药品质量缺陷所致", "C. 由于控释片破碎使硝苯地平剂量损失，血药浓度未达有效范围", "D. 药品正常使用情况下发生的不良反应", "E. 患者未在时辰药理学范畴正确使用药物"], "year": "2018", "answer": ["A"], "subject": "2018药一", "backgroundText": "患者，女，78岁。因患高血压病长期口服硝苯地平控释片(规格为30mg)，每日1次，每次1片，血压控制良好。近两日因气温骤降，感觉血压明显升高，于18时自查血压达170/110mmHg决定加服1片药，担心起效慢将其碾碎后吞服，于19时再次自测血压降至110/70mmHg，后续又出现头晕、恶心、心悸胸间，随后就医。"}
{"questionType": "单选题", "questionId": "dev_329", "questionText": "关于口服缓释、控释制剂的临床应用与注意事项的说法，错误的是", "option": ["A. 缓释制剂用药次数过多或增加给药剂量可导致血药浓度增高", "B. 部分缓释制剂的药物释放速度由制剂表面的包衣膜决定", "C. 控释制剂的服药间隔时间通常为12小时或24小时", "D. 控释制剂的药物释放速度恒定，偶尔过量服用不会影响血药浓度", "E. 缓释制剂用药次数不够会导致药物的血药浓度过低，达不到应有的疗效"], "year": "2018", "answer": ["D"], "subject": "2018药一", "backgroundText": "患者，女，78岁。因患高血压病长期口服硝苯地平控释片(规格为30mg)，每日1次，每次1片，血压控制良好。近两日因气温骤降，感觉血压明显升高，于18时自查血压达170/110mmHg决定加服1片药，担心起效慢将其碾碎后吞服，于19时再次自测血压降至110/70mmHg，后续又出现头晕、恶心、心悸胸间，随后就医。"}
{"questionType": "单选题", "questionId": "dev_330", "questionText": "硝苯地平控释片的包衣材料是", "option": ["A. 卡波姆", "B. 聚维酮", "C. 醋酸纤维素", "D. 羟丙甲纤维素", "E. 醋酸纤维素酞酸酯"], "year": "2018", "answer": ["C"], "subject": "2018药一", "backgroundText": "患者，女，78岁。因患高血压病长期口服硝苯地平控释片(规格为30mg)，每日1次，每次1片，血压控制良好。近两日因气温骤降，感觉血压明显升高，于18时自查血压达170/110mmHg决定加服1片药，担心起效慢将其碾碎后吞服，于19时再次自测血压降至110/70mmHg，后续又出现头晕、恶心、心悸胸间，随后就医。"}
{"questionType": "单选题", "questionId": "dev_331", "questionText": "醋酸氢化可的松是药品的", "option": ["A.商品名", "B.化学名", "C.通用名", "D.俗名", "E.品牌名"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_332", "questionText": "影响药物制剂稳定性的非处方因素是", "option": ["A.pH", "B.温度", "C.溶剂", "D.离子强度", "E.表面活性剂"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_333", "questionText": "药用辅料是制剂生产中必不可少的重要组成部分，其主要作用不包括的是", "option": ["A.提高药物稳定性", "B.降低药物不良反应", "C.降低药物剂型设计难度", "D.提高用药顺应性", "E.调节药物作用速度"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_334", "questionText": "抗哮喘药沙丁胺醇的化学结构式如下，其化学骨架属于img.png", "option": ["A.芳基丙酸类", "B.芳氧丙醇胺类", "C.二氢吡啶类", "D.苯二氨䓬类", "E.苯乙醇胺类"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_335", "questionText": "在药物与受体结合过程中，结合力最强的非共价键键合形式是", "option": ["A.氢键", "B.离子-偶极相互作用", "C.疏水性相互作用", "D.范德华力", "E.离子键"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_336", "questionText": ".谷胱甘肽是内源性的小分子化合物，在体内参与多种药物或毒物及其代谢产物的结合代谢，起到解毒作用。关于谷胱甘肽结构和性质的说法，错误说法的是", "option": ["A.为三肽化合物", "B.结构中含有巯基", "C.具有亲电性质", "D.可清除有害的亲电物质", "E.具有氧化还原性质"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_337", "questionText": "关于环磷酰胺（化学结构如下）结构特点和应用的说法，错误的是img.png", "option": ["A.环磷酰胺属于前药", "B.磷酰基的引入使毒性升高", "C.正常细胞内可转化为无毒代谢产物", "D.属于氨芥类药物", "E.临床用于抗肿瘤"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_338", "questionText": "异丙托溴铵制剂处方如下，处方中枸橼酸的作用是", "option": ["A.潜溶剂", "B.防腐剂", "C.助溶剂", "D.抛射剂", "E.pH 调节剂"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_339", "questionText": "主要通过氧自由基途径，导致心肌细胞氧化应激损伤，破坏了细胞膜的完整性，产生心脏毒性的药物是", "option": ["A.多柔比星", "B.地高辛", "C.维拉帕米", "D.普罗帕酮", "E.胺碘酮"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_340", "questionText": "罗拉匹坦制剂的处方如下。【处方】罗拉匹坦 0.5g 精制大豆油 50g卵磷脂 45g 泊洛沙姆 4.0g油酸钠 0.25g 甘油 22.5g注射用水加至 1000ml.该制剂是", "option": ["A.注射用混悬剂", "B.口服乳剂", "C.外用乳剂", "D.静脉注射乳剂", "E.脂质体注射液"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_341", "questionText": "关于药物主动转运特点的说法，错误的是", "option": ["A.无部位特异性", "B.逆浓度梯度转运", "C.需要消耗机体能量", "D.需要载体参与", "E.有结构特异性"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_342", "questionText": "为了使某些药物给药后能迅速达到或接近稳态血药浓度以快速发挥药效，临床可采取的给药方式是", "option": ["A.先静脉注射一个负荷剂量，再恒速静脉滴注", "B.加快静脉滴注速度", "C.多次间隔静脉注射", "D.单次大剂量静脉注射", "E.以负荷剂量持续滴注"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_343", "questionText": "两药同时使用时，一个药物可通过诱导体内生化反应而使另一个药物的药效降低。下列药物同时使用时，会发生这种相互作用的是", "option": ["A.β受体阻断药阿替洛尔与利尿药氢氯噻氢", "B.抗痛风药丙磺舒与青霉素", "C.解热镇痛药阿司匹林与对乙酰氨基酚", "D.磺胺甲噁唑与甲氧苄啶", "E.抗癫痫病药苯巴比妥与避孕药"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_344", "questionText": "用烯丙基、环丙基甲基或环丁基甲基对吗啡及其类似物的部分进行修饰后，由阿片受体激动剂转为拮抗剂。属于阿片受体拮抗剂的是", "option": ["A.img.png", "B.img.png", "C.img.png", "D.img.png", "E.img.png"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_345", "questionText": "患者服用伯氨喹后发生溶血性贫血，其原因是体内缺乏", "option": ["A.N-乙酰基转移酶", "B.假性胆碱酯酶", "C.乙醋脱氢酶D.葡萄糖-6-磷酸脱氢酶", "D.葡萄糖-6-磷酸脱氢酶", "E.异喹胍-4-羟化酶"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_346", "questionText": "下列药物制剂中，要求在冷处保存的是", "option": ["A 注射用门冬酰胺酶", "B.对乙酰氨基酚片", "C.硫酸阿托品注射液", "D.丙酸倍氯米松气雾剂", "E.红霉素软膏"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_347", "questionText": "下列在体内具有生物功能的大分子中，属于 I 相代谢酶的是", "option": ["A.拓扑异构酶", "B.葡萄糖醛酸转移酶", "C.N-乙酰基转移酶", "D.血管紧张素转化酶", "E.混合功能氧化酶"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_348", "questionText": "某患者上呼吸道感染，用氨苄西林治疗一周，未见明显好转，后改用舒他西林，症状得到改善。关于舒他西林结构和临床使用的说法，错误的是", "option": ["A.为一种前体药物", "B.给药后，在体内非特定酯酶的作用下水解成氨苄西林和舒巴坦", "C.对β-内酰胺酶的稳定性强于氨苄西林", "D.抗菌效果优于氨苄西林，原因是它在体内生成的两种药物都有较强的抗菌活性", "E.可以口服，且口服后吸收迅速"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_349", "questionText": "在药物安全指标中，药物安全范围指的是", "option": ["A.ED5和 LD95之间的距离", "B.ED95和 LD5之间的距离", "C.ED1和 LD99之间的距离", "D.ED50和 LD50之间的距离", "E.ED99和 LD1之间的距离"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_350", "questionText": "原形无效，需经代谢后产生活性的药物是", "option": ["A.甲苯磺丁脲", "B.普萘洛尔", "C.氯吡格雷", "D.地西洋", "E.丙米嗪"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_351", "questionText": "亚洲人易发生某种代谢酶基因突变，导致部分患者使用奥美拉唑时，其体内该药物的 AUC 明显增加，该代谢酶是", "option": ["A.CYP2D6", "B.CYP3A4", "C.CYP2C19", "D.CYP2C9", "E.CYP1A2"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_352", "questionText": "下列不属于 G 蛋白偶联受体的是", "option": ["A.M 胆碱受体", "B.γ-氨基丁酸受体", "C.阿片受体", "D.肾上腺素受体", "E.多巴胺受体"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_353", "questionText": "关于气雾剂质量要求的说法，错误的是", "option": ["A.无毒", "B.无刺激性", "C.容器应能耐受所需压力", "D.均应符合微生物限度检查要求", "E.应置凉暗处贮藏"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_354", "questionText": "特质性药物毒性是指药物在体内发生代谢作用生成有反应活性的代谢物而引发的毒性作用。属于特质性药物毒性的是", "option": ["A.非甾体抗炎药罗非昔布引发的心肌梗塞", "B.抗过敏药特非那定导致的药源性心律失常", "C.抗精神病药氯丙嗪引起的锥体外系反应", "D.抗高血压药依那普利引起的刺激性干咳", "E.降血糖药曲格列酮引起的硬化性腹膜炎"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_355", "questionText": ".某药物的生物半豪期约为 8h，其临床治疗的最低有效浓度约为 10μg/mL，当血药浓度达到 30μg/mL 时，会产生不良反应。关于该药物给药方案设计依据的说法，正确的是", "option": ["A.不考虑稳态血药浓度，仅根据药物半衰期进行给药", "B.根据最小稳态血药浓度不小于 10μg/mL，且最大稳态血药浓度小于 30μg/mL 给药", "C.根据平均稳态浓度为 20μg/mL 给药", "D.根据最小稳态血药浓度不小于 10μg/mL 给药", "E 根据最大稳态血药浓度小于 30μg/mL 给药"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_356", "questionText": "静脉注射某药 100mg，立即采集血样，测出血药浓度为 5μg/mL，其表观分布容积约为", "option": ["A.5L", "B.2L", "C.20L", "D.50L", "E.20mL"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_357", "questionText": "口服液体制剂中常用的潜溶剂是", "option": ["A.聚山梨酯 80", "B.乙醇", "C.苯甲酸", "D.乙二胺", "E.羟苯乙酯"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_358", "questionText": "关于非甾体抗炎药布洛芬结构和应用的说法，错误的是", "option": ["A.S-异构体的代谢产物有较高活性", "B.S-异构体的活性优于 R-异构体", "C.口服吸收快，Tmax约为 2 小时", "D.临床上常用外消旋体", "E.R-异构体在体内可转化为 S-异构体"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_359", "questionText": "复方甲地孕酮制剂处方如下。处方中羧甲基纤维素钠用【处方】甲地孕酮 15mg 戊酸雌二醇 5mg阿拉伯胶适量 明胶适量羧甲基纤维素钠（黏度 300~600 厘泊）适量硫柳汞（注射用）适量", "option": ["A.包衣囊材", "B.分散剂", "C.黏合剂", "D.助悬剂", "E.稳定剂"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_360", "questionText": "关于生物等效性研究的实施与样品采集的说法，正确的是", "option": ["A.通常采用受试制剂和参比制剂的单个最低规格制剂进行试验", "B.从 0 时到最后一个样品采集时间 t 的曲线下面积与时间从 0 到无穷大的 AUC 之比通常应当达于 70%", "C.整个采样时间不少于 3 个末端消除半哀期", "D.受试制剂与参比制剂药物含量的差值应小于 2%", "E.一般情况下，受试者试验前至少空腹 8 小时"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_361", "questionText": "《中国药典》规定，凡检查溶出度、释放度或分散均匀性的制剂，一般不再检查的项目是", "option": ["A.有关物质", "B.崩解时限", "C.残留溶剂", "D.重（装）量差异", "E.含量均匀度"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_362", "questionText": "在注射剂、滴眼剂的生产中使用的溶剂", "option": ["A.饮用水", "B.注射用水", "C.去离子水", "D.纯化水", "E.灭菌注射用水"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_363", "questionText": "氧化锌制剂处方如下，该制剂是【处方】氧化锌 250g 淀粉 250g羊毛脂 250g 凡士林 250g", "option": ["A.软膏剂", "B.糊剂", "C.硬膏剂", "D.乳膏剂", "E.凝胶剂"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_364", "questionText": ".非索非那定为 H1受体阻断药，，适用于减轻季节性过性鼻炎和慢性特发性荨麻疹引起的症状。下列关于非索非那定结构和临床使用的说法错误的是", "option": ["A.为特非那定的体内活性代谢产物", "B.具有较大的心脏毒副作用", "C.分子中含有一个羧基", "D.不易通过血-脑屏障，因而几乎无镇静作用", "E.口服后吸收迅速"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_365", "questionText": "替丁类（-tidine）代表药物西咪替丁的结构式如下。关于该类药物的构效关系和应用的说法，错误的是img.png", "option": ["A.临床上常用于治疗过敏性疾病", "B.作用于组胺 H2 受体", "C.平面极性基团是药效基团之", "D.芳环基团可为碱性基团取代的芳杂环", "E.中间连接链以四个原子为最佳"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_366", "questionText": "关于注射剂特点的说法，错误的是", "option": ["A.起效迅速、剂量准确、作用可", "B.适用于不宜口服的药物", "C.可发挥局部定位治疗作用", "D.不易发生交叉污染", "E.制造过程复杂，生产成本较高"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_367", "questionText": "口服液体制剂中，药物分散度最大的不稳定体系是", "option": ["A.高分子溶液剂", "B.低分子溶液剂", "C.乳剂", "D.混悬剂", "E.溶胶剂"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_368", "questionText": "关于竞争性拮抗药的说法，错误的是", "option": ["A.小剂量产生激动作用，大剂量产生拮抗作用", "B.可与激动药竞争同一受体", "C.与受体的亲和力较强，无内在活性", "D 可使激动药的量效曲线平行右移", "E 用拮抗参数（pA2）表示拮抗强度的大小"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_369", "questionText": "为满足临床需要，许多药物往往存在多种剂型，通常认为它们在胃肠道中的吸收顺序是", "option": ["A.混悬剂>溶液剂>胶囊剂>普通片剂>包衣片", "B.溶液剂>混悬剂>胶囊剂>普通片剂>包衣片", "C.胶囊剂>混悬剂>溶液剂>普通片剂>包衣片", "D.普通片剂>包衣片>胶囊剂>混悬剂>溶液剂", "E.混悬剂>溶液剂>胶囊剂>包衣片>普通片剂"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_370", "questionText": "慢乙酰化代谢患者使用异烟肼治疗肺结核时，会导致体内维生素 B6 缺乏，易发生的不良反应是", "option": ["A.肝坏死", "B.溶血", "C.多发性神经炎", "D.系统性红斑疮", "E.呼吸豪竭"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_371", "questionText": "不属于液体制剂的是", "option": ["A.洗剂", "B.涂剂", "C.涂膜剂", "D.贴膏剂", "E.搽剂"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_372", "questionText": "复方硫黄临床常用的剂型是", "option": ["A.洗剂", "B.涂剂", "C.涂膜剂", "D.贴膏剂", "E.搽剂"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_373", "questionText": "含有高分子材料的液体制剂是", "option": ["A.洗剂", "B.涂剂", "C.涂膜剂", "D.贴膏剂", "E.搽剂"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_374", "questionText": "因胆固醇的合成有昼夜节律夜同合成增加故使用抑制胆固醇合成药物辛伐他汀时推荐的服药时间是", "option": ["A.中午", "B.清晨", "C.上午", "D.下午", "E.临睡前"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_375", "questionText": ".因肾上腺皮质激素的分泌具有晨高昼低的特点故使用维持剂量的肾上腺皮质激素类药物时推荐的服药时间是", "option": ["A.中午", "B.清晨", "C.上午", "D.下午", "E.临睡前"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_376", "questionText": "反式己烯雌酚与雌二醇具有相同的生物活性，而顺式己烯雌酚没有此活性。产生这种差异的原因是", "option": ["A.构构象异", "B.几何异构", "C.构型异构", "D.组成差异", "E.代谢差异"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_377", "questionText": "组胺可同时作用于组胺 H1和 H2受体产生不同的生理活性产生该现象的原因", "option": ["A.构构象异", "B.几何异构", "C.构型异构", "D.组成差异", "E.代谢差异"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_378", "questionText": "氧氟沙星左旋体的抗菌活性是右旋体的 9.3 倍，产生该现象的原因是", "option": ["A.构构象异", "B.几何异构", "C.构型异构", "D.组成差异", "E.代谢差异"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_379", "questionText": "通过增敏受体发挥药效的药物是", "option": ["A.地塞米松", "B.罗格列酮", "C.普萘洛尔", "D.胰岛素", "E.异丙肾上腺素"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_380", "questionText": "长期使用可使受体增敏停药后出现“反跳”现象的药物是", "option": ["A.地塞米松", "B.罗格列酮", "C.普萘洛尔", "D.胰岛素", "E.异丙肾上腺素"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_381", "questionText": "在苯二氨䓬类药物结构中引入三氮唑环增加了代谢稳定性和活性的药物是", "option": ["A.唑吡坦", "B.艾司唑仑", "C.艾司佐匹克隆", "D.地西泮", "E.奥沙西泮"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_382", "questionText": "结构中含有手性原子通过代谢途径发现的药物是", "option": ["A.唑吡坦", "B.艾司唑仑", "C.艾司佐匹克隆", "D.地西泮", "E.奥沙西泮"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_383", "questionText": "剂量过大或药物在体内蓄积过多时发生的不良反应属于", "option": ["A.特异质反应", "B.停药反应", "C.后遗效应", "D.毒性反应", "E.继发反应"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_384", "questionText": "长期应用广谱抗生素造成二重感染的不良反应属于", "option": ["A.特异质反应", "B.停药反应", "C.后遗效应", "D.毒性反应", "E.继发反应"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_385", "questionText": "均属于无菌制剂的是", "option": ["A.舌下片", "B.滴眼液", "C.漱口液", "D.滴耳液", "E.栓剂"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_386", "questionText": "起效迅速且发挥全身作用的制剂是", "option": ["A.舌下片", "B.滴眼液", "C.漱口液", "D.滴耳液", "E.栓剂"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_387", "questionText": "常用甘油作为溶剂的制剂是", "option": ["A.舌下片", "B.滴眼液", "C.漱口液", "D.滴耳液", "E.栓剂"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_388", "questionText": "评价药物亲脂性或亲水性的参数是的", "option": ["A.pKa", "B.pH", "[α]20D", "D.LogP", "E.m.p."], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_389", "questionText": "评价药物解离程度的参数是", "option": ["A.pKa", "B.pH", "[α]21D", "D.LogP", "E.m.p."], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_390", "questionText": "表示液体酸碱度的参数是", "option": ["A.pKa", "B.pH", "[α]22D", "D.LogP", "E.m.p."], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_391", "questionText": "按分散系统分类，薄荷水属液体制剂的类型是", "option": ["A.溶胶剂", "B.高分子溶液剂", "C.乳剂", "D.混悬剂", "E.低分子溶液剂"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_392", "questionText": "按分散系统分类，碘甘油属液体制剂的类型是", "option": ["A.溶胶剂", "B.高分子溶液剂", "C.乳剂", "D.混悬剂", "E.低分子溶液剂"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_393", "questionText": "按分散系统分类，炉甘石洗剂属液体制剂的类型是", "option": ["A.溶胶剂", "B.高分子溶液剂", "C.乳剂", "D.混悬剂", "E.低分子溶液剂"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_394", "questionText": "供无破损皮肤揉擦用的剂型是", "option": ["A.糊剂", "B.凝胶剂", "C.涂剂", "D.乳膏剂", "E.搽剂"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_395", "questionText": "一般含有 1/4 以上原料药物固体粉末的剂型是", "option": ["A.糊剂", "B.凝胶剂", "C.涂剂", "D.乳膏剂", "E.搽剂"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_396", "questionText": "《中国药典》规定，药物中第三类有机剂残留量的限度是", "option": ["A.0.5%", "B.1%", "C.0.1%", "D.0.2%", "E.2%"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_397", "questionText": "《中国药典》定义，“无引湿性”系指药物的引湿性增重小于", "option": ["A.0.5%", "B.1%", "C.0.1%", "D.0.2%", "E.2%"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_398", "questionText": "《中国药典》规定，药典中未定性或未确证结构的杂质的表观含量应小于", "option": ["A.0.5%", "B.1%", "C.0.1%", "D.0.2%", "E.2%"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_399", "questionText": "可以用于粉未直接压片的黏合剂是", "option": ["A.MC", "B.HPMC", "C.EC", "D.HPC", "E.CMC-Na"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_400", "questionText": "可以作为水溶性包衣材料的是", "option": ["A.MC", "B.HPMC", "C.EC", "D.HPC", "E.CMC-Na"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_401", "questionText": "可以作为水不溶性包衣材料的是", "option": ["A.MC", "B.HPMC", "C.EC", "D.HPC", "E.CMC-Na"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_402", "questionText": "结构与氨基苯甲酸类似，通过代谢拮抗方式产生抗菌活性的药物是", "option": ["A.头孢克洛img.png", "B.氟康唑img.png", "C.特比萘芬img.png", "D.克拉维酸img.png", "E.磺胺嘧啶img.png"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_403", "questionText": "结构中含有β-内酰胺环，通过抑制β-内酰胺酶，增加阿莫西林抗菌效果的药物是", "option": ["A.头孢克洛img.png", "B.氟康唑img.png", "C.特比萘芬img.png", "D.克拉维酸img.png", "E.磺胺嘧啶img.png"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_404", "questionText": "结构中含有乙炔基团，主要用于治疗真菌感染的药物是", "option": ["A.头孢克洛img.png", "B.氟康唑img.png", "C.特比萘芬img.png", "D.克拉维酸img.png", "E.磺胺嘧啶img.png"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_405", "questionText": "有明显囊壳结构的是", "option": ["A.脂质体", "B.纳米乳", "C.微球", "D.微囊", "E.纳米粒"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_406", "questionText": "常用磷脂做载体材料的是", "option": ["A.脂质体", "B.纳米乳", "C.微球", "D.微囊", "E.纳米粒"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_407", "questionText": "含有油相的是", "option": ["A.脂质体", "B.纳米乳", "C.微球", "D.微囊", "E.纳米粒"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_408", "questionText": "蛋白质和多肽类药物的吸收机制是", "option": ["A.主动转运", "B.膜孔滤过", "C.简单扩散", "D.膜动转运", "E.易化扩散"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_409", "questionText": "多数脂溶性小分子类药物的吸收机制是", "option": ["A.主动转运", "B.膜孔滤过", "C.简单扩散", "D.膜动转运", "E.易化扩散"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_410", "questionText": "维生素 B2在小肠上段的吸收机制是", "option": ["A.主动转运", "B.膜孔滤过", "C.简单扩散", "D.膜动转运", "E.易化扩散"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_411", "questionText": "AUC 的 90%置信区应为", "option": ["A.70%~145%", "B.80%~145%", "C.70%~130%", "D.80%~130%", "E.80%~120%"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_412", "questionText": "Cmax的 90%置信区应为", "option": ["A.70%~145%", "B.80%~145%", "C.70%~130%", "D.80%~130%", "E.80%~120%"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_413", "questionText": "一般杂质检查", "option": ["A.释放度", "B.溶解度", "C.细菌内毒素", "D.氯化物", "E.含量"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_414", "questionText": "特殊项检查", "option": ["A.释放度", "B.溶解度", "C.细菌内毒素", "D.氯化物", "E.含量"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_415", "questionText": "作用于二肽基肽酶-4（DPP-4），为嘧啶二酮衍生物，适用于治疗 2 型糖尿病的药物是", "option": ["A.那格列奈", "B.阿格列汀", "C.罗格列酮", "D.达格列净", "E 格列吡嗪"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_416", "questionText": "属于胰岛素增敏剂，具有噻唑烷二酮结构，适用于治疗 2 型糖尿病的药物是", "option": ["A.那格列奈", "B.阿格列汀", "C.罗格列酮", "D.达格列净", "E 格列吡嗪"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_417", "questionText": "表示药物在体内波动程度的参数是", "option": ["A.DF", "B.MRT", "C.AUMC", "D.Cmax", "E.AUC"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_418", "questionText": "表示药物分子在体内平均滞留时间的", "option": ["A.DF", "B.MRT", "C.AUMC", "D.Cmax", "E.AUC"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_419", "questionText": "能反映药物在体内吸收程度的参数是", "option": ["A.DF", "B.MRT", "C.AUMC", "D.Cmax", "E.AUC"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_420", "questionText": "患者在服用红霉素类抗生素后，产生恶心、呕吐等胃肠道副作用的原因是", "option": ["A.药物与非治疗部位靶标结合产生的副作用", "B.药物抑制了心脏快速延迟整流钾离子通道（hERG）产生的副作用", "C.药物的代谢产物产生的副作用", "D.药物与非治疗靶标结合产生的副作用", "E.药物抑制细胞色素 P450 酶产生的副作用"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_421", "questionText": "非甾体抗炎药双氯芬酸结构中含有二苯胺片段，当长时间或大剂量使用该药物时可能会引起肝脏毒性，其原因是", "option": ["A.药物与非治疗部位靶标结合产生的副作用", "B.药物抑制了心脏快速延迟整流钾离子通道（hERG）产生的副作用", "C.药物的代谢产物产生的副作用", "D.药物与非治疗靶标结合产生的副作用", "E.药物抑制细胞色素 P451 酶产生的副作用"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_422", "questionText": "在体外无活性，需在体内水解开环发挥活性的药物是", "option": ["A 洛伐他汀", "B.氟伐他汀", "C.瑞舒伐他汀", "D.普伐他汀钠", "E.阿托伐他汀"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_423", "questionText": "用吲咪环代替六氢萘环，第一个通过全合成得到的药物是", "option": ["A 洛伐他汀", "B.氟伐他汀", "C.瑞舒伐他汀", "D.普伐他汀钠", "E.阿托伐他汀"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_424", "questionText": "结构中引入甲磺酰基，通过氢键作用增大了与酶的结合能力，使药效增强的药物是", "option": ["A 洛伐他汀", "B.氟伐他汀", "C.瑞舒伐他汀", "D.普伐他汀钠", "E.阿托伐他汀"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_425", "questionText": "罗替高汀（罗替戈汀）长效混悬型注射剂处方中含有上述主要辅料，其中：用于增加分散质的黏度，以降低微粒沉降速度的辅料是", "option": ["A.聚山梨酯 20", "B.甘露醇", "C.磷酸二氢钠", "D.PEG4000", "E.柠檬酸"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_426", "questionText": "罗替高汀（罗替戈汀）长效混悬型注射剂处方中含有上述主要辅料，其中：用于调节渗透压，降低注射剂刺激性的辅料是", "option": ["A.聚山梨酯 20", "B.甘露醇", "C.磷酸二氢钠", "D.PEG4000", "E.柠檬酸"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_427", "questionText": "鱼肝油乳处方如下：.【处方】鱼肝油 500mg 阿拉伯胶细粉 0.5g西黄蓍胶细粉 7g 糖精钠 0.1g挥发杏仁油 1ml 羟苯乙酯 0.5g纯化水加至 1000ml。处方中，阿拉伯胶用作", "option": ["A.乳化剂", "B.矫味剂", "C.溶剂", "D.稳定剂立", "E.防腐剂"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_428", "questionText": "鱼肝油乳处方如下：.【处方】鱼肝油 500mg 阿拉伯胶细粉 0.5g西黄蓍胶细粉 7g 糖精钠 0.1g挥发杏仁油 1ml 羟苯乙酯 0.5g纯化水加至 1001ml。处方中，挥发杏仁油用作", "option": ["A.乳化剂", "B.矫味剂", "C.溶剂", "D.稳定剂立", "E.防腐剂"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_429", "questionText": "作用于二肽基肽酶-4（DPP-4），为嘧啶二酮衍生物，适用于治疗 2 型糖尿病的药物是", "option": ["A.那格列奈img.png", "B.阿格列汀img.png", "C.罗格列酮img.png", "D.达格列净img.png", "E.格列吡嗪img.png"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_430", "questionText": "属于胰岛素增敏剂，具有噻唑烷二酮结构，适用于治疗 2 型糖尿病的药物是", "option": ["A.那格列奈img.png", "B.阿格列汀img.png", "C.罗格列酮img.png", "D.达格列净img.png", "E.格列吡嗪img.png"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_431", "questionText": "舍曲林的化学结构如下，体内过程符合线性药动学特征，只有极少量（<0.2%）以原型从尿中排泄，临床上常用剂量 50mg-200mg，每天给药一次，肝肾功能正常的某患者服药后的达峰时间为 5h，其消除半衰期为24h，血浆蛋白结合率为 98%。img.png.如果患者的肝清除率下降了一半，则下面说法正确的是", "option": ["", "B.此时药物的半衰期约为 48h", "C.临床使用应增加剂量", "D.此时药物的达峰时间约为 10h", "E.此时药物的浓度减小为原来的 1/2 左右"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_432", "questionText": "舍曲林的化学结构如下，体内过程符合线性药动学特征，只有极少量（<0.2%）以原型从尿中排泄，临床上常用剂量 50mg-200mg，每天给药一次，肝肾功能正常的某患者服药后的达峰时间为 5h，其消除半衰期为24h，血浆蛋白结合率为 99%。img.png.舍曲林在体内的主要代谢产物仍有活性，约为舍曲林的 1/20，该主要的代谢产物是", "option": ["A.3-羟基舍曲林", "B.去甲氨基舍曲林", "C.7-羟基舍曲林", "D.N-去甲基舍曲林", "E.N-去氨舍曲林"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_433", "questionText": "舍曲林的化学结构如下，体内过程符合线性药动学特征，只有极少量（<0.2%）以原型从尿中排泄，临床上常用剂量 50mg-200mg，每天给药一次，肝肾功能正常的某患者服药后的达峰时间为 5h，其消除半衰期为24h，血浆蛋白结合率为 100%。img.png.舍曲林与格列本脲（血浆蛋白结合率为 99%，半衰期为 6-12h）合用时可能引起低血糖，其主要原因是", "option": ["A.舍曲林抑制了肝脏中代谢格列本脲的主要药物代谢酶", "B.舍曲林诱导了肝脏中代谢格列本脲的主要药物代谢酶", "C.舍曲林对格列本脲的药效有协同作用", "D.舍曲林对格列本脲的药效有增敏作用", "E.舍曲林与格列本脲竞争结合血浆蛋白"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_434", "questionText": "舍曲林的化学结构如下，体内过程符合线性药动学特征，只有极少量（<0.2%）以原型从尿中排泄，临床上常用剂量 50mg-200mg，每天给药一次，肝肾功能正常的某患者服药后的达峰时间为 5h，其消除半衰期为24h，血浆蛋白结合率为 101%。img.png.舍曲林优选的口服剂型是", "option": ["A.缓释片", "B.普通片", "C.栓剂", "D.肠溶片", "E.舌下片"], "year": "2021", "answer": ["B"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_435", "questionText": "头孢呋辛钠是一种半合成广谱抗生素在水溶液中易降解，化学结构式如下。其药动学特征可用一室模型描述，半衰期约为 1.1h，给药 24h 内，90%以上药物以原形从尿中排出，对肝肾功能正常的患者，临床上治疗肺炎时，每日三次，每次静脉注射剂量为 0.5g。头孢呋辛钠结构属于", "option": ["A.大环内酯类", "B.四环素类", "C.β-内酰胺类", "D.氨基糖苷类", "E.喹诺酮类"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_436", "questionText": "头孢呋辛钠是一种半合成广谱抗生素在水溶液中易降解，化学结构式如下。其药动学特征可用一室模型描述，半衰期约为 1.1h，给药 24h 内，90%以上药物以原形从尿中排出，对肝肾功能正常的患者，临床上治疗肺炎时，每日三次，每次静脉注射剂量为 0.6g。某患者的表观分布容积为 20L，每次静脉注射剂量为0.5g，则多次给药后的平均稳态血药浓度是", "option": ["A.4.96mg/L", "B.75mg/L", "C.3.13mg/L", "D.119mg/L", "E.2.5mg/L"], "year": "2021", "answer": ["C"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_437", "questionText": "头孢呋辛钠是一种半合成广谱抗生素在水溶液中易降解，化学结构式如下。其药动学特征可用一室模型描述，半衰期约为 1.1h，给药 24h 内，90%以上药物以原形从尿中排出，对肝肾功能正常的患者，临床上治疗肺炎时，每日三次，每次静脉注射剂量为 0.7g。头孢呋辛钠临床优选剂型是", "option": ["A.注射用油溶液", "B.注射用浓溶液", "C.注射用乳剂", "D.注射用混悬液", "E.注射用冻干粉"], "year": "2021", "answer": ["E"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_438", "questionText": "雌二醇口服几乎无效，临床常用雌二醇贴片。近年来，随着微粉化技术问世，市面上亦出现了雌二醇片。某患者使用微粉化雌二醇片治疗雌激素缺乏综合征。每次 2mg，每天服药二次，使用一段时间后，出现肝功能异常，后改用雌二醇贴片（每片 2.5mg，每片可使用 7 日），不良反应消失。关于雌二醇应用及不良反应的说法，正确的是", "option": ["A.发生不良反应的原因与雌二醇本身的药理作用有关", "B.雌二醇口服几乎无效的主要原因，是因为雌二醇溶解度低", "C.发生不良反应的原因是雌二醇的代谢产物具有毒性", "D.使用贴片后不良反应消失，是因为雌二醇缓慢而直接进入体循环", "E.使用贴片后不良反应消失，是因为贴片主要作用于皮肤"], "year": "2021", "answer": ["D"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_439", "questionText": "雌二醇口服几乎无效，临床常用雌二醇贴片。近年来，随着微粉化技术问世，市面上亦出现了雌二醇片。某患者使用微粉化雌二醇片治疗雌激素缺乏综合征。每次 2mg，每天服药二次，使用一段时间后，出现肝功能异常，后改用雌二醇贴片（每片 2.5mg，每片可使用 8 日），不良反应消失。关于雌二醇贴片特点的说法，错误的是", "option": ["A 不存在皮肤代谢", "B.避免药物对胃肠道的副作用", "C.避免峰谷现象。降低药物不良反应", "D.出现不良反应时，可随时中断给药", "E.适用于不宜口服给药及需要长期用药的患者"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_440", "questionText": "雌二醇口服几乎无效，临床常用雌二醇贴片。近年来，随着微粉化技术问世，市面上亦出现了雌二醇片。某患者使用微粉化雌二醇片治疗雌激素缺乏综合征。每次 2mg，每天服药二次，使用一段时间后，出现肝功能异常，后改用雌二醇贴片（每片 2.5mg，每片可使用 9 日），不良反应消失。雌二醇片属于小剂量片剂，应检查含量均匀度，根据《中国药典》规定，小剂量是指每片标示量小于", "option": ["A.25mg", "B.1mg", "C.5mg", "D.10mg", "E.50mg"], "year": "2021", "answer": ["A"], "subject": "2021药一", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_441", "questionText": "为配制有效氯浓度为 500mg/L 的消毒剂 10L，需要次氯酸钠溶液（有效氯浓度为 6.0%）和纯化水的量分别 是", "option": ["A.83mL 和 9917mL", "B.830mL 和 9170mL", "C.120mL 和 9880mL", "D.150mL 和 9850mL", "E.500mL 和 9500mL"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_442", "questionText": "药学信息按照其来源通常分为三级。属于三级信息资源的是", "option": ["A.期刊发表的病例报告", "B.期刊发表的试验研究结果", "C.临床实践指南", "D.文摘数据库", "E.全文数据库"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_443", "questionText": "关于滴眼剂使用的说法，错误的是", "option": ["A.使用前需清洁双手", "B.将药液滴入下眼袋内，每次 1~2 滴", "C.滴眼后轻轻闭眼 1~2 分钟", "D 如同时使用两种眼药水，宜间隔 10 分钟", "E.两眼同时患病时，先滴病情重的眼，后滴病情轻的眼"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_444", "questionText": "医师处方：头孢呋辛酯片（规格 250mg/片），500 mg bid po。为方便患者理解，药师宜将用法标示为（", "option": ["A.每日 2 次，每次 250mg，口服", "B.每日 1~2 次，每次 1 片", "C.每日 2 次，每次 2 片，口服", "D.必要时，可餐后服用 2 片", "E.必要时服用，每日剂量不超过 2 片"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_445", "questionText": "患者，男，52 岁，支气管哮喘病史 10 年。因间断喘息发作，长期自行服用泼尼松片 20mg qd。该患者可能 出现的不良反应中，不包括的是", "option": ["A.低血压", "B.骨质疏松", "C.消化性溃疡", "D.血糖升高", "E.感染"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_446", "questionText": "患者，女，31 岁，1 个月前顺产一健康男婴。近 2 周出现心境低落、乏力纳差、失眠焦虑，有自杀倾向，无 法哺乳。诊断为产后抑郁症，给予氟西汀片 20mg qd。关于该患者用药教育的说法，错误的是", "option": ["A.应足量和足疗程用药，疗效不佳可考虑换药", "B.向患者解释“剂量滴定原则”，提示其用药剂量可能需要逐渐增加", "C.氟西汀应于每日早餐后服用", "D.为尽快恢复哺乳，患者应在症状改善 1 个月后逐渐减量，直至停药", "E.氟西汀可通过乳汁分泌，服药期间建议暂停哺乳"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_447", "questionText": "患者，男，45 岁，因消化不良（上腹饱胀，餐后明显）前去药店咨询。下列说法错误的是", "option": ["A.应除外器质性疾病", "B.可用助消化药对症治疗", "C.Hp 感染是引起消化不良的常见原因", "D.进餐时不要摄入过多的液体", "E.低脂饮食，同时避免摄入过多的膳食纤维"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_448", "questionText": "患者，女，28 岁，停经 40 天，妊娠试验结果阳性，平时月经周期 32 天。20 天前因泌尿系感染服用左氧氟 沙星片 3 天，患者担心用药对胎儿有影响，前来咨询关于药物对胎儿影响的说法，正确的是", "option": ["A.此阶段是泌尿生殖器官发育期，其结果可能为胎儿泌尿生殖器官畸形", "B.此阶段胚胎细胞尚未分化，其结果可能为 应该是死胎流产或存活成正常胎儿", "C.此阶段是心脏发育期，其结果可能为胎儿心脏畸形", "D.此阶段是骨骼、肌肉发育期，其结果可能为胎儿骨骼发育异常", "E.此阶段是牙齿、中枢神经系统发育期，其结果可能为胎儿唇腭裂"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_449", "questionText": "患者，男，28 岁，出现鼻塞，打喷嚏、流涕等症状，患者从事塔吊工作，不宜选用的是", "option": ["A.肥大细 胞稳定剂", "B.白三烯受体阻断剂", "C.第一代抗组胺药", "D.糖皮质激素", "E.鼻用抗组胺药"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_450", "questionText": "药师审核麻醉药品处方时，应逐项审核。不属于规范性审核内容的是", "option": ["A.处方医师是否有麻醉药品处方权", "B.处方用量是否严格执行国家有关规定", "C.是否有病历记录", "D.是否写明临床诊断", "E.处方字迹是否清晰"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_451", "questionText": "关于药品贮存要求的说法，正确的是", "option": ["A.常温（室温），指 10℃~30℃", "B.阴凉处，指不超过 25℃", "C.避光，指用不透光的容器包装", "D.遮光，指避免日光直射", "E.凉暗处，指避光且 2℃~10℃"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_452", "questionText": "患者，女，58 岁，房颤多年，既往服用华法林，因 INR 值波动大，反复出现牙龈出血后停用，医师建议恢 复口服抗凝药，但患者拒绝再用华法林，宜选用的药物是", "option": ["A.替格瑞洛", " B.达比加群酯", "C.氯吡格雷", "D.西洛他唑", "E.双嘧达莫"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_453", "questionText": "影响药物治疗有效性的因素不包括", "option": ["A.给药途径", "B.药品价格", "C.药物相互作用", "D.患者的病生理状态", "E.给药时间"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_454", "questionText": "经皮肤和黏膜吸收中毒的救治措施，错误的是", "option": ["A.溶于水的毒物可用大量温水清洗被污染部位", "B.温水清洗皮肤时，特别注意清除毛发中的毒物", "C.对由伤口进入局部的药物中毒，严禁用止血带结扎", "D.眼部被毒物污染时，应立即用清水冲洗，并滴入相应的中和剂", "E.不溶于水的毒物，可用适当溶剂清洗"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_455", "questionText": "患者，女，32 岁，诊断为缺铁性贫血，口服硫酸亚铁治疗。药师对该患者进行用药教育时，告知其同用可 促进铁剂吸收的是", "option": ["A.牛奶", "B.咖啡", "C.肉类", "D.钙剂", "E.茶水"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_456", "questionText": "患者，女，27 岁，外阴瘙痒 5 天，妇科检查见阴道分泌物呈豆腐渣样，擦除后露出红肿黏膜面，诊断为阴 道炎。宜选用的治疗方案是", "option": ["A.局部用克林霉素软膏", "B.局部用尼尔雌醇片", "C.局部用克霉唑栓", "D.局部用甲硝唑阴道片", "E.口服莫西沙星片"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_457", "questionText": "关于儿童药动学和药效学特点的说法，错误的是", "option": ["A.和成人相比，婴儿胃液 pH 低，对酸不稳定的药物易被破坏", "B.儿童内分泌系统不够稳定，长期使用糖皮质激素易导致发育迟缓", "C.婴幼儿血浆白蛋白与药物的结合能力低于成人，血中游离药物浓度较高", "D.儿童血-脑屏障不完善，多种药物均能通过，有可能引发不良反应", "E.儿童水、电解质调节及平衡功能较差，不宜轻易使用泻下药"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_458", "questionText": "患者，男，59 岁，诊断为 2 型糖尿病，因口服降糖药疗效欠佳，给予预混胰岛素 30R 注射液。关于该患者 用药教育的说法，错误的是", "option": ["A.应警惕发生低血糖，提醒患者随身携带木糖醇糖果", "B.未开启的胰岛素制剂应冷藏保存，冷冻后不可再使用", "C.胰岛素笔芯启用后不宜冷藏保存", "D.使用前应缓慢摇匀，确保给药剂量准确", "E.注射时应变换部位，两次注射点要间隔 2cm 以上"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_459", "questionText": "下列组合中，属于联合化疗的是", "option": ["A.CHOP 方案（环磷酰胺+阿霉素+长春新碱+泼尼松）", "B.MTX 方案（甲氨蝶呤小剂量鞘内注射+甲氨蝶岭大剂量静脉输注）", "C.CTX+美司钠（环磷酰胺+美司钠）", "D.VEGF 抑制剂+ALK 抑制剂（贝伐珠单抗+奥希替尼）", "E.EGFR 抑制剂+PD-1 抑制剂（曲妥珠单抗+帕博利珠单抗）"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_460", "questionText": "患者，男，75 岁，患高血压、冠心病、高脂血症，服用阿托伐他汀钙、阿司匹林、美托洛尔、赖诺普利、 曲美他嗪。近日患者无明显诱因出现肌肉疼痛，可能引起该症状的药物是", "option": ["A.阿司匹林", "B.美托洛尔", "C.阿托伐他汀钙", "D.赖诺普利", "E.曲美他嗪"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_461", "questionText": "患者，女，65 岁，因乳腺癌接受第二周期化疗，禁用的止吐药物是", "option": ["A.甲氧氯普胺", "B.昂丹司琼", "C.地塞米松", " D.苯海拉明", "E.阿瑞匹坦"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_462", "questionText": "患者，女，35 岁，近日去植物园游玩后出现双眼结膜充血、瘙痒伴流泪，无分泌物，诊断为过敏性结膜炎。 宜选用的药物是", "option": ["A.红霉素眼膏", "B.色甘酸钠滴眼液", "C.酞丁安滴眼液", " D.阿昔洛韦滴眼液", "E.左氧氟沙星滴眼液"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_463", "questionText": "关于干扰素α治疗病毒性乙型肝炎的说法，错误的是", "option": ["A.用药 1 周内多数患者会出现流感样症状", "B.需要监测血常规", "C.可引起甲状腺功能异常", "D.若患者出现明显流感样症状，应立即停药", "E.用药期间若出现神经精神症状，应及时就诊"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_464", "questionText": "患者，男，48 岁，诊断为 2 型糖尿病。经生活方式干预，血糖控制仍不佳，拟开始单药治疗，宜选用的药 物是", "option": ["A.门冬胰岛素", "B.二甲双胍", "C.甘精胰岛素", "D.阿卡波糖", "E.格列美脲"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_465", "questionText": "患者，男，62 岁，4 年前出现运动迟缓，诊断为帕金森病。日前症状逐渐加重并伴有轻度认知障碍，宜选 用的药物是", "option": ["A.普拉克索", "B.司来吉兰", "C.金刚烷胺", "D.恩他卡朋", "E.苄丝肼-左旋多巴"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_466", "questionText": "关于维生素 D 缺乏的临床表现及治疗的说法，错误的是", "option": ["A.孕妇维生素 D 缺乏容易出现胎儿骨及免疫功能发育障碍", "B.婴幼儿维生素 D 缺乏容易出现“枕秃”", "C.小儿维生素 D 缺乏容易出现鸡胸、漏斗胸、O 形或 X 形腿", "D.建议 6 个月以上婴幼儿适当增加户外活动，多晒太阳", "E.维生素 D 缺乏者在补充维生素 D 的同时，无需额外补充钙剂"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_467", "questionText": "患者，男，48 岁，平日体健，否认药物过敏史。3 天前受凉后出现发热、咳嗽、咳少量黄痰，体温最高 39.3℃， 血常规：WBC 16.8×109/L，N% 83.09%，CRP 80mg/L，肝肾功能正常，胸片提示肺炎，给予经验性抗感染治 疗，宜选用的药物是", "option": ["A.复方磺胺甲噁唑", "B.呋喃妥因", "C.甲硝唑", "D.阿奇霉素", "E.阿莫西林"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_468", "questionText": "患者，女，54 岁，绝经 1 年，因严重潮热、盗汗、失眠，生活受到明显影响就诊。患者想改善上述症状， 但不希望有月经。宜选用的治疗方案是", "option": ["A.雌、孕激素序贯治疗", "B.雌、孕激素连续联合治疗", "C.单纯雌激素治疗", "D.单纯孕激素周期治疗", "E.阴道局部用雌激素治疗"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_469", "questionText": "患者，男，75 岁，1 个月前诊断为阿尔茨海默病，口服多奈哌齐治疗。关于该患者教育的说法，错误的是", "option": ["A.出现兴奋症状时，应尽早使用抗精神病药物", "B.长期使用多奈哌齐需评估对患者体重的影响", "C.在给予患者必要看护的前提下，鼓励其尽量独立完成日常活动", "D.多奈哌齐仅能改善症状，并不能改变疾病的进程和结局", "E.多奈哌齐用药过程中，注意监测心率"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_470", "questionText": "患者，女，58 岁，高血压病史 3 年，服用氨氯地平控制血压。近 1 月来间断上腹痛，伴反酸，诊断为胃溃 疡，Hp（+），给予雷贝拉唑、克拉霉素、阿莫西林、枸橼酸铋钾进行 Hp 根除治疗。服药后患者自述舌苔发 黑，口中有氨味，可能引起这种现象的药物是", "option": ["A.雷贝拉唑", "B.克拉霉素", "C.枸橼酸铋钾", "D.阿莫西林", "E.氨氯地平"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_471", "questionText": "关于缺血性脑血管病防治的说法，错误的是", "option": ["A.二级预防指疾病发生后预防复发的措施", "B.通过控制血压、血脂、血糖，能有效降低复发风险", "C.积极治疗伴发疾病，如冠心病、阻塞性睡眠呼吸暂停综合征等", "D.对短暂性脑缺血发作（TIA）患者应给予抗凝药物进行级预防", "E.缺血性脑率中发病后 3 小时内溶栓，可避免或减轻脑卒中后遗症"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_472", "questionText": "妊娠 5 个月后用药，可导致日后婴儿牙齿黄染、牙釉质发育不全的药物是", "option": ["A.阿莫西林", "B.呋喃妥因", "C.甲硝唑", "D.四环素", "E.磺胺甲噁唑"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_473", "questionText": "患者，女，28 岁，因痤疮就诊，给予异维 A 酸胶囊。关于该患者用药教育的说法，错误的是", "option": ["A.治疗期间及停药后 3 个月内应做好避孕措施", "B.治疗期间若发生皮肤黏膜干燥，应减量或停药", "C.不良反应常见，但停药后绝大多数可恢复", "D.治疗最初 2 个月可能导致肝酶异常，必要时检查肝功能", "E.部分患者用药 2~4 周时出现一过性皮疹加重现象"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_474", "questionText": "患者，女，68 岁，因尿失禁就诊。无尿频、尿急、发热等症状，血常规检查未见异常，尿培养检出大肠埃 希菌，诊断为轻度压力性尿失禁。首选的治疗方案是", "option": ["A.选用头孢曲松抗感染治疗", "B.择期行阴道前壁修补术", "C.选用阿米卡星抗感染治疗", "C.选用阿米卡星抗感染治疗 D.选用左氧氟沙星抗感染治疗", "E.进行盆底功能康复训练"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_475", "questionText": "患者，男，52 岁，2 型糖尿病 4 年余，长期口服格列吡嗪。近期血糖控制不佳，考虑加用其他降糖药物， 不宜联合使用的药物是", "option": ["A.西格列汀", "B.瑞格列奈", "C.二甲双胍", "D.阿卡波糖", "E.吡格列酮"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_476", "questionText": "患者，男，52 岁，间断胸骨后灼烧痛伴餐后上腹胀、嗳气 2 个月。诊断为重度反流性食管炎，给予泮托拉 唑肠溶片 20mg qd。关于该患者用药教育的说法，错误的是", "option": ["A.泮托拉唑的最佳服药时间是早餐前 0.5~1 小时", "B.泮托拉唑肠溶片不可咀嚼或压碎后服用", "C.抑酸效果不佳时可先尝试增加至双倍剂量，仍无效则换其他 PPI", "D.发生夜间酸突破时，可在睡前加用 H2受体阻断剂", "E.症状改善 2 周后可停药"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_477", "questionText": "患者，男，43 岁，诊断为骨性关节炎，给予塞来昔布胶囊 200mg bid。关于塞来昔布的说法，错误的是 ", "option": ["A.塞来昔布可抑制血小板活性", "B.长期使用塞来昔布可增加心肌梗死风险", "C.塞来昔布与华法林合用可增加出血风险", "D.塞来昔布引起消化道溃疡的风险低", "E.重度肝功能不全者应避免使用塞来昔布"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_478", "questionText": "患者，女，83 岁，左心室肥大、慢性心力衰竭病史 5 年，NYHA 心功能Ⅲ级，肝肾功能正常，近日诊断为 2 型糖尿病，应避免使用的降糖药物是", "option": ["A.西格列汀", "B.格列齐特", "C.瑞格列亲", "D.利拉鲁肽", "E.吡格列酮"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_479", "questionText": "患者，女，52 岁，Ⅱ度房室传导阻滞多年，近期发现血压升高，非同日 3 次血压均高于 160/90mmHg，不 宜选用的抗高血压药物是", "option": ["A.氢氢噻嗪", "B.氨氯地平", "C.美托洛尔", "D.依那普利", "E.厄贝沙坦"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_480", "questionText": "患者，男，75 岁，肺癌晚期，骨转移，口服吗啡控释片止痛，近日因疼痛加剧，增加吗啡剂量后出现便秘。 不宜选用的药物是", "option": ["A.比沙可啶肠溶片", "B.多潘立酮片", "C.开塞露", "D.聚乙二醇 4000 散", "E.乳果糖口服溶液"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_481", "questionText": "患者，女，55 岁，高血压病史 10 年，近日体检发现血钾偏高，不宜选用的降压药物是", "option": ["A.α受体阻断剂", "B.噻嗪类利尿剂", "C.血管紧张素转换酶抑制剂", "D.钙通道阻滞剂", "E.β受体阻断剂"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_482", "questionText": "患者，男，50 岁，BMI 30.0kg/㎡，有痛风病史，体检查血压 175/90mmHg，不宜选用的降压药物是", "option": ["A.α受体阻断剂", "B.噻嗪类利尿剂", "C.血管紧张素转换酶抑制剂", "D.钙通道阻滞剂", "E.β受体阻断剂"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_483", "questionText": "患者，女，31 岁，自述乏力、纳差，诊断为缺铁性贫血，给予硫酸亚铁治疗，推荐的用法用量是", "option": ["A.0.3g tid", "B.20mg tid", "C.0.5g qd", "D.0.4mg qd", "E.5mg tid"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_484", "questionText": "患者，男，64 岁，诊断为巨幼细胞贫血，给予叶酸治疗。推荐的用法用量是", "option": ["A.0.4g tid", "B.21mg tid", "C.0.6g qd", "D.0.5mg qd", "E.6mg tid"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_485", "questionText": "患者，女，35 岁，备孕补充叶酸，推荐的用法用量是", "option": ["A.0.5g tid", "B.22mg tid", "C.0.7g qd", "D.0.6mg qd", "E.7mg tid"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_486", "questionText": "能客观地反映过去 3 个月内平均血糖水平的指标是", "option": ["A.HDL-C", "B.HbA1c", "C.TG", "D.LDL-C", "E.TC"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_487", "questionText": "在一定范围内，其水平与动脉粥样硬化和冠心病的发生、发展呈负相关的指标是", "option": ["A.HDL-C", "B.HbA2c", "C.TG", "D.LDL-C", "E.TC"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_488", "questionText": "患者，男，54 岁，因痛风服用非布司他，为增强降尿酸效果，可同时使用的药物是", "option": ["A.阿托伐他汀", "B.甲巯咪唑", "C.丙硫氧嘧啶", "D.氢氯噻嗪", "E.碳酸氢钠"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_489", "questionText": "患者，女，65 岁，体检结果示：低密度脂蛋白胆固醇 5.7mmol/L，颈动脉粥样硬化斑块，宜选用的药物是", "option": ["A.阿托伐他汀", "B.甲巯咪唑", "C.丙硫氧嘧啶", "D.氢氯噻嗪", "E.碳酸氢钠"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_490", "questionText": "患者，男，35 岁，近日出现足趾间皮肤瘙痒、水泡样皮疹，宜选用的药物是", "option": ["A.酮康唑乳膏", "B.甲硝唑片", "C.雌三醇乳膏", "D.硝酸咪康唑栓", "E.氟康唑胶囊"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_491", "questionText": "患者，女，28 岁，已婚未育，因阴道分泌物增多伴瘙痒 5 天就诊。妇科检查见阴道内大量黄绿色泡沫样分 泌物，有臭味，分泌物镜检见滴虫。宜选用的药物是", "option": ["A.酮康唑乳膏", "B.甲硝唑片", "C.雌三醇乳膏", "D.硝酸咪康唑栓", "E.氟康唑胶囊"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_492", "questionText": "哺乳期妇女使用，对乳儿安全无害的药物是", "option": ["A.复方炔诺酮", "B.依那普利", "C.胰岛素", "D.复方磺胺甲噁唑", "E.莫西沙星"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_493", "questionText": "哺乳期妇女使用，易诱发新生儿胆红素脑病的药物是", "option": ["A.复方炔诺酮", "B.依那普利", "C.胰岛素", "D.复方磺胺甲噁唑", "E.莫西沙星"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_494", "questionText": "哺乳期妇女使用，可致男婴乳房增大的药物是", "option": ["A.复方炔诺酮", "B.依那普利", "C.胰岛素", "D.复方磺胺甲噁唑", "E.莫西沙星"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_495", "questionText": "治疗病毒性乙型肝炎的一线药物是", "option": ["A.利巴韦林", "B.依非韦伦", "C.阿昔洛韦", "D.拉米夫定", "E.替诺福韦酯"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_496", "questionText": "治疗艾滋病的非核苷类逆转录酶抑制剂是", "option": ["A.利巴韦林", "B.依非韦伦", "C.阿昔洛韦", "D.拉米夫定", "E.替诺福韦酯"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_497", "questionText": "可引起体液变色的药物是", "option": ["A.左氧氟沙星", "B.异烟肼", "C.吡嗪酰胺", "D.乙胺丁醇", "E.利福平"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_498", "questionText": "可引起球后视神经炎的药物是", "option": ["A.左氧氟沙星", "B.异烟肼", "C.吡嗪酰胺", "D.乙胺丁醇", "E.利福平"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_499", "questionText": "药效受食物成分影响较大的药物是", "option": ["A.达比加群酯", "B.氯吡格雷", "C.尿激酶", "D.依诺肝素钠", "E.华法林"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_500", "questionText": "深静脉血栓的溶栓治疗，宜选用的药物是", "option": ["A.达比加群酯", "B.氯吡格雷", "C.尿激酶", "D.依诺肝素钠", "E.华法林"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_501", "questionText": "治疗非心源性栓塞性缺血性脑卒中，宜选用的药物是", "option": ["A.达比加群酯", "B.氯吡格雷", "C.尿激酶", "D.依诺肝素钠", "E.华法林"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_502", "questionText": "患者，男，42 岁，诊断为 2 型糖尿病，既往严重便秘，腹胀明显，不宜选用的降糖药物是", "option": ["A.瑞格列奈", "B.阿卡波糖", "C.二甲双胍", "D.沙格列汀", "E.胰岛素"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_503", "questionText": "患者，女，28 岁，诊断为妊娠期糖尿病，首选的降糖药物是", "option": ["A.瑞格列奈", "B.阿卡波糖", "C.二甲双胍", "D.沙格列汀", "E.胰岛素"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_504", "questionText": "患者，男，64 岁，空腹血糖 8.9mmol/L，餐后 2 小时血糖 14.8mmol/L，eGFR20ml/（min∙1.73m2 ），肝功 能正常。诊断为 2 型糖尿病，慢性肾功能不全。宜选用的口服降糖药物是", "option": ["A.瑞格列奈", "B.阿卡波糖", "C.二甲双胍", "D.沙格列汀", "E.胰岛素"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_505", "questionText": "用药期间饮酒可能出现“双硫仑样反应”的药物是", "option": ["A.头孢哌酮", "B.万古霉素", "C.美罗培南", "D.克拉霉素", "E.左氧氟沙星"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_506", "questionText": "静脉滴速过快，易致“红人综合征”的药物是", "option": ["A.头孢哌酮", "B.万古霉素", "C.美罗培南", "D.克拉霉素", "E.左氧氟沙星"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_507", "questionText": "避免与辛伐他汀合用的药物是", "option": ["A.头孢哌酮", "B.万古霉素", "C.美罗培南", "D.克拉霉素", "E.左氧氟沙星"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_508", "questionText": "尿毒症继发甲状旁腺功能亢进，为抑制甲状旁腺激素水平，宜选用的药物是", "option": ["A.重组人促红素", "B.碳酸镧", "C.非诺贝特", "D.氢氧化铝", "E.骨化三醇"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_509", "questionText": "长期使用有中毒风险，不推荐用于慢性肾病高磷血症的药物是", "option": ["A.重组人促红素", "B.碳酸镧", "C.非诺贝特", "D.氢氧化铝", "E.骨化三醇"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_510", "questionText": "肾性贫血宜选用的药物是", "option": ["A.重组人促红素", "B.碳酸镧", "C.非诺贝特", "D.氢氧化铝", "E.骨化三醇"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_511", "questionText": "青霉素钠用 5%葡萄糖注射液溶解，可导致", "option": ["A 产生气体", "B.溶液变色", "C.微浑浊或沉淀", " D.产生胶状不溶物", "E.药物分解、降解速度加快"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_512", "questionText": "头孢曲松钠与乳酸钠林格注射液直接混合，可导致", "option": ["A 产生气体", "B.溶液变色", "C.微浑浊或沉淀", " D.产生胶状不溶物", "E.药物分解、降解速度加快"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_513", "questionText": "两性霉素 B 用 0.9%氯化钠注射液溶解，可导致", "option": ["A 产生气体", "B.溶液变色", "C.微浑浊或沉淀", " D.产生胶状不溶物", "E.药物分解、降解速度加快"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_514", "questionText": "利巴韦林的妊娠毒性分级是", "option": ["A.X 级", "B.A 级", "C.C 级", "D.D 级", "E.B 级"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_515", "questionText": "阿莫西林的妊娠毒性分级是", "option": ["A.X 级", "B.A 级", "C.C 级", "D.D 级", "E.B 级"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_516", "questionText": "氨氯地平的妊娠毒性分级是", "option": ["A.X 级", "B.A 级", "C.C 级", "D.D 级", "E.B 级"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_517", "questionText": "有吸附胆汁的作用，可用于治疗胆汁反流的胃食管反流病的药品是", "option": ["A.铝碳酸镁咀嚼片", "B.多潘立酮片", "C.奥美拉唑肠溶胶囊", "D.乳果糖口服溶液", "E.巴氯芬片"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_518", "questionText": "可引起 Q-T 间期轻度延长的药品是", "option": ["A.铝碳酸镁咀嚼片", "B.多潘立酮片", "C.奥美拉唑肠溶胶囊", "D.乳果糖口服溶液", "E.巴氯芬片"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_519", "questionText": "可影响氯吡格雷代谢的药品是", "option": ["A.铝碳酸镁咀嚼片", "B.多潘立酮片", "C.奥美拉唑肠溶胶囊", "D.乳果糖口服溶液", "E.巴氯芬片"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_520", "questionText": "表示“必要时（长期备用）”的缩写是", "option": ["A.qs.", "B.prn", "C.hs.", "D.St.", "E.sos."], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_521", "questionText": "表示“必要时（临时备用）”的缩写是", "option": ["A.qs.", "B.prn", "C.hs.", "D.St.", "E.sos."], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_522", "questionText": "匹维溴铵片治疗胆石症，正确的用药方法是", "option": ["A.餐后半小时服用", "B.清晨空腹整片吞服，并保持上身直立至少 30 分钟", "C.睡前服用", "D.餐前 1 小时嚼碎服用", "E 进餐时整片吞服"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_523", "questionText": "吉法酯片治疗消化性溃疡，正确的用药方法是", "option": ["A.餐后半小时服用", "B.清晨空腹整片吞服，并保持上身直立至少 31 分钟", "C.睡前服用", "D.餐前 2 小时嚼碎服用", "E 进餐时整片吞服"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_524", "questionText": "中毒解救需灌肠时，宜选用的灌肠液是", "option": ["A 硫酸镁溶液", "B.淀粉溶液", "C.植物油", "D.高锰酸懈溶液（1：5000~1：10000）", "E.1%肥皂水"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_525", "questionText": "误服碘酊洗胃时，宜选用的洗胃液是", "option": ["A 硫酸镁溶液", "B.淀粉溶液", "C.植物油", "D.高锰酸懈溶液（1：5000~1：10001）", "E.2%肥皂水"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_526", "questionText": "患者，男，74 岁，青光眼病史 5 年，近期诊断为支气管哮喘，应慎用的药物是", "option": ["A.孟鲁司特钠片", "B.沙丁胺醇气雾剂", "C.氨茶碱缓释片", "D.布地奈德气雾剂", "E.异丙托溴铵气雾剂"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_527", "questionText": "患者，男，56 岁，哮喘病史 6 年，哮喘急性发作时，为快速缓解症状，首选的药物是", "option": ["A.孟鲁司特钠片", "B.沙丁胺醇气雾剂", "C.氨茶碱缓释片", "D.布地奈德气雾剂", "E.异丙托溴铵气雾剂"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_528", "questionText": "患者，男，67 岁，诊际为骨性关节炎，既往有胃溃疡病史，宜选用的药物是", "option": ["A 双氯芬酸", "B.美洛昔康", "C.阿司匹林", "D.曲马多", "E.布洛芬"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_529", "questionText": "患者，女，58 岁，诊断为骨性关节炎，经洛索洛芬单药治疗疼痛缓解不理想可联合使用的药物是", "option": ["A 双氯芬酸", "B.美洛昔康", "C.阿司匹林", "D.曲马多", "E.布洛芬"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_530", "questionText": "患儿，男，4 岁，体温 39.1℃，诊断为上呼吸道感染，有引起 Reye's 综合征风险的药物是", "option": ["A 双氯芬酸", "B.美洛昔康", "C.阿司匹林", "D.曲马多", "E.布洛芬"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_531", "questionText": "患者，女，34 岁，受凉后出现发热、流涕、鼻塞等感冒症状，自行服用对乙酰氨基酚及其他复方感冒药。 为尽快改善症状，自行加量并增加给药频次。用药 2 天后出现厌食、恶心和呕吐症状，诊断为对乙酰氨基酚中 毒。宜选用的中毒解救药物是", "option": ["A.普萘洛尔", "B.氟马西尼", "C.谷胱甘肽", "D.乙酰半胱氨酸", "E.二丙醇"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_532", "questionText": "患者，女，34 岁，受凉后出现发热、流涕、鼻塞等感冒症状，自行服用对乙酰氨基酚及其他复方感冒药。 为尽快改善症状，自行加量并增加给药频次。用药 2 天后出现厌食、恶心和呕吐症状，诊断为对乙酰氨基酚中 毒。对乙酸氨基酚有单次给药剂量和每日总剂量的限制，超剂量服用可能损伤的器官是（", "option": ["A.骨关节", " B.耳蜗神经", "C.肺", "D.心脏", "E.肝脏"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_533", "questionText": "患者，女，65 岁，52 岁绝经，自诉腰痛半年，加重 2 月，腰椎影像学检查提示腰 2 和腰 3 椎体压缩性骨 折，骨密度检查提示重度骨质疏松，既往有高血压、高脂血症和系统性红斑狼疮，长期口服缬沙坦 80mg qd， 阿托伐他汀 20mg qn，阿司匹林 10mg qd 和泼尼松 7.5mg qd。1 个月前因反流性食管炎加用奥美拉唑 20mg qd， 否认不良嗜好，否认食物药物过敏史。与该患者骨质疏松发病相关性较大的药物是", "option": ["A.缬沙坦", "B.阿司匹林", "C.阿托伐他汀", "D.泼尼松", "E.奥美拉唑"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_534", "questionText": "患者，女，65 岁，52 岁绝经，自诉腰痛半年，加重 2 月，腰椎影像学检查提示腰 2 和腰 3 椎体压缩性骨 折，骨密度检查提示重度骨质疏松，既往有高血压、高脂血症和系统性红斑狼疮，长期口服缬沙坦 80mg qd， 阿托伐他汀 20mg qn，阿司匹林 10mg qd 和泼尼松 7.5mg qd。1 个月前因反流性食管炎加用奥美拉唑 20mg qd， 否认不良嗜好，否认食物药物过敏史。能明显缓解该患者腰痛症状的药物是", "option": ["A.戊酸雌二醇", "B.鲑鱼降钙素", "C.阿仑膦酸钠", "D.磺酸钙", "E.维生素 D"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_535", "questionText": "患者，女，65 岁，52 岁绝经，自诉腰痛半年，加重 2 月，腰椎影像学检查提示腰 2 和腰 3 椎体压缩性骨 折，骨密度检查提示重度骨质疏松，既往有高血压、高脂血症和系统性红斑狼疮，长期口服缬沙坦 80mg qd， 阿托伐他汀 20mg qn，阿司匹林 10mg qd 和泼尼松 7.5mg qd。1 个月前因反流性食管炎加用奥美拉唑 20mg qd， 否认不良嗜好，否认食物药物过敏史。关于该患者骨质疏松治疗的说法，错误的是", "option": ["A.推荐每日补充维生素 D400IU", "B.每日钙推荐摄入量为 1000mg-1200mg", "C.因有反流性食管炎，可选用双磷酸盐注射剂型", "D.双磷酸盐类药物可引起一过性“流感样”症状", "E.应用双磷酸盐类药物前，需评估肾功能"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_536", "questionText": "患者，男，58 岁，有高血压、冠心病、高脂血症、便秘，骨关节炎和胃溃疡病史，2 年前接受冠脉支架植 入术。近日，患者先后在心内科、消化科、骨科就诊，开具药品如下：患者既往使用单硝酸异山梨酯缓释片，此次就诊医师开具单硝酸异山梨酯片。关于该患者用药教育的说法， 错误的是", "option": ["A.规律使用硝酸酯类药物有助于预防心绞痛发作", "B.单硝酸异山梨酯片每天早晚各服 1 片（20mg），应间隔 12 小时", "C.使用西地那非 24 小时内不可应用单硝酸异山梨酯片，避免引起严重低血压", "D.单硝酸异山梨酯缓释片与普通片均不适于心绞痛急性发作的治疗", "E.硝酸酯类药物可引起心率反射性加快"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_537", "questionText": "患者，男，58 岁，有高血压、冠心病、高脂血症、便秘，骨关节炎和胃溃疡病史，2 年前接受冠脉支架植 入术。近日，患者先后在心内科、消化科、骨科就诊，开具药品如下：关于该患者使用阿司匹林的说法，正确的是", "option": ["A.阿司匹林属于冠心病一级预防，长期使用方可获益", "B.阿司匹林用药期间，需定期监测 INR", "C.用药期间，应关注腹痛、柏油样便或呕血等消化道出血症状", "D.阿司匹林肠溶片在进餐时服用，以减轻对胃肠道的刺激", "E.阿司匹林不耐受时，可换用替格瑞洛进行长期抗血小板"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_538", "questionText": "患者，男，58 岁，有高血压、冠心病、高脂血症、便秘，骨关节炎和胃溃疡病史，2 年前接受冠脉支架植 入术。近日，患者先后在心内科、消化科、骨科就诊，开具药品如下：关于该患者药物治疗方案的说法，错误的是", "option": ["A.美托洛尔会影响阿司匹林的抗血小板活性，应停用", "B.阿托伐他汀钙用于冠心病的治疗，需长期规律用药", "C.如大便次数规律（如每日 1 次），聚乙二醇 4000 散可按需使用", "D.同时使用双氯芬酸钠与阿司匹林会增加消化道出血风险，两药不宜合用", "E.麝香保心丸和复方丹参片均属活血剂，选用其中一种即可"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_539", "questionText": "患者，男，72 岁。体重 75kg，1 小时前出现右上肢体活动不利，半小时后自行缓解。查体：血压 210/90mmHg； 检查结果示：糖化血红蛋白 9.3%，血肌酐 143.2μmol/L。既往有高血压、糖尿病、冠心病病史。诊断为短暂 性脑缺血发作。首选的抗血栓药物是", "option": ["A.阿司匹林联合氯吡格雷", "B.阿司匹林", "C.阿替普酶", "D.氯吡格雷", "E.依诺肝素"], "year": "2021", "answer": ["A"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_540", "questionText": "患者，男，72 岁。体重 75kg，1 小时前出现右上肢体活动不利，半小时后自行缓解。查体：血压 210/90mmHg； 检查结果示：糖化血红蛋白 9.3%，血肌酐 143.2μmol/L。既往有高血压、糖尿病、冠心病病史。诊断为短暂 性脑缺血发作。关于缺血性脑血管病抗凝治疗的说法，正确的是", "option": ["A.合并感染性心内膜炎时，应积极抗凝治疗", "B.短暂性脑缺血发作，应常规抗凝治疗", "C.接受人工机械瓣置换术患者，推荐使用新型口服抗凝药", "D.伴发心房纤颤的患者，需要抗凝治疗", "E.合并风湿性二尖瓣病变患者，若无其它危险因素，不推荐抗凝治疗"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_541", "questionText": "患者，男，69 岁，BMI 27.8kg/m2，既往有骨性关节炎病史，近期爬山后，再次出现膝关节疼痛，患者热 敷后疼痛未缓解，前来咨询如何选用“止痛药”。药师在与患者沟通时，应告知其止痛药对疼痛的治疗属于", "option": ["A.姑息治疗", "B.对因治疗", "C.缓和治疗", "D.对症治疗", "E.替代治疗"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_542", "questionText": "患者，男，69 岁，BMI 27.8kg/m2，既往有骨性关节炎病史，近期爬山后，再次出现膝关节疼痛，患者热 敷后疼痛未缓解，前来咨询如何选用“止痛药”。下列药物中，适用于该患者的止痛药是", "option": ["A.吗啡控释片", "B.双氯芬酸钠缓释片", "C.颠茄片", "D.加巴喷丁胶襄", "E.卡马西平片"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_543", "questionText": "患者，男，69 岁，BMI 27.8kg/m2，既往有骨性关节炎病史，近期爬山后，再次出现膝关节疼痛，患者热 敷后疼痛未缓解，前来咨询如何选用“止痛药”。如服用所选止痛药，需关注的不良反应是", "option": ["A.便秘", "B.肾损害", "C.口干", "D.共济失调", "E.剥脱性皮炎"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_544", "questionText": "患者，男，69 岁，BMI 27.8kg/m2，既往有骨性关节炎病史，近期爬山后，再次出现膝关节疼痛，患者热 敷后疼痛未缓解，前来咨询如何选用“止痛药”。关于该患者教育的说法，错误的是（", "option": ["A.注意关节保暖", "B.遵医嘱，不得自行增加剂量", "C.疼痛加重时，可将止痛药嚼碎服用", "D.应适当减轻体重", "E.避免关节过度劳累，减少不合理的运动"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_545", "questionText": "患者，男，75 岁，有高血压，长期服用厄贝沙坦氢氯噻嗪片（150mg/12.5mg）1 片 qd，血压控制平稳。 因排尿困难、尿频和尿不尽感就诊，诊断为良性前列腺增生。给予非那雄胺片 5mg qd，特拉唑嗪片 5mg qd。 患者用药后出现头晕，前来咨询。关于解答该患者所咨询问题的说法，正确的是", "option": ["A.非那雄胺可增强降压药的降压效果，建议更换降压药", "B.建议睡前服用特拉唑嗪，有助于缓解头晕症状", "C.头晕可能与患者焦虑有关，继续用药会逐渐缓解", "D.非那雄胺可引起直立性低血压，头晕可能与此相关", "E.将非那雄胺换成小剂量片剂（1mg）即可缓解头晕"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_546", "questionText": "患者，男，75 岁，有高血压，长期服用厄贝沙坦氢氯噻嗪片（150mg/12.5mg）1 片 qd，血压控制平稳。 因排尿困难、尿频和尿不尽感就诊，诊断为良性前列腺增生。给予非那雄胺片 5mg qd，特拉唑嗪片 5mg qd。 患者用药后出现头晕，前来咨询。关于该患者教育的说法，错误的是", "option": ["A.注意药物相互作用，合用其他药物前请咨询医师或药师", "B.日常生活中避免久坐，切勿憋尿", "C.如出现尿路感染症状，应尽早就诊", "D.非那雄胺可快速缓解症状，与特拉唑嗪合用可产生协同作用", "E.症状缓解后，仍需按医嘱用药，不宜自行停药"], "year": "2021", "answer": ["D"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_547", "questionText": "患者，男，53 岁，季节性过敏性鼻炎病史 5 年，3 天前，受凉后出现流涕、鼻塞、咳嗽，咳痰，低热，头 痛，无胸闷、气短等其他不适，已在医院发热门诊完成了鼻拭子检查，排除了甲型流感和乙型流感，诊断为普 通感冒。为缓解该患者的感冒症状，不宜选用的药物是", "option": ["A.含伪麻黄碱的复方抗感冒药", "B.神经氨酸酶抑制剂", "C.鼻用减充血剂", "D.解热镇痛药", "E.祛痰剂"], "year": "2021", "answer": ["B"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_548", "questionText": "患者，男，53 岁，季节性过敏性鼻炎病史 5 年，3 天前，受凉后出现流涕、鼻塞、咳嗽，咳痰，低热，头 痛，无胸闷、气短等其他不适，已在医院发热门诊完成了鼻拭子检查，排除了甲型流感和乙型流感，诊断为普 通感冒。关于该患者咳嗽治疗的说法，错误的是", "option": ["A.若剧烈干咳伴胸痛，仅伴有少量白痰，可选用中枢性镇咳药", "B.单独使用抗组胺药物，对止咳无效", "C.若痰多而黏稠，应慎用镇咳药", "D.若使用含右美沙芬的药物，需告知服药期间应避免驾驶", "E.尽早使用抗菌药物治疗，能更有效地缓解咳嗽"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_549", "questionText": "患者，男，53 岁，季节性过敏性鼻炎病史 5 年，3 天前，受凉后出现流涕、鼻塞、咳嗽，咳痰，低热，头 痛，无胸闷、气短等其他不适，已在医院发热门诊完成了鼻拭子检查，排除了甲型流感和乙型流感，诊断为普 通感冒。关于普通感冒患者教育的说法，错误的是", "option": ["A.目前尚无特效的抗病毒药物", "B.治疗以对症治疗，缓解症状为主", "C.注意休息，适当补充水分", "D.首选口服药物，避免盲目输液", "E.接种流感疫苗可预防普通感冒"], "year": "2021", "answer": ["E"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_550", "questionText": "患者，男，53 岁，季节性过敏性鼻炎病史 5 年，3 天前，受凉后出现流涕、鼻塞、咳嗽，咳痰，低热，头 痛，无胸闷、气短等其他不适，已在医院发热门诊完成了鼻拭子检查，排除了甲型流感和乙型流感，诊断为普 通感冒。患者在花粉季过敏性鼻炎发作，使用鼻用糖皮质激素治疗后，鼻塞症状未缓解，可联合应用的药品是", "option": ["A.泼尼松片", "B.氯苯那敏片", "C.色甘酸钠滴鼻剂", "D.氯雷他定片", "E.孟鲁司特钠片"], "year": "2021", "answer": ["C"], "subject": "2021药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_551", "questionText": "在患者入院、转科和出院时，药师通过核对新开的医嘱和己有的医嘱，核对患者目前的整体用药情况，避免漏用药物、重复用药、剂量错误和不良药物相互作用等，以保证患者用药安全的药学服务过程，属于", "option": ["A. 药物重整", "B. 处方审核", "C. 药物利用研究和评价", "D. 药学干预", "E. 处方点评"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_552", "questionText": "患者，男，65岁，临床诊断：2型糖尿病并发周围神经病变、冠心病，医生处方：美托洛尔缓释片47.5mg qd po、单硝酸异山梨酯缓释片10mg qd po、瑞格列奈片1 mg tid po、阿卡波糖片50 mg tid po、甲钴铵片0.5 mg tid po；药师对该处方的审核和分析正确的是", "option": ["A. 选用美托洛尔缓释片不合理", "B. 单硝酸异山梨酯缓释片用量不合理", "C. 瑞格列奈片用量不合理", "D. 选用阿卡波糖片不合理", "E. 甲钴铵片用量不合理"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_553", "questionText": "患者，男，40岁，无基础疾病,拟行甲状腺切除术，术前半小时使用头孢噻肟钠预防感染。对该用药的评价，正确的是", "option": ["A. 不宜选用头孢噻肟钠，应选用头孢唑林钠", "B. 不宜选用头孢噻肟钠，应选用青霉素钠", "C. 不宜在术前半小时用药，应在术中用药", "D. 不宜在术前半小时用药，应在术后用药", "E. 不必使用抗菌药物，属无临床指征用药"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_554", "questionText": "患者，男，16岁，因“急性细菌性扁桃体炎”使用青霉素钠治疗，用药前进行青霉素皮试。关于青霉素皮试液浓度和给药方法的说法，正确的是", "option": ["A. 浓度5000U/ml，皮内注射0.1ml", "B. 浓度5000U/ml，肌内注射0.1ml", "C. 浓度500U/ml，皮内注射0.1ml", "D. 浓度500U/ml，肌内注射0.1ml", "E. 浓度500U/ml，皮内注射1ml"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_555", "questionText": "患者，女，69岁，近一个月出现入睡困难，白天有头昏、疲倦等不适感，尝试非药物治疗无改善，推荐的药物治疗方案是", "option": ["A. 唑吡坦5 mg po qn", "B. 苯巴比妥100 mg po qn", "C. 地西泮5 mg po qn", "D. 氯硝西泮2 mg po qn", "E. 艾司唑仑1 mg po qn"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_556", "questionText": "对半衰期短的药物，为了减少血药浓度波动，可采取的方法是", "option": ["A. 延长给药间隔", "B. 缩短给药间隔的同时减少单剂量", "C. 增加给药剂量", "D. 减少给药剂量", "E. 增加给药剂量的同时延长给药间隔"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_557", "questionText": "可引起嗜酸性粒细胞增多的药物是", "option": ["A. 氯苯那敏", "B. 碳酸氢钠", "C. 坎地沙坦", "D. 头孢氨苄", "E. 地塞米松"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_558", "questionText": "患者，男，46岁，因“类风湿性关节炎”长期使用免疫抑制剂，近日因出现发热、咳嗽、咳痰入院，经病原学检查，诊断为侵袭性肺曲霉菌病，临床欲使用伏立康唑治疗。患者同时合并肝功能不全，Child- Turcotte-Pugh(CTP)评分为13分(CTPC级)。根据CTP评分结果，药师的用药建议是", "option": ["A. 该患者重度肝功能不全，不建议使用伏立康唑", "B. 该患者轻度肝功能不全，伏立康唑维持剂量不变", "C. 该患者轻度肝功能不全，伏立康唑维持剂量减少25%", "D. 该患者中度肝功能不全，伏立康唑维持剂量减少50%", "E. 该患者中度肝功能不全伏立康唑维持剂量减少75%"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_559", "questionText": "根据英国 Cochrane中心联合循证医学和临床流行病学专家共同制定的循证医学证据分级标准，“未经严格论证或评估的专家意见”在循证医学评价中的证据级别属于", "option": ["A. Ⅰ级", "B. Ⅱ级", "C. Ⅲ级", "D. Ⅴ级", "E. Ⅳ级"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_560", "questionText": "患者，男，67岁，慢性咳喘20余年，现因哮喘急性发作就诊，首选的治疗药物是", "option": ["A. 氨茶碱片", "B. 二羟丙茶碱片", "C. 沙丁胺醇气雾剂", "D. 异丙托溴铵气雾剂", "E. 布地奈德溶液"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_561", "questionText": "患者，男，80岁，临床诊断为前列腺增生症，给予多沙唑嗪治疗。药师对该患者的用药指导，正确的是", "option": ["A. 每日服用一次，定期监测血糖，防止发生低血糖反应", "B. 睡前服用，定期监测肝功能", "C. 睡前服用，注意监测肾功能", "D. 睡前服用，起床站立时应缓慢，预防体位性低血压", "E. 清晨服用，注意监测血压，预防体位性低血压"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_562", "questionText": "患者，男，57岁，化验结果：TC4.6mmoL/L(参考值<5.2mmoL/L)，TG11.0mmoL/L(参考值0.56—1.70mmoL/L)。血尿酸508μmoL/L(参考值<420μmo/L)，应首选的调脂药物为", "option": ["A. 烟酸", "B. 考来烯胺", "C. 非诺贝特", "D. 依折麦布", "E. 普罗布考"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_563", "questionText": "患者，男，70岁，外出登山途中突然出现胸前区疼痛，疼痛放射至左肩，休息2分钟后缓解，立即急诊就医。查体：血压150/95mmHg，心率55次/min。化验结果：TC 5.0mmol/L，TG 1.78mmol/L。结合心电图检查结果，临床诊断为稳定型心绞痛。该患者不宜选用的药物是", "option": ["A. 比索洛尔片", "B. 阿司匹林肠溶片", "C. 依那普利片", "D. 阿托伐他汀钙片", "E. 硝酸甘油片"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_564", "questionText": "患者，男，80岁，患有高血压、2型糖尿病、前列腺增生症，近日出现暂时性尿失禁症状，怀疑与其服用的药物有关。复核其使用的药物，可能造成其尿失禁的药物是", "option": ["A. 二甲双胍", "B. 非那雄胺", "C. 依那普利", "D. 珍菊降压片(含氢氯噻嗪)", "E. 消渴丸（含格列本脲）"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_565", "questionText": "患者，女，21岁，近半年来食欲亢进，多汗、体重明显减轻，伴有乏力、心悸。就诊查体见双手震颤，心率104次/分，化验结果：血清促甲状腺素(TSH)<0.1mIU/L，FT3、FT4明显升高，肝肾功能基本正常，白细胞计数正常，诊断为甲状腺功能亢进症。首选的治疗方案是", "option": ["A. 碘化钾治疗，定期复查", "B. 注意休息、补充营养，使用甲巯咪唑治疗", "C. 选用131I治疗", "D. 甲状腺次全切除手术", "E. 避免服用富碘食物，使用碳酸锂治疗"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_566", "questionText": "患者，女，46岁，高血压病史3年。2年前出现关节晨僵、手关节及膝关节疼痛，诊断为类风湿关节炎。半年前症状加重，采用了联合用药方案：甲氨蝶呤片 10mg qw po、羟氯喹片 0. 2g bid po、双氯芬酸钠缓释片 75 mg qd po、白芍总苷胶囊 0.6g bid po、氨氯地平片 5mg qd po；近日患者岀现眼睛视物模糊，经检查排除疾病因素，前来询问药师是否因服药引起。根据患者用药情况，可能引起该患者视物模糊的药物是", "option": ["A. 甲氨蝶呤片", "B. 羟氯喹片", "C. 双氯芬酸钠缓释片", "D. 氨氯地平片", "E. 白芍总苷胶囊"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_567", "questionText": "患者，女，50岁，近期出现失眠、潮热、出汗、烦躁等不适症状，临床诊断为围绝经期综合征，在使用激素替代治疗之前应先排除禁忌证。下列情况不属于禁忌证但属于慎用的是", "option": ["A. 乳腺增生", "B. 近6个月内患活动性静脉栓塞性疾病", "C. 严重肝功能障碍", "D. 耳硬化症", "E. 脑膜瘤"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_568", "questionText": "用于胆石症的非手术治疗，属于钙通道阻滞剂，不可掰开嚼碎且须避免卧位服用的药物是", "option": ["A. 熊去氧胆酸片", "B. 鹅去氧胆酸片", "C. 匹维溴铵片", "D. 山莨菪碱片", "E. 消炎利胆片"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_569", "questionText": "患者，男，74岁，患有冠心病、高血压、高脂血症、2型糖尿病和严重骨质疏松症。无偏食，每日饮牛乳300ml。药师记录的患者用药情况如下表：image.png，该患者用药中，用法错误的是", "option": ["A. 二甲双胍片", "B. 贝那普利片", "C. 阿司匹林肠溶片", "D. 美托洛尔片", "E. 阿托伐他汀钙片"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_570", "questionText": "患者，女，42岁，因“成骨肉瘤”使用环磷酰胺、甲氨蝶呤联合化疗。用药过程中，患者发生出血性膀胱炎，适宜的处理措施是", "option": ["A. 停药，给予糖皮质激素", "B. 给予糖皮质激素冲击治疗", "C. 停药，水化，给予美司钠治疗", "D. 停药，给予亚叶酸钙治疗", "E. 停药，给予洛哌丁胺治疗"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_571", "questionText": "患者，女，31岁，因“丙型病毒性肝炎”使用α-干扰素联合利巴韦林治疗。下列关于用药期间避孕和备孕措施的说法，正确的是", "option": ["A. 干扰素、利巴韦林易引起畸胎或者胚胎致死效应，治疗期间和治疗后6个月内，必须采取避孕措施", "B. 干扰素、利巴韦林较为安全，不必停药即可备孕", "C. 干扰素、利巴韦林较为安全，停药后即可备孕", "D. 干扰素、利巴韦林较为安全，停药3个月后可备孕", "E. 干扰素、利巴韦林易引起畸胎或者胚胎致死效应，停药3个月后可备孕"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_572", "questionText": "患者，女，67岁，有高血压病史，右手抖动、行走缓慢4年，诊断为帕金森病。服用复方左旋多巴治疗，症状一度好转后又反复加重，随后采用加大复方左旋多巴剂量，并加用苯海索的治疗方案。患者同时服用氨氯地平、缬沙坦等药物控制血压。近日出现运动症状波动，伴有异动症。导致该不良反应的药物是", "option": ["A. 左旋多巴", "B. 苄丝肼", "C. 苯海索", "D. 氨氯地平", "E. 缬沙坦"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_573", "questionText": "患者，女，19岁，面部出现多个丘疹和脓疱，有脱皮表现，临床诊断为痤疮。外用制剂改善不佳，换用异维A酸片。使用异维A酸片的用药注意事项和用药指导，不包括", "option": ["A. 用药前排除妊娠", "B. 治疗期间或治疗后1个月内避免献血", "C. 监测精神症状", "D. 每1—3个月监测血尿酸水平", "E. 每1—3个月监测肝功能"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_574", "questionText": "临床上将酚妥拉明20mg、多巴胺20mg、呋塞米20mg加入到5%葡萄糖注射液250ml后，出现黑色沉淀。出现沉淀的原因是", "option": ["A. 酚妥拉明和多巴胺发生反应", "B. 酚妥拉明和呋塞米发生反应", "C. 多巴胺和呋塞米发生反应", "D. 酚妥拉明在葡萄糖溶液中分解", "E. 多巴胺在葡萄糖溶液中分解"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_575", "questionText": "患者，男，49岁，近1个月出现血压升高，BP155/95mmHg；同时伴有高尿酸血症，血尿酸508μmol/L。使用别嘌醇100 mg bid，氯沙坦钾50mg qd，碳酸氢钠1g tid治疗。关于该患者用药指导的说法，正确的是", "option": ["A. 严格限制蛋白质的摄入，每天不超过0.6g/kg", "B. 别嘌醇用药后可出现眩晕，用药后不宜驾车", "C. 氯沙坦钾可引起血尿酸升高", "D. 关节疼痛时可选用贝诺酯止痛", "E. 使用碳酸氢钠碱化尿液，维持尿液pH值在7.5"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_576", "questionText": "患者，男，68岁，肺癌晚期，平日清晨、晚间8点使用吗啡缓释片控制疼痛。目前出现暴发性疼痛，应采取的治疗措施是", "option": ["A. 即刻加用吗啡缓释片一次", "B. 即刻加用吗啡片一次", "C. 即刻加用芬太尼透皮贴剂", "D. 即刻加用可待因片一次", "E. 即刻注射哌替啶注射液一次"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_577", "questionText": "患者，女，25岁，产后2个月，哺乳期。因尿路感染需要给予抗感染治疗，首选的药物是", "option": ["A. 阿米卡星", "B. 左氧氟沙星", "C. 多西环素", "D. 头孢呋辛", "E. 复方磺胺甲噁唑"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_578", "questionText": "下列药物中，可以增加缺血性脑卒中发作风险的药物是", "option": ["A. 口服避孕药", "B. 叶酸", "C. 阿司匹林", "D. 银杏叶片", "E. 非洛地平"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_579", "questionText": "患者，女，68岁，体重45kg，因发热、咳嗽、咳痰入院治疗，临床诊断为社区获得性肺炎。化验结果：白细胞计数11.76×109/L，肌酐清除率18ml/min。该患者使用下列抗菌药物治疗时，不需要减量的是", "option": ["A. 左氧氟沙星", "B. 莫西沙星", "C. 头孢噻肟钠", "D. 阿莫西林", "E. 头孢吡肟"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_580", "questionText": "患者，男，65岁，诊断为持续性心房颤动，医生处方胺碘酮和华法林治疗。患者既往有高血压、糖尿病、冠心病和高脂血症，目前正在服用贝那普利、美托洛尔、二甲双胍、阿卡波糖、辛伐他汀等药物治疗。根据患者用药情况，药师提出的合理化药物治疗建议，但应不包括", "option": ["A. 患者在复律成功后，尽可能以最小的胺碘酮剂量维持治疗", "B. 因为胺碘酮和贝那普利存在临床意义的相互作用，建议换成氨氯地平等CCB降压药", "C. 胺碘酮可以显著抑制CYP2D6，减慢美托洛尔的代谢，应该根据患者心率和血压调整美托洛尔剂量", "D. 胺碘酮能増加华法林的抗凝活性，在逐渐降低胺碘酮剂量的同时，注意随时根据INR值调整华法林的剂量", "E. 胺碘酮和辛伐他汀存在临床意义的相互作用，合用时应该限制辛伐他汀的日剂量(不超过20mg/d)"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_581", "questionText": "为比较不同质子泵抑制剂治疗十二指肠溃疡的经济性，将药物治疗的成本与产生的效用指标以货币为单位进行评估，此药物经济学评价方法是", "option": ["A. 成本-效益分析", "B. 最小成本分析", "C. 成本-效果分析", "D. 成本-效用分析", "E. 成本-费用分析"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_582", "questionText": "患者，男，56岁，体检发现血尿酸530μmol/L(正常参考值180~440μmoL/L)。患者向药师咨询维生素使用问题，药师应告知患者可引起尿酸升高的维生素是", "option": ["A. 维生素B12", "B. 维生素C", "C. 维生素B2", "D. 维生素B6", "E. 维生素E"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_583", "questionText": "患者，男，59岁，高血压病史5年，因头痛伴有恶心、呕吐就诊，MRI检查结果显示蛛网膜下腔出血。为防治脑血管痉挛，早期宣选用的药物", "option": ["A. 尼莫地平", "B. 硝苯地平", "C. 氨氯地平", "D. 缬沙坦", "E. 氢氯噻嗪"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_584", "questionText": "患者，女，30岁，妊娠7个月，既往有磺胺类药过敏史。近日双眼沙眼症状加剧，发痒、分泌物多并有烧灼感。去年曾用酞丁安滴眼液治疗相似症状，疗效较好，今天到药店想再次购买该药。药师给予的用药建议是", "option": ["A. 酞丁安滴眼液", "B. 利巴韦林滴眼液", "C. 磺胺醋酰钠滴眼液", "D. 硫酸锌滴眼液", "E. 醋酸可的松滴眼液"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_585", "questionText": "患者，女，34岁，因易疲劳、体重增加、反应退钝、肌肉痉挛就诊。化验结果显示TSH增高，TT3、TT4减低。临床诊断为甲状腺功能减退症。使用左甲状腺素钠100ug qd治疗。药师对该患者的用药指导，正确的是", "option": ["A. 早餐后半小时，顿服", "B. 早餐前半小时，顿服", "C. 睡前顿服", "D. 晚餐后顿服", "E. 可在一天中任意时间服用"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_586", "questionText": "患者入院诊断为肺部感染，病原学检查为耐甲氧西林金黄色葡萄球菌。使用万古霉素1000mg/次，静脉滴注，每12h应用1次。为使血栓性静脉炎的发生风险最小化，临床需要将万古霉素溶液的浓度稀释为4mg/ml。在配制过程中，需要5%葡萄糖注射液的容量是", "option": ["A. 250ml", "B. 48ml", "C. 100ml", "D. 480ml", "E. 800ml"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_587", "questionText": "患者，男，72岁，患有阿尔茨海默病，给予卡巴拉汀每日3mg治疗。药师对该患者的用药指导，正确的是", "option": ["A. 每日清晨空腹口服", "B. 每晚睡前口服", "C. 每日清晨、晚间与食物同服", "D. 每日清晨、晚间空腹口服", "E. 每日两次餐前服用"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_588", "questionText": "患儿，男，出生后50天，体重5kg，时值夏季，体温37.9℃，出现烦躁，哭闹不安，无其他症状。其家人到药店询问购买退热药，药师应推荐", "option": ["A. 减少衣被，可施行物理降温或必要时就诊", "B. 阿苯片，半片，研碎后溶解于少量温开水服用", "C. 阿司匹林泡腾片（500mg）1/10片，溶于少量温开水服用", "D. 对乙酰基酚片（500mg）1/10片，溶于少量温开水服用", "E. 布洛芬口服液（0.1g/10ml)3ml，口服"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_589", "questionText": "患者，女，53岁，冠心病史2年，目前服用硝酸异山梨酯、阿托伐他汀钙。近三个月因“胃痛、心境低落并有自杀倾向”就诊，临床诊断为消化性溃疡、抑郁症。给予奥美拉唑肠溶片40mg qd po文拉法辛缓释片150 mg qd po，谷维素片10 mg tid po治疗，患者用药后出现血压升高可能导致该患者血压升高的药物是", "option": ["A. 文拉法辛缓释片", "B. 硝酸异山梨酯片", "C. 阿托伐他汀钙片", "D. 奧美拉唑肠溶片", "E. 谷维素片"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_590", "questionText": "患者，女，38岁，已婚，妊娠2个月，近日自觉心慌、多汗。检查FT3，FT4偏高TSHo.01mU/L，临床诊断为甲状腺功能亢进症适宜的治疗方案为", "option": ["A. 终止妊娠，选用丙硫氧嘧啶治疗", "B. 维持妊娠，行甲状腺切除手木", "C. 维持妊娠，选用甲巯咪唑治疗", "D. 维持妊娠，选用丙硫氧嘧啶治疗", "E. 维持妊娠，选用放射性131I治疗"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_591", "questionText": "患者，女，46岁，因琐事与家人吵架后，服用艾司唑仑100片。可选用的解救药物是", "option": ["A. 亚甲蓝", "B. 氟马西尼", "C. 纳洛酮", "D. 二巯丙醇", "E. 乙酰胺"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_592", "questionText": "患儿，女，5岁，误服灭鼠药(氟乙酰胺)。可选用的解救药物是", "option": ["A. 亚甲蓝", "B. 氟马西尼", "C. 纳洛酮", "D. 二巯丙醇", "E. 乙酰胺"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_593", "questionText": "患者，男，64岁，为缓解剧烈癌痛，同时使用5片芬太尼透皮贴剂后，出现呼吸抑制。可选用的解救药物是", "option": ["A. 亚甲蓝", "B. 氟马西尼", "C. 纳洛酮", "D. 二巯丙醇", "E. 乙酰胺"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_594", "questionText": "患者近期出现双手关节肿胀、疼痛，伴晨僵，诊断为类风湿性关节炎，应选用的药物是", "option": ["A. 对乙酰氨基酚片", "B. 芬太尼透皮贴剂", "C. 羟考酮缓释片", "D. 卡马西平片", "E. 塞来昔布胶囊"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_595", "questionText": "患者由带状疱疹所致的严重后遗神经痛，应选的药物是", "option": ["A. 对乙酰氨基酚片", "B. 芬太尼透皮贴剂", "C. 羟考酮缓释片", "D. 卡马西平片", "E. 塞来昔布胶囊"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_596", "questionText": "服用华法林期间应进行监测的指标是", "option": ["A. ALT", "B. APTT", "C. INR", "D. RBC", "E. WBC"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_597", "questionText": "使用肝素静脉滴注期间需监测的指标是", "option": ["A. ALT", "B. APTT", "C. INR", "D. RBC", "E. WBC"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_598", "questionText": "患者，男，36岁，因发热、咳嗽就诊，查血常规：白细胞计数6.28×109/L，中性粒细胞百分比65.7%，淋巴细胞百分比15.1%。诊断为感冒。医生处方：阿奇霉素片0.5g qd po。该处方属于", "option": ["A. 无适应证用药", "B. 用法与用量不适宜", "C. 有配伍禁忌用药", "D. 有禁忌证用药", "E. 重复给药"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_599", "questionText": "患者，男，65岁，因腹胀，呕吐就诊。医生处方：甲氧氯普胺片20 mg tid po该处方属于", "option": ["A. 无适应证用药", "B. 用法与用量不适宜", "C. 有配伍禁忌用药", "D. 有禁忌证用药", "E. 重复给药"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_600", "questionText": "患者，女，45岁因发热、流涕就诊，诊断为感冒。医生处方：感冒清片2片 tid po，维C银翘片2片 tid po。该处方属于", "option": ["A. 无适应证用药", "B. 用法与用量不适宜", "C. 有配伍禁忌用药", "D. 有禁忌证用药", "E. 重复给药"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_601", "questionText": "可以引起视物模糊、红绿色盲，视野受限的抗结核药物是", "option": ["A. 对氨基水杨酸钠", "B. 乙胺丁醇", "C. 异烟肼", "D. 链霉素", "E. 利福平"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_602", "questionText": "可以加速多种药物代谢，对肝药酶有强诱导作用的抗结核药物是", "option": ["A. 对氨基水杨酸钠", "B. 乙胺丁醇", "C. 异烟肼", "D. 链霉素", "E. 利福平"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_603", "questionText": "患者，男，60岁，因水疱型足癣到药店购药，药师应推荐的药品是", "option": ["A. 利巴韦林软膏", "B. 特比萘芬乳膏", "C. 10%樟脑软膏", "D. 氢化可的松软膏", "E. 红霉素软膏"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_604", "questionText": "患者，男，60岁，因上臂出现慢性湿疹到药店购药，药师应推荐的药品是", "option": ["A. 利巴韦林软膏", "B. 特比萘芬乳膏", "C. 10%樟脑软膏", "D. 氢化可的松软膏", "E. 红霉素软膏"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_605", "questionText": "患者，男，60岁，因轻度冻疮(无破溃)到药店购药，药师应推荐的药品是", "option": ["A. 利巴韦林软膏", "B. 特比萘芬乳膏", "C. 10%樟脑软膏", "D. 氢化可的松软膏", "E. 红霉素软膏"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_606", "questionText": "瑞舒伐他汀钙的日剂量范围是", "option": ["A. 10—80mg", "B. 5—20mg", "C. 10—20mg", "D. 40—200mg", "E. 10—100mg"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_607", "questionText": "阿托伐他汀钙的日剂量范围是", "option": ["A. 10—80mg", "B. 5—20mg", "C. 10—20mg", "D. 40—200mg", "E. 10—100mg"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_608", "questionText": "患者，女，35岁，因感冒所致流涕、咳嗽发热等症状到药店购药，药师应推荐的药品是", "option": ["A. 酚麻美敏片", "B. 萘甲唑啉滴鼻液", "C. 氯苯那敏片", "D. 对乙酰氨基酚片", "E. 奥司他韦胶囊"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_609", "questionText": "患者，女，30岁，因感冒所致发热(体温38.5℃)并伴有头痛、全身酸痛到药店购药，药师应推荐的药品是", "option": ["A. 酚麻美敏片", "B. 萘甲唑啉滴鼻液", "C. 氯苯那敏片", "D. 对乙酰氨基酚片", "E. 奥司他韦胶囊"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_610", "questionText": "患者，男，40岁，因感冒所致鼻塞到药店购药，药师应推荐的药品是", "option": ["A. 酚麻美敏片", "B. 萘甲唑啉滴鼻液", "C. 氯苯那敏片", "D. 对乙酰氨基酚片", "E. 奥司他韦胶囊"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_611", "questionText": "老年女性，心功能衰竭，服用呋塞米及螺内酯片，正确的使用方法是", "option": ["A. 清晨服用", "B. 用温水调服", "C. 应同时碱化尿液", "D. 舌下含服", "E. 睡前服用"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_612", "questionText": "婴幼儿腹泻，服用地衣芽孢杆菌活菌制剂，正确的使用方法是", "option": ["A. 清晨服用", "B. 用温水调服", "C. 应同时碱化尿液", "D. 舌下含服", "E. 睡前服用"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_613", "questionText": "患者突发心前区压榨性疼痛，立即取出硝酸甘油片，正确的使用方法是", "option": ["A. 清晨服用", "B. 用温水调服", "C. 应同时碱化尿液", "D. 舌下含服", "E. 睡前服用"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_614", "questionText": "根据中国营养学会推荐，老年人在每日饮食之外，应补充的元素钙剂量为", "option": ["A. 2000—4000mg", "B. 50mg", "C. 100mg", "D. 500—600mg", "E. 1000—1200mg"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_615", "questionText": "根据中国营养学会推荐，孕妇和乳母的每日元素钙摄入推荐量是", "option": ["A. 2000—4000mg", "B. 50mg", "C. 100mg", "D. 500—600mg", "E. 1000—1200mg"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_616", "questionText": "过敏性结膜炎和春季卡他性结膜炎可选用", "option": ["A. 色甘酸钠滴眼液", "B. 七叶洋地黄双苷滴眼液", "C. 玻璃酸钠滴眼液", "D. 氧氟沙星滴眼液", "E. 碘苷滴眼液"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_617", "questionText": "干眼症可选用", "option": ["A. 色甘酸钠滴眼液", "B. 七叶洋地黄双苷滴眼液", "C. 玻璃酸钠滴眼液", "D. 氧氟沙星滴眼液", "E. 碘苷滴眼液"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_618", "questionText": "流行性结膜炎可选用", "option": ["A. 色甘酸钠滴眼液", "B. 七叶洋地黄双苷滴眼液", "C. 玻璃酸钠滴眼液", "D. 氧氟沙星滴眼液", "E. 碘苷滴眼液"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_619", "questionText": "患者，女，30岁，既往体健，无癫痫病史，怀孕8个月，突然出现抽搐，从下腹开始，发展至全身，口唇发绀，意识丧失，诊断为子痫，应选用的治疗方法是", "option": ["A. 50%葡萄糖注射液湿敷", "B. 50%硫酸镁溶液口服", "C. 25%硫酸镁注射液稀释后静脉注射", "D. 5%氯化钙注射液静脉滴注", "E. 50%硫酸镁溶液湿敷"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_620", "questionText": "患者，男，36岁，在静脉滴注复方氨基酸注射液过程中，穿刺部位出现水肿，可选用的治疗方法是", "option": ["A. 50%葡萄糖注射液湿敷", "B. 50%硫酸镁溶液口服", "C. 25%硫酸镁注射液稀释后静脉注射", "D. 5%氯化钙注射液静脉滴注", "E. 50%硫酸镁溶液湿敷"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_621", "questionText": "患者，男，46岁，拟行肠道手术，术前1天使用导泻药的方法是", "option": ["A. 50%葡萄糖注射液湿敷", "B. 50%硫酸镁溶液口服", "C. 25%硫酸镁注射液稀释后静脉注射", "D. 5%氯化钙注射液静脉滴注", "E. 50%硫酸镁溶液湿敷"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_622", "questionText": "阿司匹林所致哮喘患者除使用沙丁胺醇外还应联合应用的药物是", "option": ["A. 异丙托溴铵", "B. 沙美特罗", "C. 茶碱", "D. 奥马珠单抗(抗lgE抗体)", "E. 孟鲁司特"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_623", "questionText": "甲状腺功能亢进症合并哮喘的患者慎用的药物是", "option": ["A. 异丙托溴铵", "B. 沙美特罗", "C. 茶碱", "D. 奥马珠单抗(抗lgE抗体)", "E. 孟鲁司特"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_624", "questionText": "患儿，14岁，体重50kg，体温38.7℃，使用布洛芬退热，单次给药剂量是", "option": ["A. 200—400mg", "B. 500—1000mg", "C. 300—600mg", "D. 10—15mg", "E. 100—150mg"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_625", "questionText": "患儿，1岁，体重10kg，体温39℃使用对乙酰氨基酚退热，单次给药剂量是", "option": ["A. 200—400mg", "B. 500—1000mg", "C. 300—600mg", "D. 10—15mg", "E. 100—150mg"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_626", "questionText": "患者，男，62岁，临床使用青蒿素和乙胺嘧啶联合治疗疟疾，产生的药物相互作用属于", "option": ["A. 敏感化作用，药品不良反应增加", "B. 降低抗药性，疗效增加", "C. 拮抗作用，药品不良反应增加", "D. 增加靶器官药物浓度，药品不良反应减少", "E. 拮抗作用，药品不良反应减少"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_627", "questionText": "患者，男，71岁，因高血压、心力衰竭给予氢氯噻嗪、地高辛等治疗，产生的药物相互作用属于", "option": ["A. 敏感化作用，药品不良反应增加", "B. 降低抗药性，疗效增加", "C. 拮抗作用，药品不良反应增加", "D. 增加靶器官药物浓度，药品不良反应减少", "E. 拮抗作用，药品不良反应减少"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_628", "questionText": "患者，男，82岁，诊断为帕金森病，给予左旋多巴联合卡比多巴治疗，产生的药物相互作用属于", "option": ["A. 敏感化作用，药品不良反应增加", "B. 降低抗药性，疗效增加", "C. 拮抗作用，药品不良反应增加", "D. 增加靶器官药物浓度，药品不良反应减少", "E. 拮抗作用，药品不良反应减少"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_629", "questionText": "药师应掌握处方中常用的外文缩写，“必要时”长期用药的缩写是", "option": ["A. qid", "B. qn", "C.  Prn", "D. qd", "E. q4h"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_630", "questionText": "药师应掌握处方中常用的外文缩写，“每晚”用药的缩写是", "option": ["A. qid", "B. qn", "C.  Prn", "D. qd", "E. q4h"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_631", "questionText": "患者，男，69岁，因高血压长期服用抗高血压药，近日患者出现足踝部水肿，可引起此不良反应的药物是", "option": ["A. 普萘洛尔", "B. 非洛地平", "C. 卡托普利", "D. 多沙唑嗪", "E. 氢氯噻嗪"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_632", "questionText": "患者，男，65岁，诊断为高血压2级，同时有哮喘病史，不宜选用的药物是", "option": ["A. 普萘洛尔", "B. 非洛地平", "C. 卡托普利", "D. 多沙唑嗪", "E. 氢氯噻嗪"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_633", "questionText": "患者，女，48岁，因进食高蛋白食物过多导致消化不良、胃胀气到药店购药，药师应推荐的药品是", "option": ["A. 多潘立酮片", "B. 酵母片", "C. 乳酶生片", "D. 甲氧氯普胺片", "E. 铝碳酸镁咀嚼片"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_634", "questionText": "患者，女，60岁，因胃食管反流病而致腹痛来药店购药，药师应推荐的药品是", "option": ["A. 多潘立酮片", "B. 酵母片", "C. 乳酶生片", "D. 甲氧氯普胺片", "E. 铝碳酸镁咀嚼片"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_635", "questionText": "患者，男，53岁，因纳差、食欲减退来药店购药，药师应推荐的药品是", "option": ["A. 多潘立酮片", "B. 酵母片", "C. 乳酶生片", "D. 甲氧氯普胺片", "E. 铝碳酸镁咀嚼片"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_636", "questionText": "举重运动员使用后，可短时间内急速降低体重，因此需按兴奋剂管理的药物是", "option": ["A. 缬沙坦", "B. 呋塞米", "C. 普茶洛尔", "D. 硝苯地平", "E. 卡托普利"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_637", "questionText": "射击运动员使用后，可减慢心率，减少心肌耗氧量，消除比赛前紧张心理，因此被列入兴奋剂管理的药物是", "option": ["A. 缬沙坦", "B. 呋塞米", "C. 普茶洛尔", "D. 硝苯地平", "E. 卡托普利"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_638", "questionText": "患者，女，47岁，出现一侧颜面部骤然发作性闪痛，诊断为三叉神经痛，应选用的药物是", "option": ["A. 山莨菪碱", "B. 布洛芬", "C. 麦角胺咖啡因", "D. 卡马西平", "E. 吗啡"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_639", "questionText": "患者，女，25岁，痛经，应选用的药物是", "option": ["A. 山莨菪碱", "B. 布洛芬", "C. 麦角胺咖啡因", "D. 卡马西平", "E. 吗啡"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_640", "questionText": "患者，男，38岁，因腹部受寒致胃痉挛性疼痛，应选用的药物是", "option": ["A. 山莨菪碱", "B. 布洛芬", "C. 麦角胺咖啡因", "D. 卡马西平", "E. 吗啡"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": ""}
{"questionType": "单选题", "questionId": "dev_641", "questionText": "该患者住院后的抗感染治疗应选用的药物是", "option": ["A. 氨苄西林", "B. 莫西沙星", "C. 阿莫西林", "D. 头孢吡肟", "E. 美罗培南"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": "（一）患者，男，58岁，体重68kg，高血压病史5年，5天前出现咳嗽、咳痰伴发热。入院查体：BP 120/80mmHg，T 38.9℃。化验结果：白细胞计数14.6×109/L，中性粒细胞百分比86%。X线胸片：右下肺纹理增粗，诊断为社区获得性肺炎。青霉素皮试阳性。"}
{"questionType": "单选题", "questionId": "dev_642", "questionText": "患者经过治疗5天后，咳嗽、咳痰稍减轻，仍有发热，体温波动于37.8~38.6℃之间，化验结果：白细胞计数11.9×109/L，中性粒细胞百分比79%；痰培养结果为铜绿假单胞菌，该患者抗感治疗药物应调整为", "option": ["A. 哌拉西林", "B. 头孢曲松", "C. 阿奇霉素", "D. 头孢他啶", "E. 万古霉素"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": "患者，男，58岁，体重68kg，高血压病史5年，5天前出现咳嗽、咳痰伴发热。入院查体：BP 120/80mmHg，T 38.9℃。化验结果：白细胞计数14.6×109/L，中性粒细胞百分比86%。X线胸片：右下肺纹理增粗，诊断为社区获得性肺炎。青霉素皮试阳性。"}
{"questionType": "单选题", "questionId": "dev_643", "questionText": "某女士，从另一种避孕方式(复方口服激素避孕药、阴道环或者透皮貼剂避孕)，改为服用题干阐述材料所示的避孕药复方制剂进行避孕，其用法错误的是", "option": ["A. 在取出最后一个阴道环的当日开始服用本品", "B. 在取出最后一个周期包中的透皮贴剂的当天开始服用本品", "C. 在服用以前所用的另一种复方口服激素避孕药的停药期末开始服用本品", "D. 在服用前一种复方口服激素避孕药最后一片的当日开始服用本品", "E. 在前一种不含激素的避孕药的使用期末开始服用本品"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": "（二）某避孕药复方制剂，其成分为：每片含屈螺酮3mg和炔雌醇0.03mg。说明书部分内容节选如下，请在仔细阅读后回答问题。【用法用量】部分注明如下内容：开始服药前，未使用激素避孕药的妇女(过去一个月)应该在妇女自然月经周期的第1天开始服药(即月经出血的第1天)。也可以在第2~5天开始，这种情况下，推荐在第一个服药周期的最初7天内，加用屏障避孕法。从另一种复方激素避孕药[复方口服避孕药（COC）]，缓释阴道环或者透皮贴剂改服的妇女，最好在服用以前所用的COC最后一片含激素药物后，第2天即开始服用本品，最晚应在以前所用COC的停药期末或使用不含激素药物期末立即开始服用本品。对于曾经使用过阴道环或透皮贴剂的妇女，最好在取出最后一个阴道环或者周期包中的透皮贴剂的当日开始服用本品，但最晚不迟于下一次应使用阴道环或透皮贴剂的当日开始服用本品。早期妊娠流产后的妇女，可以立即开始服药。在这种情况下，未加用其他避孕方法。分娩后或者中期妊娠流产后，应建议妇女在分娩后或中期妊娠流产后第21~28天开始服用。如果开始较晚，应建议妇女在服药的最初7天内加用屏障避孕法。然而，如果已经发生性行为，应该先除外妊娠的可能性后再开始服用本品，或者需要等第一次月经来潮时再服用。【漏服药的处理】部分注明如下内容。如果使用者忘记服药的时间在12小时以内，避孕保护作用不会降低。一旦妇女想起，就必须立即补服，下一片药物应在常规时间服用。如果忘记服药的时间超过12小时，避孕保护作用可能降低。漏服药的处理可遵循以下两项基本原则。⑴在任何情况下停止服药不能超过7天。⑵需要不间断地连服7天，以保持对下丘脑-垂体-卵巢轴的充分抑制。因此在日常服药中可给出如下建议。第1周 使用者应该在想起来时尽快服用漏服的药片，即使意味着同时服用两片药。然后在常规时间继续服药。此外，在以后的7天内要加用屏障避孕法如避孕套。如果此前7天内已发生性行为，应考虑有妊娠的可能。漏服的药片越多并且越接近常规的停药期，发生妊娠的风险越高。第2周 使用者应该在想起来时尽快服用漏服的药片，即使这意味着同时服用两片药。然后在常规的时间继续服药。假若使用者在第1片漏服药的前7天内均正确服药，则不需要加用额外的避孕措施。但是，如果不是这种情况，或者漏服药不止1片，那么应建议其加用额外的避孕措施7天。第3周 因为临近停药期，所以避孕可靠性降低的风险加大。然而，通过调整服药计划，仍可防止避孕保护作用的降低。假如妇女在漏服第1片药的前7天内均正确服药，则遵照以下两项建议的任一项，使用者没有必要采用额外的避孕措施。但是，如果不是这种情况，建议妇女遵照以下两项建议的第一项，并在以后的7天内加用额外的避孕措施。①使用者应该在想起来时尽快服用漏服的药片，即使这意味着同时服用两片药。然后在常规时间继续服药。一盒药服完后立即开始服用下盒药，即两盒药之间没有停药期。使用者在服完第二盒药之前，撤退性出血的发生可能性较低，但可能在服药期间出现点滴淋漓性不规则阴道流血或突破性出血。②还可以建议妇女不再继续服用此周期药物。该妇女应该经过7天的停药期，其中包括漏服的天数，然后再开始继续服用下一周期的药物。如果妇女漏服了药物，而且在随后的第一个正常停药间隔期未出现撤退性出血，则应考虑妊娠的可能性。【对发生胃肠道素乱者的建议】部分注明如下内容。如果发生重度胃肠道紊乱，则药物吸收可能不完全，应采取额外的避孕措施。如果服用药物后3~4小时内发生呕吐，可以采用【漏服药的处理】并参见【用法用量】的建议。如果妇女不想改变正常的服药计划，她必须从另一盒中取出药物补服。"}
{"questionType": "单选题", "questionId": "dev_644", "questionText": "假如某女士在2018年4月15日20:00开始服用新一周期的药物，在4月25日20：00发现4月24日应服的药片漏服，之前均正确服药。在这种情况下，患者对漏服药的处理，正确的是", "option": ["A. 在常规时间20：00服用4月25日的药片，不用补服4月24日的药片", "B. 尽快同时服用两片药，然后在常规时间继续服药，在以后的7天内要加用屏障避孕法", "C. 不再继续服用此周期药物，经过一个7天的停药期，再开始继续服用下一周期的药物", "D. 尽快同时服用两片药，然后在常规时间继续服药，不需要加用额外的避孕措施", "E. 尽快同时服用两片药，然后在常现时间继续服药，一盒药服完后立即开始服用下一盒药，即两盒药之间没有停药期"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": "某避孕药复方制剂，其成分为：每片含屈螺酮3mg和炔雌醇0.03mg。说明书部分内容节选如下，请在仔细阅读后回答问题。【用法用量】部分注明如下内容：开始服药前，未使用激素避孕药的妇女(过去一个月)应该在妇女自然月经周期的第1天开始服药(即月经出血的第1天)。也可以在第2~5天开始，这种情况下，推荐在第一个服药周期的最初7天内，加用屏障避孕法。从另一种复方激素避孕药[复方口服避孕药（COC）]，缓释阴道环或者透皮贴剂改服的妇女，最好在服用以前所用的COC最后一片含激素药物后，第2天即开始服用本品，最晚应在以前所用COC的停药期末或使用不含激素药物期末立即开始服用本品。对于曾经使用过阴道环或透皮贴剂的妇女，最好在取出最后一个阴道环或者周期包中的透皮贴剂的当日开始服用本品，但最晚不迟于下一次应使用阴道环或透皮贴剂的当日开始服用本品。早期妊娠流产后的妇女，可以立即开始服药。在这种情况下，未加用其他避孕方法。分娩后或者中期妊娠流产后，应建议妇女在分娩后或中期妊娠流产后第21~28天开始服用。如果开始较晚，应建议妇女在服药的最初7天内加用屏障避孕法。然而，如果已经发生性行为，应该先除外妊娠的可能性后再开始服用本品，或者需要等第一次月经来潮时再服用。【漏服药的处理】部分注明如下内容。如果使用者忘记服药的时间在12小时以内，避孕保护作用不会降低。一旦妇女想起，就必须立即补服，下一片药物应在常规时间服用。如果忘记服药的时间超过12小时，避孕保护作用可能降低。漏服药的处理可遵循以下两项基本原则。⑴在任何情况下停止服药不能超过7天。⑵需要不间断地连服7天，以保持对下丘脑-垂体-卵巢轴的充分抑制。因此在日常服药中可给出如下建议。第1周 使用者应该在想起来时尽快服用漏服的药片，即使意味着同时服用两片药。然后在常规时间继续服药。此外，在以后的7天内要加用屏障避孕法如避孕套。如果此前7天内已发生性行为，应考虑有妊娠的可能。漏服的药片越多并且越接近常规的停药期，发生妊娠的风险越高。第2周 使用者应该在想起来时尽快服用漏服的药片，即使这意味着同时服用两片药。然后在常规的时间继续服药。假若使用者在第1片漏服药的前7天内均正确服药，则不需要加用额外的避孕措施。但是，如果不是这种情况，或者漏服药不止1片，那么应建议其加用额外的避孕措施7天。第3周 因为临近停药期，所以避孕可靠性降低的风险加大。然而，通过调整服药计划，仍可防止避孕保护作用的降低。假如妇女在漏服第1片药的前7天内均正确服药，则遵照以下两项建议的任一项，使用者没有必要采用额外的避孕措施。但是，如果不是这种情况，建议妇女遵照以下两项建议的第一项，并在以后的7天内加用额外的避孕措施。①使用者应该在想起来时尽快服用漏服的药片，即使这意味着同时服用两片药。然后在常规时间继续服药。一盒药服完后立即开始服用下盒药，即两盒药之间没有停药期。使用者在服完第二盒药之前，撤退性出血的发生可能性较低，但可能在服药期间出现点滴淋漓性不规则阴道流血或突破性出血。②还可以建议妇女不再继续服用此周期药物。该妇女应该经过7天的停药期，其中包括漏服的天数，然后再开始继续服用下一周期的药物。如果妇女漏服了药物，而且在随后的第一个正常停药间隔期未出现撤退性出血，则应考虑妊娠的可能性。【对发生胃肠道素乱者的建议】部分注明如下内容。如果发生重度胃肠道紊乱，则药物吸收可能不完全，应采取额外的避孕措施。如果服用药物后3~4小时内发生呕吐，可以采用【漏服药的处理】并参见【用法用量】的建议。如果妇女不想改变正常的服药计划，她必须从另一盒中取出药物补服。"}
{"questionType": "单选题", "questionId": "dev_645", "questionText": "假如某女士在2018年5月15日20：00开始服用新一周期的药物，5月20日患者服用该药后3小时左右发生明显呕吐，对患者的用药建议是", "option": ["A. 到5月21日20：00再同时服用两片药，然后在常规时间继续服药", "B. 尽快补服一片，然后在常规时间继续服药", "C. 尽快同时服用两片药，然后在常规时间继续服药，在以后的7天内要加用屏障避孕法", "D. 不再继续服用此周期药物，经过一个7天的停药期，再开始继续服用下一周期的药物", "E. 尽快同时服用两片药，然后在常规时间继续服药，不需要使用额外的避孕措施"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": "某避孕药复方制剂，其成分为：每片含屈螺酮3mg和炔雌醇0.03mg。说明书部分内容节选如下，请在仔细阅读后回答问题。【用法用量】部分注明如下内容：开始服药前，未使用激素避孕药的妇女(过去一个月)应该在妇女自然月经周期的第1天开始服药(即月经出血的第1天)。也可以在第2~5天开始，这种情况下，推荐在第一个服药周期的最初7天内，加用屏障避孕法。从另一种复方激素避孕药[复方口服避孕药（COC）]，缓释阴道环或者透皮贴剂改服的妇女，最好在服用以前所用的COC最后一片含激素药物后，第2天即开始服用本品，最晚应在以前所用COC的停药期末或使用不含激素药物期末立即开始服用本品。对于曾经使用过阴道环或透皮贴剂的妇女，最好在取出最后一个阴道环或者周期包中的透皮贴剂的当日开始服用本品，但最晚不迟于下一次应使用阴道环或透皮贴剂的当日开始服用本品。早期妊娠流产后的妇女，可以立即开始服药。在这种情况下，未加用其他避孕方法。分娩后或者中期妊娠流产后，应建议妇女在分娩后或中期妊娠流产后第21~28天开始服用。如果开始较晚，应建议妇女在服药的最初7天内加用屏障避孕法。然而，如果已经发生性行为，应该先除外妊娠的可能性后再开始服用本品，或者需要等第一次月经来潮时再服用。【漏服药的处理】部分注明如下内容。如果使用者忘记服药的时间在12小时以内，避孕保护作用不会降低。一旦妇女想起，就必须立即补服，下一片药物应在常规时间服用。如果忘记服药的时间超过12小时，避孕保护作用可能降低。漏服药的处理可遵循以下两项基本原则。⑴在任何情况下停止服药不能超过7天。⑵需要不间断地连服7天，以保持对下丘脑-垂体-卵巢轴的充分抑制。因此在日常服药中可给出如下建议。第1周 使用者应该在想起来时尽快服用漏服的药片，即使意味着同时服用两片药。然后在常规时间继续服药。此外，在以后的7天内要加用屏障避孕法如避孕套。如果此前7天内已发生性行为，应考虑有妊娠的可能。漏服的药片越多并且越接近常规的停药期，发生妊娠的风险越高。第2周 使用者应该在想起来时尽快服用漏服的药片，即使这意味着同时服用两片药。然后在常规的时间继续服药。假若使用者在第1片漏服药的前7天内均正确服药，则不需要加用额外的避孕措施。但是，如果不是这种情况，或者漏服药不止1片，那么应建议其加用额外的避孕措施7天。第3周 因为临近停药期，所以避孕可靠性降低的风险加大。然而，通过调整服药计划，仍可防止避孕保护作用的降低。假如妇女在漏服第1片药的前7天内均正确服药，则遵照以下两项建议的任一项，使用者没有必要采用额外的避孕措施。但是，如果不是这种情况，建议妇女遵照以下两项建议的第一项，并在以后的7天内加用额外的避孕措施。①使用者应该在想起来时尽快服用漏服的药片，即使这意味着同时服用两片药。然后在常规时间继续服药。一盒药服完后立即开始服用下盒药，即两盒药之间没有停药期。使用者在服完第二盒药之前，撤退性出血的发生可能性较低，但可能在服药期间出现点滴淋漓性不规则阴道流血或突破性出血。②还可以建议妇女不再继续服用此周期药物。该妇女应该经过7天的停药期，其中包括漏服的天数，然后再开始继续服用下一周期的药物。如果妇女漏服了药物，而且在随后的第一个正常停药间隔期未出现撤退性出血，则应考虑妊娠的可能性。【对发生胃肠道素乱者的建议】部分注明如下内容。如果发生重度胃肠道紊乱，则药物吸收可能不完全，应采取额外的避孕措施。如果服用药物后3~4小时内发生呕吐，可以采用【漏服药的处理】并参见【用法用量】的建议。如果妇女不想改变正常的服药计划，她必须从另一盒中取出药物补服。"}
{"questionType": "单选题", "questionId": "dev_646", "questionText": "患者用药中，用法用量错误的是", "option": ["A. 二甲双胍片0.5g tid po", "B. 格列美脲片2mg tid po", "C. 罗格列酮片2mg bid po", "D. 甲钴胺片0.5 mg tid po", "E. 羟苯磺酸钙软胶囊250mg bid po"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": "（三）患者，女，71岁，2型糖尿病史10年。化验结果：糖化血红蛋白(HbAlc)9.2%，空腹血糖10.5mmol/L，餐后血糖15.5mmol/L。目前服用二甲双胍片0.5g tid po，格列美脲片2mg tid po，罗格列酮片2mg bid po，甲钴胺片0.5mg tid po，羟苯磺酸钙胶囊250mg bid po。"}
{"questionType": "单选题", "questionId": "dev_647", "questionText": "针对患者病情，临床加用胰岛素治疗，应选用的治疗方案是", "option": ["A. 门冬胰岛素，餐前30~60min，皮下注射，tid", "B. 甘精胰岛素，睡前30min，皮下注射，qd", "C. 普通胰岛素，餐前30min，皮下注射，qd", "D. 低精蛋白锌胰岛素，餐前30mn，皮下注射tid", "E. 精蛋白锌胰岛素餐前30min，皮下注射，tid"], "year": "2018", "answer": ["B"], "subject": "2018药综", "backgroundText": "患者，女，71岁，2型糖尿病史10年。化验结果：糖化血红蛋白(HbAlc)9.2%，空腹血糖10.5mmol/L，餐后血糖15.5mmol/L。目前服用二甲双胍片0.5g tid po，格列美脲片2mg tid po，罗格列酮片2mg bid po，甲钴胺片0.5mg tid po，羟苯磺酸钙胶囊250mg bid po。"}
{"questionType": "单选题", "questionId": "dev_648", "questionText": "患者在用药过程中，出现心悸、大汗、无力和饥饿感正确的处理方法是", "option": ["A. 立刻喝白开水200mL", "B. 立刻舌下含服硝酸甘油片", "C. 立刻口服糖水或糖块", "D. 立刻服用美托洛尔片", "E. 立刻服用阿卡波糖片"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": "患者，女，71岁，2型糖尿病史10年。化验结果：糖化血红蛋白(HbAlc)9.2%，空腹血糖10.5mmol/L，餐后血糖15.5mmol/L。目前服用二甲双胍片0.5g tid po，格列美脲片2mg tid po，罗格列酮片2mg bid po，甲钴胺片0.5mg tid po，羟苯磺酸钙胶囊250mg bid po。"}
{"questionType": "单选题", "questionId": "dev_649", "questionText": "对该患者注射胰岛素制剂的注意事项和用药指导的说法，正确的是", "option": ["A. 在注射胰岛素制剂时，针头可重复使用", "B. 未使用的胰岛素可以冷冻保存", "C. 注射胰岛素制剂时，应变换注射部位，两次注射点要间隔2cm", "D. 开启的胰岛素需要冷藏保存", "E. 使用中的胰岛素笔芯可以室温保存8周"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": "患者，女，71岁，2型糖尿病史10年。化验结果：糖化血红蛋白(HbAlc)9.2%，空腹血糖10.5mmol/L，餐后血糖15.5mmol/L。目前服用二甲双胍片0.5g tid po，格列美脲片2mg tid po，罗格列酮片2mg bid po，甲钴胺片0.5mg tid po，羟苯磺酸钙胶囊250mg bid po。"}
{"questionType": "单选题", "questionId": "dev_650", "questionText": "药师审核医嘱认为存在不合理用药，其分析理由和结论，下列说法正确的是", "option": ["A. 左氧氟沙星片给药间隔不合理", "B. 氨溴索片给药剂量不合理", "C. 阿司匹林泡腾片给药剂量不合理", "D. 维生素C片用法用量不合理", "E. 板蓝根冲剂给药间隔不合理"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": "（四）患者，女，49岁，近日因发热、咳嗽、咳黄痰就诊，临床诊断为下细菌性上呼吸道感染感染，医师处方如下：左氧氟沙星片0.5 g tid po、氨溴索片30 mg tid、阿司匹林泡腾片0.5gprn冲服、维生素C片0.2 g tid po、板蓝根冲剂1袋 tid po"}
{"questionType": "单选题", "questionId": "dev_651", "questionText": "服药1周后患者出现上腹疼痛，大便呈黑色经胃镜检查诊断为胃溃疡。可能引起该患者胃溃疡的药物是", "option": ["A. 阿司匹林泡腾片", "B. 左氧氟沙星片", "C. 氨溴索片", "D. 维生素C片", "E. 板蓝根冲剂"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": "（四）患者，女，49岁，近日因发热、咳嗽、咳黄痰就诊，临床诊断为下细菌性上呼吸道感染感染，医师处方如下：左氧氟沙星片0.5 g tid po、氨溴索片30 mg tid、阿司匹林泡腾片0.5gprn冲服、维生素C片0.2 g tid po、板蓝根冲剂1袋 tid po"}
{"questionType": "单选题", "questionId": "dev_652", "questionText": "患者Hp(+)，采用了PPI、克拉霉素，甲硝唑、铋剂的方案治疗。关于该患者的用药指导的说法，正确的是", "option": ["A. 质子泵抑制剂餐后服用", "B. 甲硝唑餐前服用", "C. 甲硝唑餐后服用", "D. 铋剂餐后服用", "E. 铋剂餐中服用"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": "（四）患者，女，49岁，近日因发热、咳嗽、咳黄痰就诊，临床诊断为下细菌性上呼吸道感染感染，医师处方如下：左氧氟沙星片0.5 g tid po、氨溴索片30 mg tid、阿司匹林泡腾片0.5gprn冲服、维生素C片0.2 g tid po、板蓝根冲剂1袋 tid po"}
{"questionType": "单选题", "questionId": "dev_653", "questionText": "在服用PPI、克拉霉素、甲硝唑、铋剂等药物时，下列注意事项中，错误的是", "option": ["A. 用牛奶服药，减少对胃肠道的刺激", "B. 服药期间及停药一周内，避免饮用含酒精饮品", "C. 服药时避免与钙片同服，以免影响药物的作用", "D. 服药期间，可能会发生便秘", "E. 服药期间，大便颜色可能会变成黑色"], "year": "2018", "answer": ["A"], "subject": "2018药综", "backgroundText": "（四）患者，女，49岁，近日因发热、咳嗽、咳黄痰就诊，临床诊断为下细菌性上呼吸道感染感染，医师处方如下：左氧氟沙星片0.5 g tid po、氨溴索片30 mg tid、阿司匹林泡腾片0.5gprn冲服、维生素C片0.2 g tid po、板蓝根冲剂1袋 tid po"}
{"questionType": "单选题", "questionId": "dev_654", "questionText": "对急性期焦虑的治疗，首选的药物是", "option": ["A. 5-羟色胺和去甲肾上腺素再摄取抑制剂", "B. 选择性5—羟色胺再摄取抑制剂", "C. 三环类抗抑郁药", "D. 苯二氮卓类药物", "E. 单胺氧化酶抑制剂"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": "（五）患者，女，75岁，近来因家庭变故出现焦虑相关的精神和躯体症状，入睡困难，多梦易惊醒，诊断为焦虑症。核查其用药记录，患者在服用氨氯地平、阿托伐他汀钙。"}
{"questionType": "单选题", "questionId": "dev_655", "questionText": "老年人使用104题所选择抗焦虑药物时，需要关注的风险是", "option": ["A. 极度烦躁不安的自伤和伤人行为", "B. 心悸、震颤", "C. 可致宿醉现象，容易跌倒", "D. 体重增加", "E. 5-羟色胺综合征"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": "患者，女，75岁，近来因家庭变故出现焦虑相关的精神和躯体症状，入睡困难，多梦易惊醒，诊断为焦虑症。核查其用药记录，患者在服用氨氯地平、阿托伐他汀钙。"}
{"questionType": "单选题", "questionId": "dev_656", "questionText": "该患者首选的治疗方案是", "option": ["A. 华法林3 mg st po", "B. 氯吡格雷片75 mg qd po", "C. 阿司匹林肠溶片100 mg qd po", "D. 阿司匹林300 mg st po", "E. 注射用阿替普酶09mg/kg iv"], "year": "2018", "answer": ["E"], "subject": "2018药综", "backgroundText": "（六）患者，男58岁，高血压病史5年；吸烟史40年，日均40支。2小时前出现左侧肢体无力，并逐渐加重，不能站立；家属发现其说话迟钝、言语含混，右侧鼻唇沟变浅，意识清楚。急送医院急诊，BP 190/120mmHg；血常规基本正常；头颅CT检查未见高密度病灶。诊断为急性脑梗死。"}
{"questionType": "单选题", "questionId": "dev_657", "questionText": "治疗过程中患者出现颅内压升高，此时应用的治疗方案是", "option": ["A. 呋塞米片20mg qd po", "B. 甘油果糖注射液500mg bid iv gtt", "C. 甘露醇注射液250ml q6h ⅳ gtt", "D. 尼莫地平注射液200mg qd iv gtt", "E. 依达拉奉注射液30 mg bid ⅳ"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": "患者，男58岁，高血压病史5年；吸烟史40年，日均40支。2小时前出现左侧肢体无力，并逐渐加重，不能站立；家属发现其说话迟钝、言语含混，右侧鼻唇沟变浅，意识清楚。急送医院急诊，BP 190/120mmHg；血常规基本正常；头颅CT检查未见高密度病灶。诊断为急性脑梗死。"}
{"questionType": "单选题", "questionId": "dev_658", "questionText": "经过对症支持治疗，患者恢复良好，出院后应接受的长期预防药物的首选是", "option": ["A. 华法林片3 mg qd po", "B. 阿司匹林肠溶片300 mg qd po", "C. 阿司匹林肠溶片100 mg qd po", "D. 氯吡格雷片75 mg qd po", "E. 氯吡格雷片150 mg qd po"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": "患者，男58岁，高血压病史5年；吸烟史40年，日均40支。2小时前出现左侧肢体无力，并逐渐加重，不能站立；家属发现其说话迟钝、言语含混，右侧鼻唇沟变浅，意识清楚。急送医院急诊，BP 190/120mmHg；血常规基本正常；头颅CT检查未见高密度病灶。诊断为急性脑梗死。"}
{"questionType": "单选题", "questionId": "dev_659", "questionText": "与该患者出现脱发，体重增加、胃肠道功能紊乱关联性较大的抗癫痫药物是", "option": ["A. 地西泮", "B. 卡马西平", "C. 丙戊酸钠", "D. 苯巴比妥", "E. 苯妥英钠"], "year": "2018", "answer": ["C"], "subject": "2018药综", "backgroundText": "（七）患者，女，45岁，5个月前因出现口吐白沫、意识丧失、二便失禁。在神经专科医生指导下进行抗癫痫药物治疗监测效果较好。近3个月服用西咪替丁，患者出现脱发、体重增加、胃肠道功能素乱。该患者各地求医，服用各种药物，具体药物品种不详。围绕该病例，药师与医师对抗癫痫药的安全用药和用药事项进行用药讨论"}
{"questionType": "单选题", "questionId": "dev_660", "questionText": "关于抗癫痫药患者的抗癫痫药物合理应用与药学监护，下列说法错误的是", "option": ["A. 长期规律用药", "B. 定期监测肝功能、血常规", "C. 有条件者应监测血药浓度", "D. 遵从联合治疗原则", "E. 因病情需要必须合并服用其他药物时，应先咨询医师或药师，切忌自行用药"], "year": "2018", "answer": ["D"], "subject": "2018药综", "backgroundText": "患者，女，45岁，5个月前因出现口吐白沫、意识丧失、二便失禁。在神经专科医生指导下进行抗癫痫药物治疗监测效果较好。近3个月服用西咪替丁，患者出现脱发、体重增加、胃肠道功能素乱。该患者各地求医，服用各种药物，具体药物品种不详。围绕该病例，药师与医师对抗癫痫药的安全用药和用药事项进行用药讨论"}
